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ABSTRACT
HYALURONATE LYASE GENE OF STREPTOCOCCUS PYOGENES: 
MOLECULAR CHARACTERIZATION AND REGULATION
Sheryl Lynne Walton 
Old Dominion University, 2003 
Director: Dr. Wayne Hynes
Streptococcus pyogenes causes an assortment of diseases ranging from 
pharyngitis to necrotizing fasciitis. This bacterium has the ability to elaborate 
several extracellular products capable of causing tissue damage; one of which is 
a hyaluronate lyase. Little information is available regarding the regulation of 
streptococcal hyaluronidase. As such, the expression of hylA in the hyaluronate 
lyase-producing strain ATCC 10403 and in strains that do not produce detectable 
enzyme was analyzed by RT-PCR and quantitative PCR. Hyaluronate lyase 
transcript was detected throughout growth for all strains; however, expression of 
hylA in the enzymatically inactive strains, 71698 and SF370, was determined to 
have a different pattern of expression than that of the active strain 10403.
The effect of various environmental conditions on hylA expression was 
evaluated. Temperature had little effect on the relative amount of hylA transcript 
for strain 10403. However, hylA expression was slightly decreased after growth 
in pH 5.0 and increased under anaerobic and increased carbon dioxide 
conditions. The presence of hyaluronic acid in the growth media resulted in a 
two-fold increase in hylA expression. However, no difference was detected in 
the titer of enzymatic activity.
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Expression of hylA and hasA were examined for the hyaluronate lyase 
non-producing strain 71698; and indicated the relative amount of hasA transcript 
was considerably greater than that of hylA.
Also, 176 strains of S. pyogenes were screened by PCR for hylA'and 
showed all contained the gene; however, 34 strains showed a decrease in the 
size of the 3’ region. The 3’ region was PCR amplified, cloned, and the 
sequence determined from six of these 34 strains. Comparison of the 
sequences revealed a deletion of 183 bp in the same location in all six strains.
A preliminary analysis of the role of hyaluronate lyase in streptococcal 
infection was evaluated. Preliminary data suggests hyaluronate lyase to be an 
important virulence factor as was determined by a 5.7% reversion of single­
recombinant mutant strain 10403::pHAS:/?y/A from a HylA-negative to a HylA- 
positive phenotype.
For future virulence studies, an isogenic mutant strain 1Q403A/?y/A was 
created by replacing an internal portion of hylA with erythromycin resistance 
gene (ermR). Inactivation of hyaluronate lyase did not affect growth or protease 
or hemolytic activities.
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1INTRODUCTION
Streptococcus pyogenes. Streptococcus pyogenes is a Gram-positive, 
non-endospore forming, facultatively anaerobic, coccus that is classified in the 
family Streptococcaceae. The term “streptococcos” was initially used by Billroth 
in 1874 to describe chain-forming, spherical shaped bacteria that he isolated 
from the wounds of animals (16). The term, however, was merely used as a 
descriptive term for the congregation in which the bacterial cells were most 
found. A decade later, Streptococcus was first used by Rosenbach as the genus 
name to describe chain-forming cocci, which he isolated from suppurative 
lesions in man; Rosenbach named these cocci Streptococcus pyogenes (135).
Since the initial naming of S. pyogenes by Rosenbach, the classification 
of the organism as well as other streptococci has taken many turns over the past 
century. The first definitive classification came in 1906 when Andrewes and 
Horder (2) classified streptococci into eight separate groups based on the 
carbohydrate fermentation capabilities, morphological observations, and the 
characteristics of the streptococci when grown on milk.
Based on Andrewes and Horder’s assessment, S. pyogenes was 
classified in a group by itself, and was separate from S. equinus, S. mitis, S. 
salivarius, S. faecalis, and the pneumococci (2). This classification was modified 
in 1937 by Sherman (141), who divided the streptococci into four main groups:
The model for this dissertation is the journal Infection and Immunity.
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Pyogenic, Viridans, Lactic, and Enterococcus. S. pyogenes was incorporated in 
the pyogenic division as it adhered to the criteria of being pathogenic to man, p- 
hemolytic, and contained a group polysaccharide that could be isolated by the 
Lancefield precipitin technique (84).
Prior to the classification set forth by Sherman, it was determined by 
Hitchcock in 1924 that a ‘residue antigen’ was common among all streptococci 
(68). This antigen was examined further by Lancefield who grouped the 
streptococci by the presence of specific group polysaccharides or “C” 
substances, which could be precipitated by fairly simple techniques (91). Based 
on this finding, Lancefield categorized both hemolytic and non-hemolytic 
streptococci into groups A to E and N (91). A correlation was seen between the 
categories set forth by Lancefield and those outlined by Sherman, such that most 
serological groups could be equated with particular species. For example, group 
A streptococci were synonymous with strains of S. pyogenes. Since 
Lancefield’s initial grouping into groups Ato E and N, there have been additional 
groups (F, G, H, K, L, M, O, P, Q, R, S, T, U, V) formed based on further 
characterization of the streptococci (84). Lancefield’s classification was ideal in 
its simplicity; however, for purposes of specificity it was also necessary to 
analyze the biochemical activities for distinguishing the different groups of 
streptococci.
Among the groups determined through the Lancefield serological grouping 
and biochemical analyses, several are known to cause disease in humans, 
including groups A, B, C, D, and G. Group B streptococci are associated with
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
bacterial endocarditis and neonatal meningitis; groups C and G are associated 
with pharyngitis (126). Perhaps the most pathogenic to humans and quite 
possibly the most dynamic of the different groups of streptococci is the group A 
streptococcus, S. pyogenes. S. pyogenes is the causative agent for a plethora 
of inflammatory infections, including pharyngitis, impetigo, scarlet fever, toxic 
shock-like syndrome, cellulitis, necrotizing fasciitis, as well as the delayed 
sequelae rheumatic fever and post-streptococcal glomerulonephritis. In recent 
years, group A streptococci have also been suggested to be associated with 
Tourette’s syndrome, attention deficit disorders, and obsessive compulsive 
disorders (54).
S. pyogenes has caused disease for centuries, having been documented 
as causing scarlet fever epidemics as early as the 1600’s (152). Although the 
organism has been ever-present and remains sensitive to penicillin, there has 
been an unexplained reemergence of rheumatic fever, as well as, the 
emergence of streptococcal toxic shock syndrome and invasive group A 
streptococcal skin and soft tissue infections since the 1980’s (85). Perhaps the 
most devastatingly damaging, and possibly the most frightening streptococcal 
infection that has reemerged in the past few decades is necrotizing fasciitis 
(151), a severe, invasive soft tissue infection that may result in debilitation or 
possibly death. The severely invasive forms of streptococcal infection prompted 
the Weekly World News and The National Examiner to run headlines in 1994 
such as “Killer Bug Ate My Face,” “Flesh-Eating Virus Invades the US,” “Watch 
for Killer Bug.” Headlines such as these, combined with text in the articles such
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as “...streptomania hits home...,” “...get eaten to death...,” and “...strepto- 
death...” struck fear and panic into the hearts of many. The severity and the 
bizarreness of the flesh-eating infections has even led such shows as “The X- 
files” to describe an unknown death in one episode as having been caused by a 
“...deadly, flesh-eating group A streptococcal infection that resulted in the loss of 
the victim’s face.” In 1998, Guinness World Book of Records anointed S. 
pyogenes “the world’s most dangerous bug” due to its ability to cause such 
debilitating and fatal infections.
Due to the increased morbidity and mortality, both general and scientific 
media suggested that S. pyogenes had changed in some way to become more 
virulent. No evidence exists to date to corroborate these suggestions. The 
notoriety that developed may in fact be the result of better epidemiological 
studies, which have increased public knowledge of the number of extreme 
streptococcal infections that exist, and may not be a result of changes in the 
bacterium (31).
How S. pyogenes can be the etiological agent for such a wide range of 
diseases is not known; however, studies have suggested that this ability is due to 
the number of extracellular products the bacterium has the potential to elaborate. 
To gain a better understanding of streptococcal infections, the numerous 
products of the bacterium and their role in streptococcal infections must be better 
evaluated and understood. Group A streptococci elaborate a number of 
products that are believed to specifically aid in the infectious process (Fig. 1). 
Although all of these products are potentially important in streptococcal
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
pathogenesis and their role will be discussed briefly, the characteristics and role 
in infection of hyaluronate lyase will be the focus of this work.
Streptococcal virulence factors. Many pathogenic bacteria, including
S. pyogenes, produce extracellular products that have tissue-damaging effects. 
Some of these products may play roles in the pathogenesis of disease by 
facilitating the spread of bacteria or their toxins through tissues. Virulence 
factors secreted by streptococci may act as anti-phagocytic mechanisms, 
spreading factors (substances that increase the permeability of such 
components of connective tissues as fibrin, collagen, and hyaluronic acid (39)), 
or assist in the tissue damage seen during infection.
M protein. M protein is a surface antigen that is anchored in the cell 
membrane and confers antiphagocytic properties to S. pyogenes (48). Studies 
have shown that absence of the M protein gene (emm), resulting in loss of M 
protein, resulted in rapid phagocytosis of cells (140); however, when an emm 
gene was introduced into an M-negative strain, phagocytosis was greatly 
impaired (127). M protein gives antiphagocytic properties by binding to 
complement regulatory protein factor H (129) and fibrinogen (165,166). The 
binding to fibrinogen ultimately results in the acquirement and activation of 
plasminogen, which can later be converted to its active form, plasmin, by 
streptokinase (103). M protein has also been found to enhance vasoactivity 
through the binding of human kininogen, which releases a peptide vaso- 
enhancer, bradykinin (9). Clearly there is an immense role for M protein during
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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FIG. 1. Some of the potential virulence factors produced by group A 
streptococci.
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7the course of streptococcal infection whether it be antiphagocytic, or indirectly as 
a spreading factor. Studies have also shown that immunity to M protein confers 
protection against S. pyogenes infection (32, 33), further evidence to the 
important role of this protein in infection.
Extracellular cysteine protease. One of the important secreted 
virulence factors group A streptococcal (GAS) strains produce is extracellular 
cysteine protease, otherwise known as pyrogenic exotoxin type B (SpeB).
Several pyrogenic exotoxins are produced by GAS that have been implicated in 
the pathogenesis of the severe invasive streptococcal infections including 
necrotizing fasciitis. The pyrogenic exotoxins known to be produced by GAS are 
A, B, C, D, E, F, F, G, H, J and Z (31, 121, 122). These toxins appear to act as 
superantigens in that they interact with major histocompatibility complex (MHC) 
class II and Vp regions of the T lymphocyte receptor to activate T cells, resulting 
in the release of inflammatory cytokines such as tumor necrosis factor and 
gamma interferon (44, 62,122). Although each exotoxin is thought to be 
important during an infection, many studies have focused on SpeB. Recently, 
SpeB was implicated in the pathogenesis of invasive infections. Patients having 
such infections had elevated levels of antibodies against exotoxin B (60). 
Cysteine protease acts directly and indirectly as a spreading factor. This 
protease directly cleaves human extracellular matrix components such as 
fibronectin and virtonectin, which are involved in maintaining the shape of cells 
and the integrity of tissues (87). Furthermore, Burns et al (19) demonstrated that 
SpeB indirectly causes tissue damage by activating a human endothelial cell
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8matrix metailoprotease, a protein involved in the maintenance of proper tissue 
structure and function. Such activity would help the bacteria invade to the 
underlying tissues. SpeB has also been shown to cleave human interleukin 1 (3 
into its active form (86). Vascular permeability is also affected by the activity of 
SpeB through the cleavage of plasma kininogen, which results in the release of 
kinin (104). Kinin increases vascular permeability allowing for the dissemination 
of bacteria throughout the host. SpeB also affects a few group A streptococcal 
virulence factors including hyaluronic acid capsule synthesis (167), streptolysin 
O (130), M protein, protein H, and C5a peptidase (11). Epidemiological and 
sequence analyses have shown that 3 variants of the cysteine protease gene are 
common among isolates from streptococcal infections (153). Further analysis of 
the variants showed a distinct association between one variant of exotoxin B, 
mSpeB2, and the exceedingly virulent M1 strains connected with invasive 
streptococcal infections worldwide (153) The action of SpeB provides a 
mechanism for the streptococci to spread throughout the host, resulting in tissue 
damage and shock-like manifestations associated with some streptococcal 
infections.
Streptolysins O and S. S. pyogenes produces two distinct cytolysins, an 
oxygen-labile streptolysin O (SLO) and oxygen-stable streptolysin S (S IS ) (156). 
Streptolysin S is a potent hemolysin that is part of a nine-gene operon that 
consists of the SLS prepropeptide gene (sagA), genes responsible for the 
proteolytic cleavage of the prepropeptide (sagBCD), cellular immunity (sagE), 
and transport (sagFGHI) (120). When plated on blood agar, (3-hemolysis is seen
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9surrounding the colony; this hemolysis has been primarily attributed to the 
presence of SLS (57). Cells lysed by the action of SIS  are not limited to 
erythrocytes, but also include lymphocytes, polymorphonuclear leukocytes, 
platelets, several tissue culture cell lines, bacterial protoplasts, and intracellular 
organelles such as lysosomes and mitochondria (57). SLS has been suggested 
to be required for the formation of necrotic lesions in mouse models as was 
evidenced by reduced virulence of S. pyogenes following inactivation of the 
gene for SLS, sagA (15). Lesion formation was minimal when compared to wild- 
type strains in a mouse model (15).
Streptolysin O is also a secreted protein that has cytolysin properties and 
is very similar in action to thiol-cytolysins from other pathogenic bacteria, 
including the perfringolysin from Clostridium perfringens, pneumolysin from 
Streptococcus pneumoniae, and the listeriolysin from Listeria monocytogenes (1, 
14, 27,144). SLO has a variety of target cell types including erythrocytes, 
leukocytes, macrophages, platelets, and various cell culture lines. The lysin acts 
by interacting with cholesterol in the host cells to form pores, thereby disrupting 
the osmolar balance (67, 94). When SLO is injected intravenously into mice or 
rabbits, death of the animal results in minutes (7, 72). Inactivation of slo resulted 
in a loss of virulence, as well, as reduced necrosis and mortality when compared 
to infection with wild-type S. pyogenes in a mouse model for invasive 
streptococcal infection (101).
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Streptokinase. Various strains of streptococci secrete streptokinase (18, 
73). The exact role of streptokinase in virulence has not been established, but 
the presence of antibodies to the protein implies that it is produced during an 
infection and therefore, involved in the virulence of the pathogen. Streptokinase 
has been implicated as a spreading factor, though the action as a spreading 
factor is indirect. Although streptokinase is not an active protease and has no 
inherent enzymatic activity, it triggers a protease-like reaction (41,106,107). The 
primary activity known to be associated with the molecule is the species-specific 
activation of human blood plasminogen to plasmin (3). The exact biochemical 
mechanisms the protein uses is unknown; however, it is known that by 
stoichiometrically binding plasminogen, a conformational change and self­
cleavage of plasminogen at a specific arginine-valine peptide bond results in the 
formation of the serine protease, plasmin, from plasminogen (3,103,106,107). 
The formation of plasmin is important in that it is the plasmin that is able to 
degrade a broad range of mammalian proteins including matrix proteins, fibrin 
and soluble plasma proteins. During an infection, fibrin clots form to limit the 
spread of the infection. Since streptokinase has the ability to cause a reaction 
that ultimately results in the destruction of these clots, a means for the 
pathogens to spread is provided.
Deoxyribonuclease. Deoxyribonuclease (DNase) is an extracellular 
endonuclease that is produced by group A streptococci. The fact that antibodies 
to DNase are commonly found in patients suffering from streptococcal infections 
(56,133) gives support that DNase is involved in the pathogenesis of the
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infection in some way, and therefore, DNase could be a potential virulence 
factor. Although no specific role of DNase in pathogenesis has been elucidated, 
the studies have suggested that the activities of DNase provide a means for the 
spreading of streptococci by catalyzing the cleavage of the 3’-phosphate bond of 
native host DNA released on cell lysis, resulting in variable lengths of 5’ 
fragments (56,133). During a streptococcal infection various virulence factors 
result in the lysis of cells releasing DNA into the environment, thereby increasing 
the viscosity of the surrounding areas. Since the activity of DNase is directed 
towards DNA, the streptococci may produce the enzyme to depolymerize the 
viscous DNA in its surrounding environment to enable further spreading. By 
degrading the DNA that may hinder the spread of bacteria, the DNase provides 
the bacteria with a means to spread throughout the body of the host, not to 
mention a source of nutrients for survival. The replication of S. pneumoniae is 
known, which secrete DNase, is enhanced by the products formed by DNA 
degradation (47).
Hyaluronic acid capsule. Group A streptococci have a protective 
capsule of which the sole component is hyaluronic acid. Hyaluronic acid is 
comprised of repeating units of glucuronic acid and N-acetylglucosamine (154). 
Synthesis of the capsule is the result of the hyaluronate synthase operon, which 
is comprised of three genes: hasA, hasB, and hasC (35). The hasA gene 
encodes hyaluronate synthase, which adds alternating N-acetyl-D-glucosamine 
and D-glucuronic acid residues to form hyaluronic acid (34, 36); hasB encodes 
UDP-glucose dehydrogenase, which forms glucuronic acid from UDP-glucose
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(37); hasC encodes UDP-glucose pyrophosphorylase, which froms UDP-glucose 
from UTP and glucose-1 -phosphate (29). Of the three genes, only hasA and 
hasB have been found to be required for capsule synthesis (5). The hyaluronic 
acid capsule of S. pyogenes is similar in its make-up to the hyaluronic acid found 
in many animal tissues, confers resistance to phagocytosis and shields the cells 
from recognition from the host immune response (163). In addition to providing 
anti-phagocytic properties to the streptococci, studies have suggested that the 
capsule acts as an adhesin in the pharynx due to its ability to bind CD44 on 
epithelial cells (138). Epidemiological analyses have shown a connection 
between occurrences of rheumatic fever and invasive streptococcal infections as 
a result of infections caused by mucoid strains of GAS (83), further 
substantiating the need for hyaluronic acid capsule during a streptococcal 
infection. Studies have shown a decrease in virulence associated with loss of 
the capsule (75, 137, 163). Mouse studies in which both capsular and acapsular 
strains were inoculated into mice intraperitoneally and subcutaneously showed 
that encapsulated strains produced dermal necrosis, purulent inflammation, and 
bacteremia, whereas, the acapsular strains produced a mild inflammation (139, 
163, 164).
Hyaluronate lyase. Although somewhat paradoxical, S. pyogenes also 
produces hyaluronidase, an enzyme that is found in many kinds of organisms, 
both eukaryotic and prokaryotic (82). Hyaluronidases have hyaluronic acid, a 
major constituent of human connective tissues and the sole component of the 
streptococcal capsule, as their substrate. Hyaluronic acid is a polymer of N-
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acetyl glucosamine and glucuronic acid, linked by p 1-3 and (31-4 glycosidic 
bonds, that lacks any covalently linked peptide (95). Hyaluronidases are 
separated into three main types based upon their mode of cleavage of the 
hyaluronic acid. The first type are the testicular-type hyaluronidases, 
hyaluronate 4-glycanohydrolase, found in mammalian spermatozoa, lysosomes, 
and the venoms of stonefish, bees, scorpions, and various other insects and 
snakes (28, 90, 93). By acting as endo-p-N-acetyl-D-hexosaminidases, these 
hyaluronidases degrade hyaluronic acid and/or chondroitin sulfate to a 
tetrasaccharide. The second type of hyaluronidase, hyaluronate 3- 
glycanohydrolase, is found in leeches and some hookworms (70, 71). This type 
of hyaluronidase degrades hyaluronic acid to a tetrasaccharide through 
endoglucuronidase activity. Bacterial hyaluronidases, hyaluronate lyases, 
comprise the third type of hyaluronidases. These carry out an elimination 
reaction of the p-1-4 linkage in hyaluronic acid, yielding disaccharide end 
products (Fig. 2) (59, 82). Since the hyaluronidase from S. pyogenes uses this 
action for hydrolysis of hyaluronic acid (66), streptococcal extracellular 
hyaluronidase will be referred to as a hyaluronate lyase.
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FIG. 2. The structure of hyaluronic acid and the resulting disaccharide 
products following hydrolysis by bacterial hyaluronate lyases.
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Although information regarding other bacterial hyaluronidases exists, most 
of the literature pertaining to streptococcal hyaluronidases is from studies on 
streptococcal infections. Hyaluronate lyase production has been found in 
streptococcal groups A, B, C, F, and G (61). Group A streptococci produce at 
least two hyaluronidases: [1] secreted as an extracellular product, which is the 
hyaluronate lyase, and [2] encoded by a bacteriophage that allows for the 
bacteriophage to penetrate a streptococcal hyaluronic acid capsule (80). 
Additionally, another putative hyaluronidase, Spy1600, has been identified (46). 
Although the extracellular hyaluronate lyase is considered to be a putative 
virulence factor, very little is known about the effects of the enzyme during a 
streptococcal infection. Since group A streptococci produce a capsule of which 
its sole component is hyaluronic acid, it appears to be contradictory to produce 
an enzyme that also degrades the capsule. The relationship between 
hyaluronate lyase and the hyaluronic acid capsule remains to be determined; 
however, some form of regulation probably exists between these two 
streptococcal factors. Early studies suggested that hyaluronic acid capsule is 
produced early in the growth of the organism, while hyaluronate lyase is found 
later in the growth cycle (108); however, the time of production for hyaluronate 
lyase is not known for S. pyogenes. Additionally, no information is available 
regarding the conditions under which the enzyme is produced. However, 
studies showed that when hyaluronic acid was added to the media, there was an 
increase in the production of hyaluronate lyase (66).
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The streptococcal capsule appears to be utilized by the bacterium as a 
means of protection from the host defense system (51, 117). Thus, by producing 
an enzyme that can destroy this protective mechanism, the bacterium is 
exposing itself to the harsh elements of the host defense. However, by 
degrading the hyaluronic acid capsule, the bacterium potentially establishes the 
ability to replicate freely, and by continually producing hyaluronate lyase, 
institutes the means to degrade the hyaluronic acid constituent of the host’s 
connective tissues for further bacterial or toxin spread. Destruction of the 
hyaluronic acid of the connective tissues may result in the clinical manifestations, 
primarily the severe tissue damage seen in streptococcal infections such as 
necrotizing fasciitis. Because hyaluronate lyase produced by streptococci is 
capable of degrading hyaluronic acid and may potentially deteriorate the integrity 
of human connective tissues to allow for better dissemination through the 
infected organism, the enzyme has been referred to as a spreading factor (39).
Although hyaluronate lyase has been acknowledged as a spreading 
factor, only approximately 25% of the strains tested using an in vitro assay for 
activity actually produced the enzyme (80). Although in vitro analysis indicates 
only a small number of group A streptococci produce hyaluronate lyase, 
antibodies directed to both extracellular hyaluronate lyase and the bacteriophage 
hyaluronidase have been found in patients following streptococcal infection (63, 
161,162). The presence of these antibodies indicates that hyaluronate lyase, in 
either an active or inactive form, is produced in vivo during infection. This finding 
suggests that there may be some means of regulation by the bacterium that
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allows for the expression of hyaluronidase in vivo. In other words, some factor 
that is not present in vitro may “turn on” expression of the gene for hyaluronate 
lyase during infection. Although what that factor may be, or what form of 
regulation exists for the production of hyaluronate lyase has not yet been 
determined, studies have shown that in vivo conditions may turn on gene 
expression. McClean (108) in early studies showed that strains that did not 
appear to produce hyaluronate lyase on initial screening were found to have 
enzymatic activity after serial passage through mice. The passage of the 
apparent non-producing strains through the mice “resulted in a considerable 
increase in the virulence of the strains" (108). This induction of the production of 
hyaluronate lyase after animal passage supports the suggestion that hyaluronate 
lyase production is necessary for streptococcal infection. When one considers 
the potential ability of hyaluronate lyase to allow for the dissemination of the 
producing organism, as well as its toxins, the enzyme can be considered as an 
important factor for streptococcal infection. The immense tissue destruction that 
is elicited during streptococcal infection can also in part be due to the activity of 
hyaluronate lyase. Therefore, hyaluronate lyase must be further analyzed to 
establish the exact mechanisms of its activities, and what role this enzyme may 
have in streptococcal infections.
Hyaluronate lyase production has been suggested to be involved in the 
virulence of various pathogenic organisms (42, 82). The role of hyaluronate 
lyase for bacterial pathogens may be to enable the organisms to spread through 
the connective tissues from the initial site of infection, more readily giving access
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to the underlying tissues. Pathogens capable of causing infection on mucosal 
areas and on the skin, which is estimated to be comprised of approximately 50% 
of hyaluronic acid (95), have been speculated to produce hyaluronate lyase as a 
means of entry through the hyaluronic acid-rich skin into the deeper tissues. To 
date, little evidence is available to substantiate this claim. Incidentally, 
information regarding the function of the hyaluronate lyases produced by 
bacterial pathogens is limited; however, since connective tissues provide a 
means of defense against bacterial infection, any enzyme capable of 
deteriorating that line of defense could potentially be important in enhancing the 
spread of pathogens from the initial site of infection.
Little information is available regarding the genetic composition of 
hyaluronate lyase. Relatively little information exists regarding sequence 
analysis of hyaluronate lyase genes. Eleven bacterial hyaluronidase genes and 
two bacteriophage genes have been sequenced. The sequence for the 
hyaluronate lyase gene from the ATCC T-type 22 hyaluronidase-producing S. 
pyogenes strain 10403 (hylA) has been determined (76). The gene is 2607 bp in 
length, encoding a 99.6 kDa protein. Hyaluronidase gene sequences are also 
available for multiple serotypes of Streptococcus pyogenes (10, 46, 145), 
Staphylococcus aureus (43), Streptococcus agalactiae (52), Streptococcus 
pneumoniae (13), Propionibacterium acnes (148), Streptomyces griseus (123), 
Streptomyces coelicolor (123), Proteus vulgaris (136), Streptococcus 
intermedius (155), Streptococcus constellatus (155) and Clostridium perfringens 
(20). Additionally, spy1600 a putative hyaluronidase gene was also identified
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from the sequence of the streptococcal chromosome (46). The bacteriophage 
hyaluronidases, hylP (78) and hylP2 (80) that have been sequenced are both 
derived from phages that infect group A streptococci. Streptococcal 
chromosomal sequences have identified additional bacteriophages, all of which 
encode hyaluronidases (10, 145). Having sequence analysis for these various 
hyaluronate lyase genes has allowed for comparisons between the genes, and 
has shown significant similarity between some, as well as, distinct differences 
between others (82). Interestingly, the hyaluronidase, or mu toxin, produced by 
C. perfringens was the most distinct of all the other hyaluronidases, having little 
similarity when compared to the sequences of the other genes. Spy1600 also 
had very little similarity when compared to other hyaluronidase genes and 
shared the most similarity (30%) with the mu toxin from C. perfringens. The 
hyaluronate lyases produced by these bacteria vary in molecular weight from 
that of S. pyogenes. Although the conditions under which hyaluronidases are 
produced have not been determined, by gaining further knowledge regarding the 
sequences of the various bacterial hyaluronidase genes and therefore, the 
respective proteins, a better understanding of the exact enzymatic mechanisms 
of hyaluronate lyase may be gained and in doing so, its role in streptococcal 
infections will be better understood.
Streptococcal regulatory mechanisms. By summarizing some of the 
putative virulence factors produced by group A streptococci, the relationship 
between the streptococcal products and clinical manifestations of the different 
streptococcal diseases becomes apparent. However, nearly all strains produce
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most, if not all, of the factors described, suggesting some other relationship 
between the diseases produced by S. pyogenes and the organism itself. Also, 
epidemiological studies suggest that a single strain of S.pyogenes can cause 
more than one type of disease (118). One possibility could be that the various 
diseases are a result of the organism’s reaction to the different stimuli 
encountered in the human host. S. pyogenes can survive and replicate in blood, 
the gastrointestinal tract, skin, throat, and the female urogenital tract (31). 
Therefore, the bacterium must adjust its gene expression to acclimate to the 
surrounding environment for survival. Inasmuch, the regulatory mechanisms 
possessed by S. pyogenes, which control the expression of various genes in 
response to different environmental conditions, are probably critical for 
understanding the process of the bacterium during the course of infection. 
Unfortunately, very little is known about the global regulators present in group A 
streptococci. However, since the completion of the sequence for the 
streptococcal chromosome from various serotypes of S. pyogenes (10, 46,145), 
studies have been designed to ascertain the complex regulatory mechanisms of 
this bacterium.
One mechanism that S. pyogenes uses to modify gene expression as an 
adaptation to the bacterium’s environment involves two-component signaling 
systems. Two-component systems are comprised of a surface-located histidine 
kinase protein that becomes stimulated by some external signal, such as pH, 
temperature, osmolarity, and carbon dioxide; upon stimulation, the kinase is 
autophosphorylated. The kinase in turn, phosphorylates its cytoplasmic partner,
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a response regulator protein (69). The sequence of the group A streptococcal 
genome from SF370 revealed a total of 13 two-component regulators, 
suggesting a complex global network of regulation exists; for seven of these 
pathways a function has been identified (46, 89). Two-component systems are 
associated with regulating various cell functions, including salivaricin lantibiotic 
operon and the competence factor response system, which is regulated by 
ComD/ComE (38). Additionally, virulence factors streptolysin S (sagA), 
hyaluronic acid capsule (hasAB), and pyrogenic exotoxin B (speB) expression 
are regulated by another pathway, CovR/CovS (45, 65). Another regulatory 
mechanism, Mga, regulates M protein (emm), C5a peptidase (scpA), M-like 
proteins (mrp, enn, and fcR), serum opacity factor (sof), and secreted inhibitor of 
complement (sic) expression (128,143). Furthermore, the two-component 
system, spy2026/spy2027 (Ihk/lrr (45)), is suggested to be involved in bacterial 
virulence (46). Additionally, a recent study has reported that the Ihk/lrr system 
controls expression of genes necessary for evading and surviving phagocytosis 
(160). One other two-component pathway (SPy0528/Spy0529) that has been 
identified is thought to be a homolog of two-component systems (YycR-AucG 
and hk02-rr02) that are essential for growth in Bacillus subtilis and S. 
pneumoniae, respectively (92). Yet another pathway, the fas regulon, functions 
to positively regulate gene expression for streptokinase (ska) and streptolysin S 
(sagA), while negatively regulating fibronectin (fbp) and fibrinogen (mrp) binding 
(89). Of the seven, the Mga and CovR/CovS systems are the most understood.
The most studied regulator in S. pyogenes is Mga, the multiple gene
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regulator in group A streptococci. The gene (mga) has homology to 
phosphorylation acceptor motifs, suggestive of a role as a response regulator 
protein of a two-component system; however, the primary protein, ie. the sensor 
kinase, of the pathway has yet to be identified (128). Initially identified by 
Simpson et al as virR (143) and by Perez-Casal et al as mry (128), the gene was 
established to be a positive transcriptional regulator for M protein gene (emm) 
expression. The gene was later named mga to indicate its role in regulation of 
multiple genes in group A streptococci. Mga functions as a transcriptional 
activator by binding to the promoter of the genes it regulates (128). Studies 
involving inactivation of mga resulted in the loss of M protein expression, 
signifying a positive regulation by Mga (147). Since the initial discovery of the 
involvement of Mga with M protein expression, studies have determined that the 
Mga system regulates a number of virulence factor genes, including C5a 
peptidase (scpA), M-like proteins (mrp, enn, and fcR), serum opacity factor (sof), 
and secreted inhibitor of complement (sic) (25, 26, 109,112,131) Mga is also 
responsible for the regulation of its own gene expression (124). Studies 
involving emm expression have helped to elucidate the role of the mga regulon. 
By investigating emm expression under different environmental conditions, such 
as various concentrations of carbon dioxide (21), osmolarity, temperature, iron, 
and growth with free exchange of gases (shaking) (110), it was suggested that 
Mga regulates expression of the various genes under its control in response to 
environmental stimuli. Although Mga appears to function solely as a positive 
regulator allowing for rapid production of necessary factors, the response is also
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controlled by a negative regulator, Nra (negative regulator of group A 
streptococcus) (132). Nra is a global negative regulator that was found to 
regulate mga gene expression, as well as expression of the fibronectin-binding 
protein F2 gene (prtF2), and a collagen-binding protein (cpa)(132). Interestingly, 
Nra negatively regulates its own expression; in contrast, it is positively regulated 
by Mga (132). In contrast, another global regulator, RofA (rofA), is an 
autoregulated, positive-transcriptional regulator of the gene encoding the 
fibronectin-binding protein (50). Additionally, RofA was shown to suppress mga 
expression (8).
The other two-component signaling pathway found in S. pyogenes for 
which information is available is the CovR-CovS (Cov = control of virulence) 
regulon (45), also known as the CsrR-CsrS regulon (97). Whereas Mga is a 
positive transcriptional regulator, CovR-CovS is a negative transcriptional 
regulator for many virulence genes. CovS acts as the sensor protein, with CovR 
being the response regulator (97). Inactivation of covR has been shown to affect 
transcription of has A, the first gene in the hyaluronic acid capsule operon, such 
that expression was increased, which resulted in more mucoid colonies (97). 
Additionally, inactivation of covR resulted in an increase in streptokinase (ska), 
streptolysin S (sagA), and mitogenic factor (speMF) (45). Furthermore, CovR 
negatively regulates its own operon’s expression (45). Recently studies have 
shown that CovR directly, or indirectly, affects transcription for at least 15% or 
271 genes from S. pyogenes, including genes responsible for stress adaptation, 
gene regulation, as well as the virulence factors already described (58). How
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CovR negatively regulates these genes is not known; however, studies have 
shown that CovR regulates hasA transcription by directly binding to the promoter 
region upstream of the has operon (12).
Although the CovR pathway represses a number of genes independent of 
those controlled by the Mga regulon, CovR neither affects nor is affected by 
Mga (45). However, ska, sag A, and speB, which are all regulated by CovR, are 
also influenced by other regulators (8, 89,149). Kreikemeyer et al (89) found 
the fas operon (fasBCAX), a two-component pathway, which controls genes for 
streptokinase and streptolysin S. The fas operon encodes two histidine kinases 
(fasBC), as well as, a response regulator protein (fasA). Interestingly, a gene 
(fasX) downstream of the fas operon was found to be required for Fas to function 
(89). Rgg was found to positively regulate expression of speB (22,105). 
Chaussee et al reported that Rgg also affects the expression of a number of 
genes associated with the streptococcal stress response (23, 24). Interestingly, 
another regulator RopA, which was shown to suppress transcription of mga, has 
also been shown to suppress expression of sagA (8). An additional global 
regulator, Pel (pleiotropic effect locus), was found to interact directly, or 
indirectly, with both negative or positive regulatory systems, such that 
inactivation of pel resulted in loss of streptolysin S, reduction or loss of M protein 
and cysteine protease (SpeB), as well as affected production of streptokinase, 
fibronectin binding proteins, and superoxide dismutase (100).
Additionally, genes controlled by the various regulatory pathways, as well 
as the genes mga and fas, were affected by growth phase, a third regulatory
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mechanism in S. pyogenes (45,111). Gene expression of CovR, however, was 
not affected by growth phase (45). Regulation of nra expression also appears to 
be influenced in a growth phase-dependent manner as is seen by its late 
exponential expression (132). Growth phase-dependent regulation is a common 
form of regulation for many group A streptococcal virulence factors; however, the 
exact signals responsible have not been identified. Some genes, including 
emm, scpA, has A, and mga, show increased expression during exponential and 
late exponential growth phases; however, genes such as sagA and speMF have 
elevated expression during stationary phase (15, 30,111). Another mode of 
regulation related to growth phase-dependent regulation that S. pyogenes may 
use in response to environmental signals involves the use of secondary sigma 
factors. The sequence of the genome of S. pyogenes revealed a potential 
secondary sigma factor that had similarity with <xH, a secondary sigma factor 
implicated with stationary-phase gene regulation in Bacillus subtilis and S. 
pneumoniae (4, 96). Opdyke et al (125) investigated the locus as well as the 
protein, which they named sigX (ax) and concluded that axwas indeed a 
secondary sigma factor due to its ability to initiate transcription from two 
promoters (pcinA and pfemB) the functions of which have yet to be identified. 
Although orx was shown to initiate transcription of cinA and femB, attempts to 
express has A, which is dependent on the primary sigma factor (cta), were not 
successful (125). The actual role of this secondary sigma factor at this time is 
unknown; however, as with that of B. subtilis, it may be involved in gene 
regulation during stationary-phase of growth.
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With respect to growth phase-dependent regulation, the response of S. 
pyogenes to amino acid depletion is also important. During stages of infection, 
as well as in culture, streptococci encounter various niches in which free amino 
acids may be limited. In response to the lack of amino acids, streptococci restrict 
RNA synthesis for the corresponding aminoacyl-transfer RNA (tRNA) (40) and 
consequently protein synthesis to prevent synthesis of elements that may not be 
needed at the time, such as virulence factors (150). Studies involving amino 
acid starvation have revealed a complex network of regulatory factors, which 
were previously unknown. These investigations have shown that gene 
expression for the stringent response regulator protein RelA {re I A) are enhanced 
following the depletion of amino acids (115,116). As a result, a global regulator, 
ppGpp, is synthesized and rRNA and tRNA synthesis is inhibited (115,116).
More recent studies, however, have explicated a more intricate regulation pattern 
resulting from amino acid depletion. Steiner and Malke (150) investigated a relA- 
independent response to limited amino acids and showed that the fas and 
covR/covS signal transducers were stimulated (150). Another study involving 
nutritional stress showed that the virulence regulator, Rgg was stimulated as well 
(149). While CovR/S negatively regulates the transcription of ska, sag A, and 
speB, Rgg stimulates expression of speB, and Fas positively regulates ska and 
sag A. Through this intricate network of regulation, the level of expression for 
these genes is maintained to prevent loss or over-production of their products.
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Hypotheses and specific aims. Although literature regarding many
virulence factors of S. pyogenes exists, hyaluronate lyase has been neglected. 
The objective of these studies will primarily focus on developing a better 
understanding of the role of streptococcal hyaluronate lyase as a virulence 
factor, and perhaps begin to understand under what conditions the enzyme is 
produced. Through these studies a preliminary understanding may be attained 
into the relationship between the streptococcal hyaluronate lyase and hyaluronic 
acid capsule. In order to complete these objectives, hyaluronate lyase was 
examined at the molecular level; as well as under conditions to simulate an in 
vivo environment. For this study, there were two main hypotheses: 1) the 
production of hyaluronate lyase is regulated by some environmental factor, and 
2) that a hyaluronate lyase gene is present in all group A streptococci. The 
ability of group A streptococci to cause a variety of diseases has been linked with 
its capacity to elaborate numerous extracellular products. Although 
streptococcal hyaluronate lyase has a potential role in the pathogenesis, there is 
relatively little information regarding the enzyme, and no information regarding its 
regulation. By gaining information regarding the production of hyaluronate lyase, 
it may be possible to better comprehend the role of the enzyme in streptococcal 
infections.
The Specific Aims of this study were:
SPECIFIC AIM 1- Regulatory studies: Evaluate the regulatory mechanisms of 
hyaluronidase gene expression by examining the relationship between the
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production of hyaluronidase and such factors as temperature, pH, aeration, 
presence of substrate, and the production of a hyaluronic acid capsule.
SPECIFIC AIM 2- Hyaluronate lyase gene size variability studies: Determine 
size and location of a deletion seen in some hyaluronidase genes of group A 
streptococcal strains and examine the importance of these deletions in 
hyaluronidase activity.
SPECIFIC AIM 3- Inactivation of hylA studies: Inactivate the hyaluronate lyase 
gene (hylA) and determine its effect on the growth of S. pyogenes, as well as the 
effect on other enzymatic properties of S. pyogenes.
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GENERAL LABORATORY MATERIALS AND METHODS
Chemicals and equipment. A list of chemicals, equipment, and their 
respective manufacturers, used throughout this study can be found in either in 
Appendix I, or where used in the text.
Bacterial strains. One hundred seventy-six strains of S. pyogenes were 
used in this study. Strains were isolated from various geographic locations and 
from different diseases (Appendix II). S. pyogenes strains were generously 
provided from the culture collection of Professor J.J. Ferretti, University of 
Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, the Center for 
Pediatric Research, Eastern Virginia Medical School, Norfolk, Virginia, the 
culture collection of Dr. W. Hynes, Old Dominion University, Norfolk, Virginia, or 
by Professor J. Tagg, Otago University, Dunedin, New Zealand. S. pyogenes 
cultures were stored at -80°C, plated on blood agar, then subcultured before use. 
Escherichia coli strains used in this study were JM109 (Promega), BHB2600 (a 
gift from Professor Adwin Vriesema, The Netherlands), DB11 (University of 
Oklahoma Health Sciences Center), or DH5a (Life Technologies).
Oligonucleotide primers and dual-labeled probes. Oligonucleotide 
primers and dual-labeled probes used in these studies are outlined in Table 1 
and were purchased from Integrated DNA Technologies. Primers and probes 
were prepared in nuclease-free water as a 100 pM stock concentration and were 
stored at -20°C. Dual-labeled probes (HylA-Probe, GyrA-Probe, HasA-Probe) 
were labeled with a 5’ 5-carboxyfluorescein (FAM) label and the 3’ end with a
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black-hole quencher (BHQ). Probes were diluted to a working concentration of 
2.0 pM, stored at -20°C, and were used within one week from dilution.
Media preparation. The following media were utilized in these studies. 
Todd-Hewitt Broth (THB) was prepared by adding 30g Todd-Hewitt medium to a 
final volume of one liter (L) of water. The pH was adjusted to 7.8 or to an 
otherwise noted pH. The solution was autoclaved and stored at room 
temperature. Antibiotics were added aseptically when required.
Todd-Hewitt Agar (THA) was prepared in the same manner as THB; 
however, following pH adjustment, 1.5% granulated agar was added to the broth. 
The medium was autoclaved, cooled to room temperature, and if required, 
antibiotics were added. Twenty milliliters of THA were aseptically aliquoted into 
a 100 x 15 mm petri dish, allowed to solidify, and stored at 4°C.
2x YT Media was prepared by combining 16g tryptone, 10g yeast extract, 
and 5g sodium chloride (NaCI) with water to a final volume of 1L. The pH was 
adjusted to 7.5 and autoclaved. Bottles of broth were stored at room 
temperature. Antibiotics were added aseptically prior to use if required. 2x YT 
agar was prepared by adding 1.5% agar prior to autoclaving. Following 
autoclaving, agar was cooled to room temperature, required antibiotics, or other 
additives, such as isopropyl p-D-thiogalactopyranoside (IPTG) (final 
concentration 100 pM) and 5-bromo-4-chloro-3-indolyl-(3-D-galactoside (X-gal) 
(final concentration 20 pg/mL) and dispensed to 100 x 15 mm petri dish.
SOB Broth was prepared by adding 10g tryptone, 5g yeast extract, 5g 
NaCI, 10 mM magnesium chloride (MgCfe), and 10 mM magnesium sulfate
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(MgSC>4 ) to water to a final volume of 1 liter; pH was adjusted to pH 7.5 and 
autoclaved. Sterile broths were stored at room temperature.
Brain Heart Infusion-Bovine Serum Albumin-Hyaluronic Acid Medium 
(BHB) was prepared as previously described (77). Briefly, the medium was 
prepared by combining 3.7g Brain Heart Infusion Medium (BHI) and 1g purified 
agar with 60 ml_ of water. Following autoclaving, the agar was cooled to 55°C. 
Sterilized 2 mg/mL hyaluronic acid and filter-sterilized 5% bovine serum albumin 
(BSA), pre-warmed to 55°C were gradually added, in the above order, to 
autoclaved BHI agar such that the media contained a final concentration of 
400 pg/mL hyaluronic acid and 1% BSA. Twenty m l aliquots of BHB were 
poured into 100 x 15 mm petri dishes.
Hyaluronidase Assay plates were prepared as previously described (76). 
Briefly, 1g purified agar was resuspended in 60 mL 0.2 M sodium phosphate 
buffer (0.2 M Na^PCU, 0.2 M Na2 HP0 4 ), pH 6.5 and was autoclaved. Following 
autoclaving, agar was cooled to 55°C and pre-warmed sterile 2 mg/mL 
hyaluronic acid and 5% BSA were gradually added, in that order, to give final 
concentrations of 400 pg/mL hyaluronic acid and 1% BSA. Medium, in 20mL 
aliquots, was dispensed into 100 x 15 mm petri dishes and stored at4°C.
Agarose gel preparation. Agarose gels for routine screening of plasmid 
or PCR products were prepared by adding 0.8% agarose to TBE buffer (Tris; 
boric acid; EDTA) or TAE buffer (Tris; glacial acetic acid; EDTA). Agarose gels 
used for the separation of DNA fragments smaller than 200 bp were prepared by 
adding 3% Super Fine Resolution (SFR) agarose to TBE buffer. The mixture
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was microwaved to melt agarose, cooled to 55°C, and poured into the gel 
chamber. To visualize DNA fragments, ethidium bromide was added to the 
agarose for a final concentration of 0.5 pg/mL.
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TABLE 1. Oligonucleotide primers and dual-labeled probes used in this study.
Primer/Probe Oligonucleotide Sequence (5’-3’) Reference
Hyl-A CAATTT CAAT AT CATTACGG (76)
Hyl-B GOAT CT CT GAAAG AAGAAG (76)
Hyl-C G AACGCCCT CG AGT CAT AT C (76)
Hyl-D CAAAAGT ACCCTT ACT GTTC (76)
Hyl-E GCTTT ACAACT GGAGCTT ACGG (76)
Hyl-F GACGT GOAT CAT CT GTT GACT AT C (76)
Hyl-G AGCTATTGTTTATGTAAGGG
Hyl-H TGTGCAAAAATAAGTATTCAC
Hyl-J AGCAAAGCTAAGGAATAGGTTTGAA
Hyl-K GTGAATACTTAI I I I IGCAC
Hyl-L GGCAGTT CCTT GGCCCAT CAT
Hyl-M COAT ACT C AAGAT GGCG ATCG
Hyl-N CT AAAT CCTT AAGT CTTT CT
Hyl-0 AT GAT GGGCCAAGGAACTGC
GyrA-F TT AT CACGTTCCAAACCAGTCAA (23)
GyrA-R CGACTT GTCT GAACGCCAAA (23)
HasA-F ACCGTT CCCTT GT CAAT AAAGG (23)
HasA-R CGT CAGCGT CAGAT CTTT CAAA (23)
pJC2-A GCCTTT G AGT GAG CT GATAC
pJC2-B CACT G ACAG AAAATTT GTG C
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TABLE 1. Continued.
Primer/Probe Oligonucleotide Sequence (5’-3’) Reference
M13 Forward CGCCCAGGGTTTT CCCAGT CACGAC
M13 Reverse T C AC ACAG G AAAC AG CT AT G AC
Gfp-F ATGAGTAAAGGAGAAGAACT
Gfp-R CT ATTT GTAT AGTT CAT CCAT G
HylA-Probe* CAATT ACT ACTTT ATT C AAACCT ATT C
GyrA-Probe* CGACGCAAACGCATATCCAAAATAGCTTG (23)
HasA-Probe* CGCCATGCTCAAGCGTGGGC (23)
* 5’ FAM-3’ BHQ
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3510 bp
FIG. 3. Location of primers for the hyaluronate lyase gene regions used 
in this study. The HylA-Probe* was labeled with a 5’ 5-carboxyfluorescein (FAM) 
label and the 3’ end with a black-hole quencher (BHQ).
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METHODS FOR REGULATORY STUDIES
Bacterial strains and growth for regulation studies. ATCC strain 
10403 (M-type 22), strain SF370 (M-type 1), and strain 71698 (M-type 28) were 
grown on Sheep Blood agar (BBL, MD) at 37°C and subcultured before 
inoculating into Todd-Hewitt broth (THB) supplemented with 5% horse serum. 
Broth cultures for examination of hylA expression at different pHs were prepared 
at pH of 5.0, 7.4, 7.6, and 9.0. These cultures were then grown aerobically at 
37°C. For aeration studies, cultures were grown in anaerobic, increased CO2 , 
and aerobic conditions at 37°C. Cultures were also grown with (shaking) and 
without (stationary) free exchange of gases at 37°C. Cultures for temperature 
studies were grown aerobically at 32°C, 37°C, and 42°C. To analyze the effect 
of hyaluronic acid on hylA expression, 600 pg/mL hyaluronic acid was added to 
the medium as previously described (66).
Production of hyaluronate lyase. To determine the time of production 
for hyaluronate lyase by strain 10403, an overnight culture was diluted 1:100 into 
fresh THB + 5% horse serum and incubated at 37°C. Prior to inoculation, the 
overnight culture was pelleted and washed with isotonic saline to remove 
residual extracellular HylA. Samples were taken at 60-minute intervals for 
determination of optical density at a wavelength of 600nm. A 1 mL aliquot from 
each time point was transferred to a microcentrifuge tube. The cells were 
pelleted by centrifugation at 16000 x g and the supernatant collected. 
Hyaluronidase activity in the supernatant was detected by transferring 20 pL of
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supernatant to wells in the hyaluronidase assay plates prepared as previously 
described and incubated at 37°C for 18 hours (77). Following the addition of 2N 
acetic acid to precipitate the bovine serum albumin-hyaluronic acid complex, 
hyaluronidase activity was determined by measuring the diameter of the zone of 
clearing in a plate assay. Hyaluronate lyase titer was determined by serially 
diluting the supernatant and assaying for activity as above. The titer of 
hyaluronate lyase is recorded as arbitrary units per m l (AU). The greatest 
dilution of the supernatant to give detectable clearing was considered to contain 
one AU.
Polymerase chain reaction (PGR) of potential promoter regions of 
the hyaluronate lyase gene from S. pyogenes strain 10403. To determine 
the region upstream of hylA on the S. pyogenes chromosome that exhibits 
promoter activity, specific primers were used to amplify the potential promoter- 
containing fragments by PCR. Primers were developed to amplify a 128 bp 
fragment upstream of the proposed GTG initiator codon (Hyl-G, Hyl H; Table 1; 
Fig. 3), a 198 bp fragment upstream of the potential ATG initiator codon (Hyl-G, 
Hyl-L; Table 1; Fig. 3), and a 90 bp fragment internal to the GTG and ATG 
codons (Hyl-K, Hyl-L; Table 1; Fig. 3). PGR reactions were prepared according 
to manufacturer’s guidelines for Takara Ex Taq™ Polymerase such that the 
reactions contained final concentrations of 1x Takara Ex Taq Buffer, 2.5 mM 
dNTP Mix, 20 pmol each primer, 200-500 ng DNA template, 1.25 U Takara Ex 
Taq DNA Polymerase, and water to a final volume of 50 pL. PCR amplification
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was performed using the following protocol: initial denaturation for 1 minute at 
94°C, 30 cycles of denaturation at 94°G for 1 minute, annealing at 49°C for 
1 minute, and extension at 72°C for 1 minute, followed by a final extension at 
72°C for 10 minutes. PCR products were electrophoresed on a 3% SFR TBE 
agarose gel at 75 V for 2 hours. Desired fragments were isolated from the gel 
using the QIAEX II Gel Extraction Kit in accordance with manufacturer’s 
guidelines. Briefly, the gel slice was weighed and solubilized in the presence of 
QIAEX II silica particles with Buffer QX1. The QIAEX II silica particles-DNA 
fragment complex was washed with PE buffer and the purified DNA fragment 
was eluted from the particles with nuclease-free water.
Construction of plasmids containing potential promoters for hylA.
Plasmid pJC2 (102), containing promoter-less green fluorescent protein gene 
(:gfp), was purified from a transformed culture of £. coli strain JM109 using the 
Wizard® Plus SV Mini-prep DNA Purification System as outlined in the 
manufacturer’s instructions. Briefly, an overnight 2 m l culture of JM109:pJC2 
was pelleted by centrifugation at 16000 x g. The pellet was resuspended in Cell 
Resuspension Solution (50 mM Tris-HCI pH 7.5, 10 mM EDTA, 100 pg/mL 
RNase A). Following resuspension, cells were lysed with the addition of Cell 
Lysis Solution (0.2 M NaOH, 1% SDS). Neutralization Solution was added. 
Following neutralization, lysate was centrifuged for 1 minute at 16000 x g. 
Supernatant was transferred to Column, and centrifuged 1 minute at 16000 x g. 
Plasmid DNA collected on the filter of the column was washed with Column 
Wash Solution, and plasmid DNA was eluted in nuclease-free water. The
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plasmid was linearized by digestion with restriction enzyme Smal. Plasmid 
digest was electrophoresed on a TBE 1 % agarose gel. Linearized plasmid was 
isolated from the gel using the QIAEX II Gel Extraction Kit as outlined by the 
manufacturer. As the Taq DNA polymerase used for amplification of the 
fragments added 3’ A overhangs to the amplicon, the addition of T-overhangs to 
the plasmid was necessary to facilitate ligation between the PCR product and 
plasmid pJC2. The addition of T-overhangs was accomplished using standard 
protocols (6). Briefly, a reaction containing 2-5 pg blunt-ended vector pJC2,1x 
Taq DNA Polymerase Buffer, 2.5 mM MgCfe, 1 mM dTTP, 5 U Thermophilic Taq 
DNA Polymerase, and sterile water to a final volume of 100 pL was incubated for 
2 hours at 75°C. Ligation between pJC2 and the PCR products was performed 
using manufacturer’s guidelines for DNA ligase. In short, ligation reactions were 
prepared such that there was a 3:1 ratio of insert DNA to vector DNA, 1x ligation 
buffer, 2 U T4 DNA ligase, and water to a final volume of 20 pL. Reactions were 
incubated at 14°C for at least 18 hours. Ligations were assessed by 
electrophoresing an aliquot of ligation mixture on a 0.8% agarose gel. For 
simplicity, plasmids containing Hyl-G-Hyl-H fragment, Hyl-G-Hyl-L fragment, and 
the Hyl-K-Hyl-L fragment were named pSW5-GTG, pSW5-ATG, and pSWGTG- 
ATG, respectively.
Transformation of plasmids into E. coli. Ligation mixes were 
transformed into E. coli strain JM109 by standard protocols (6). Briefly, an 
overnight culture of E. coli strain JM109 was diluted 1:100 into pre-warmed SOB 
broth and was incubated at 37°C for a period of 2.5 hours (OD6oo=0.375). Cells
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were washed by centrifugation at 16000 x g and resuspended in Transformation 
Buffer (TFB) (100 mM potassium chloride, 45 mM manganese chloride, 10 mM 
calcium chloride, 3mM hexamminecobalt (III) chloride (HAC0 CI3 ), 10 mM 
potassium 2-(4-morpholino)-ethane sulfonic acid (K-MES)). After further 
centrifugation cells were resuspended at 1/12 original volume in TFB with the 
addition of DnD (1 M diothiothreitol (DTT), 90% dimethyl sulfoxide (DMSO),
10 mM potassium acetate). Competent cells were incubated on ice with ligation 
mix for 30 minutes, cells heat-shocked at 42°C for 90 seconds, allowed to grow 
for 60 minutes in SOB, and plated on 2x YT agar containing 100 pg/mL 
ampicillin. Plates were incubated at 37°C overnight and resulting colonies 
screened for fluorescence by exposing colonies to ultraviolet light. Fluorescing 
colonies were picked and screened for presence of promoter fragment by PCR 
or restriction enzyme digests. Further confirmation of insert was attained by 
sequencing with primers specific for the plasmid (pJC2-A and pJC2-B).
Sequencing of plasmids containing potential promoter regions.
Sequencing of pSW5-GTG, pSW5-ATG, and pSWGTG-ATG was performed 
using dideoxy-sequencing method outlined for the ABI PRISM 310 Genetic 
Analyzer. Briefly, sequencing reactions were prepared as outlined for the Big 
Dye™ Terminator v3.0 Cycle Sequencing Ready Reaction. Reactions contained 
200-500 ng plasmid DNA, 4.0 pmol primer (pJC2-A or pJC2-B; Table 1), 5.4 pL 
Bioline Half-Dye Buffer, 2.6 pL Big Dye, and sterile water to a final volume 20 pL. 
The incorporation of the dideoxy-labeled nucleotides was accomplished by using 
the following PCR reaction as outlined by the manufacturer: twenty-four cycles
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of denaturation at 96°C for 30 seconds, annealing at 50°C for 15 seconds, and 
extension at 60°C for 4 minutes. The ramping speed for each step was 1°C per 
second. Following the PCR, unincorporated dyes were removed by precipitation 
with 95% reagent ethanol, 3 M sodium acetate pH 5, and sterile water for one 
hour. Sequencing reactions were pelleted by centrifugation at 16000 x g, pellets 
were washed with 70% ethanol, and pellets were dried by heating at 90°C for 
1 minute. Pellets were resuspended in ABI PRISM Template Suppression 
Reagent and were heated to 95°C for 2.5 minutes prior to being loaded onto the 
ABI PRISM 310 Genetic Analyzer. Sequences obtained were analyzed by using 
the Vector NT I Suite of programs (Informax, MD).
Insertion of the green fluorescent protein gene (gfp) into S. 
pyogenes strain 10403. Once a successful fusion between the potential hylA 
promoters and gfp was achieved, pSW5-GTG, pSW5-ATG, and pSWGTG-ATG 
were digested with restriction enzymes, EcoRI and Xbal, such that the 
promotengfp fusions were excised from the vector. The isolated fragments were 
inserted into either streptococcal integration vector, p7int (114), or E. coli-S. 
pyogenes shuttle vectors pAT28 and pAT29 (157). Following ligation, the 
plasmids were transformed into either E. coli strain JM109, DB11, or BHB2600. 
After transformation with the plasmid containing p7int-fusion, the cells were 
plated on 2xYT agar containing either 1 mg/ml (JM109) or 250 pg/mL 
erythromycin (DB11, BHB2600). Cells transformed with the pAT28/29 vectors 
were plated on 2xYT containing 250pg/mL spectinomycin. The presence of the 
insert was confirmed by PCR using primers specific for the amplification of gfp
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(Gfp-F, Gfp-R; Table 1) and by sequencing. The plasmids were electroporated 
into S. pyogenes strain 10403 using a previously described technique (142). 
Briefly, 1 m l of an overnight culture of S. pyogenes strain 10403 was diluted in 
49 mL pre-warmed THB supplemented with 5% horse serum and incubated for 
three hours (ODsoo= 0.200). The cells were pelleted by centrifugation at 
15,300 xg  at 4°C. The pellet was resuspended in 0.5 M sucrose, transferred to 
a microcentrifuge tube, and pelleted by centrifugation at 16000 x g. The 
supernatant was removed and cell pellet was washed in 0.5 M sucrose a total of 
five times. Following the last wash, the cells were resuspended in 100 pL of 
0.5 M sucrose. An aliquot of 40 pL of cells was transferred to a microcentrifuge 
tube, 1-5 pL of plasmid was added, and the mixture transferred to a 2 mm 
electroporation cuvette. The cells were exposed to a single pulse of 2.5 kV,
25 pF, 200 Q on a BTX Transporator™ Plus. Cells were incubated at 37°C for 
2 hours for expression. Electroporated cells were then plated on THA containing
2.5 pg/mL erythromycin (p7int) or 250 pg/mL spectinomycin (pAT28/pAT29) for 
selection of the desired streptococci. Colonies that grew on the plates were 
analyzed by PCR for the presence of gfp. Colonies were directly viewed for GFP 
on a Nikon fluorescent microscope using an excitation wavelength of 365 nm 
and an emission wavelength of 470 nm.
RNA isolation. S. pyogenes cultures were prepared by inoculating 1 mL 
of an 18-hour culture into 50 mL pre-warmed THB supplemented with 5% horse 
serum. RNA was isolated at two hour intervals for an 18 hour period, or from 
cultures grown under various conditions to an OD6oo= 0.375 (cfu/mL= 3.0 x 107).
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For the environmental conditions, OD6oo= 0.375 (4 hour growth) was randomly 
chosen and represents mid-growth. Cells were pelleted and RNA was isolated 
using a modification of extraction protocols previously outlined (113,134).
Briefly, lysis of cells was executed by resuspending the cell pellet in 1 mL RNA 
Lysis buffer (4 M guanidium thiocyanate, 25 mM sodium citrate, 0.5% Sarkosyl, 
0.01 M p-mercaptoethanol). The cell resuspension was transferred to a 1.5 mL 
bead-beater tube filled 1/3 with 0.1 pm glass beads. The resuspension was 
subjected to two rounds of bead-beating and the lysate transferred to a 1.5 mL 
microcentrifuge tube. RNA was purified using acid phenol and chloroform 
extractions, in which equal volumes of acid phenol and chloroform were added to 
lysate. Prior to extractions, acid phenol was pre-warmed to 65°C. RNA was 
separated from phenol/chloroform by centrifugation at 16000 x g. The upper 
aqueous layer containing RNA was transferred to a sterile nuclease-free 
microcentrifuge tube. Phenol and chloroform extractions were repeated until a 
white precipitant interface no longer appeared between the two layers. The 
upper aqueous layer was transferred to a sterile microcentrifuge tube and 
precipitation of RNA was achieved by adding 0.1 volume diethylpyrrocarbonate- 
treated 5 M ammonium acetate and 2.5 volumes 95% reagent ethanol, followed 
by precipitation at -20°C for 18 hours. Following centrifugation at 16000 x g for 
20 minutes, the RNA pellet was washed once with RNAse-free 70% ethanol. 
Precipitated RNA was resuspended in 200 pL of RNA Storage Solution and, to 
facilitate resuspension, the RNA was heated to 65°C for 10 minutes. RNA was 
stored at -20°C for further use. For long term storage, RNA was stored at -80°C.
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DNase-treatment of RNA isolate. To remove residual DNA
contamination, total RNA was treated with RQ1 RNase-Free DNase in 
accordance with manufacturer’s instructions. Briefly, 20 pL total RNA was 
diluted in 1X RQ1 RNase-Free DNAse Reaction Buffer, 1U RQ1 RNAse-Free 
DNase, and nuclease-free water to a final volume of 100 pL. Reactions were 
incubated at 37°C for three hours. Following incubation, digestion was 
terminated with the addition of 2 pL of RQ1 DNase Stop Solution followed by 
incubation at 65°C for 10 minutes. DNase-treated RNA was stored at -20°C or 
for long-term storage at -80°C.
Reverse-transcription-polymerase chain reaction (RT-PCR). Total 
RNA was used in RT reaction as outlined by manufacturer’s instructions for the 
Improm-ll™ Reverse Transcription System. In brief, 25 ng total RNA was 
incubated with 20 pmol of reverse primers specific for hylA, gyrA, or hasA (Table 
1) for 5 minutes at 70°C to anneal primers to RNA template. Following 
incubation, the reaction was immediately cooled at 4°C for 5 minutes. A master- 
mix containing 3 mM MgC^, 1X ImProm-H™ Reaction Buffer, 0.5 mM dNTP, 20 U 
Recombinant RNasin® Ribonuclease Inhibitor, 1 pL ImProm-ll™ Reverse 
Transcriptase, and nuclease-free water was added such that the RT reaction had 
a final volume of 20 pL. Negative controls, which tested for DNA contamination, 
were prepared where ImProm-ll™ Reverse Transcriptase was not added to the 
reaction. Synthesis and extension of cDNA was achieved by incubating 
reactions at 37°C for one hour. Inactivation of the reverse transcriptase was
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performed by heating the reaction to 70°C for 15 minutes. Newly synthesized 
cDNA was stored at -20°C until use in either a standard PCR reaction or in a 
real-time PCR reaction as described below.
Standard PCR reactions for the amplification of a 90 bp fragment of hylk 
contained 2 pL cDNA, 1X Taq DNA Polymerase Buffer, 2.5 mM MgCh, 1.6 mM 
dNTP, 1 U Taq DNA Polymerase, 20 pmol forward and reverse primers (Hyl-K, 
Hyl-L; Table 1), and nuclease-free water to a final volume of 25 pL. Amplification 
was achieved using the protocol previously outlined (p. 38).
Preparation of standard curve for real-time analysis. Chromosomal 
DNA from S. pyogenes ATCC strain 10403 was quantified using an Eppendorf 
Biophotometer. Chromosomal DNA was serially diluted and an aliquot of each 
dilution was used in a real-time PCR reaction (TaqMan assay) on a Smart 
Cycler® system (Cepheid, CA). Real-time PCR reactions were prepared such 
that each reaction contained 10 pL DNA, 1X Taq DNA Polymerase Buffer,
2.5 mM MgCh, 1.0 mM dNTP, 20 pmol each forward and reverse primer [specific 
for hylk (Hyl-K, Hyl-L; Table 1; Fig. 3), gyrA (GyrA-F, GyrA-R; Table 1), or hasA 
(HasA-F, HasA-R; Table 1)], 3.0 pmol fluorescein-labeled probe specific for hylk, 
gyrA, or hasA (Table 1), 1 U Taq DNA Polymerase, and sterile water to a final 
volume of 25 pL. The program used to amplify hylk was: initial denaturation at 
95°C for 75 seconds without optics, followed by 45 cycles of denaturation at 
95°C for 5 seconds without optics and an annealing/extension stage at 49°C for 
40 seconds with optics. The programs for gyrA and hasA were similar to that of 
hylk with the exception of the annealing temperature, which was adjusted to
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55°C and 59°C, respectively. Each dilution was programmed as a standardized 
sample on the Smart Cycler® system and cycle threshold value, the cycle at 
which fluorescence becomes significant above background fluorescence, for 
each was plotted accordingly. Resultant standard curves were used for 
determination of relative transcript amounts in subsequent experimental 
reactions.
Quantitative polymerase chain reaction (Real-time PCR). Real-time 
PCR was carried out essentially as previously described (24). An aliquot of 
cDNA from a RT reaction, no-RT controls, and fluorescein-labeled probes were 
used in TaqMan assays on a Smart Cycler® system for detection of hylk, gyrA, 
and hasA as described above. The cycle threshold for each sample was plotted 
against a standard curve and raw abundance values for transcript quantities 
were determined. The hylk cDNA raw abundance values were normalized 
against gyrA cDNA raw abundance values (hylk cDNA quantityIgyrA cDNA 
quantity) to determine relative hylk expression from each RNA isolate. The 
same procedures were performed for the determination of hasA transcript levels. 
The process was repeated in triplicate from at least two independently isolated 
RNA preparations. The mean normalized value from each isolation was used to 
determine the overall mean normalized value for the sample (mean from all 
extractions). The mean +/- the standard error of the mean for each sample is 
reported.
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Comparison between intracellular and extracellular hyaluronate 
lyase. Eighteen hour cultures of S. pyogenes strains were diluted 1:100 into 
pre-warmed THB containing 5% horse serum. The cultures were grown for 
periods of 12 hours with 1 mL aliquots collected at 1 hour time points. Cells 
were pelleted by centrifugation at 16000 x g, supernatant was collected and 
assayed for hyaluronate lyase activity by dispensing 20 pL into wells in a 
hyaluronidase assay plate as previously described (76). To remove 
bound/attached extracellular hyaluronate lyase from cells, cell pellets were 
washed twice by resuspending in 1mL 0.89% saline solution, pelleting by 
centrifugation at 16000 xg. To release any intracellular hyaluronate lyase, cell 
pellets were lysed by resuspending cells in 500 pL of Lysis Solution (1XTE  
Buffer (Tris-HCI, EDTA pH 8.0); 50 mg/mL Lysozyme), followed by incubation at 
37°C for one hour. Following incubation, cells were sonicated on ice for 5 one 
minute blasts at 35% on Virsonic Cell Disrupter. An aliquot of cell lysate was 
Gram stained to determine cell lysis. Cell debris was pelleted by centrifugation 
and twenty microliters of cell lysate was transferred into wells on a hyaluronidase 
assay plate as previously described; plates were incubated for eighteen hours. 
Following the addition of 2N acetic acid to the assay plate, zones of clearing 
surrounding the point of inoculation were measured.
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METHODS FOR HYALURONATE LYASE GENE SIZE VARIABILITY STUDIES
Bacterial strains and hyaluronate lyase assay. Strains of S. pyogenes 
used in this study are outlined in Appendix II. Strains 350, 422, 872,1020,1055, 
and 94-146, along with ATCC strain 10403 and strain SF370 (M-type 1) were 
used in the additional analysis described here. All strains were grown on Todd- 
Hewitt agar or Sheep Blood agar at 37°C. Hyaluronidase activity of the strains 
was detected using the BHB plates prepared as previously described (77). 
Escherichia coli strains were grown on 2x YT media supplemented with 
antibiotics as required.
Crude lysis of S, pyogenes for PCR. DNA was obtained from 176 
strains of S. pyogenes using a crude cell lysis procedure previously described 
(79). In brief, a 2mL overnight culture of S. pyogenes was pelleted by 
centrifugation at 16000 x g. The supernatant was removed and ceil walls were 
weakened by resuspending pellets in 1 mL STE buffer (20% sucrose, 10mM 
Tris-HCI pH 8, 1Q0mM NaCI, 1mM EDTA) containing 25mg/mL lysozyme and 
50U/mL mutanolysin, followed by incubation at 37°C for 1 hour. Cell suspension 
was centrifuged, supernatant was removed, and cells were lysed by 
resuspending and incubating the cell pellet in 1 mL lysis buffer (100 mM KCI, 
1GmM Tris-HCI pH 8.3, 0.1mg/mL gelatin, 0.45% Igepal, 0.45% Tween 20) 
containing 100|jg/mL proteinase K for 1 hour at 60°C. After incubation, 
proteinase K was inactivated by heating to 95°C for 10 minutes. DNA from each 
of the 176 strains was analyzed for the presence of hylA by PCR as described
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earlier (p. 38). Primers derived from the sequence of hylk were used to amplify 
the 3’ regions (Hyl-B, Hyl-D; Fig. 3) of all tested strains and are listed in Table 1. 
Additionally, the entire gene (Hyl-A, Hyl-B; Table 1; Fig. 3), the internal region 
(Hyl-E, Hyl-F; Table 1; Fig. 3), and the 5’ region (Hyl-A, Hyl-C; Table 1; Fig. 3) of 
the gene were amplified. DNA fragments were amplified using Taq DNA 
polymerase, or Takara Ex Taq. PCR products were electrophoresed on a 0.8% 
TBE agarose gel at 150V for 1.5 hours.
Cloning of the 3’ region of the hyaluronate lyase gene. PCR amplified 
3’ regions from strains 350, 422, 872, 1020,1055, 94916, 10403, and SF370 
were cloned into E. coli using either the pCR 2.1 vector system or the pGEM-T 
Easy vector system according to the manufacturer’s instructions. Briefly, 3’ 
amplicons were ligated with the above vectors using the protocol described 
above. Ligation mixtures were incubated with competent E. coli strain JM109 on 
ice for 1 hour; cells were heat shocked at 42°C for 90 seconds and allowed to 
express in SOB at 37°C for 1 hour, then plated on 2x YT agar containing 
10Opg/mL ampicillin, X-GAL, and IPTG. Blue-white screening allowed for the 
picking of colonies that contained an insert. Transformants were screened either 
by restriction enzyme digestion or by PCR using primers specific for the 3' region 
of hylk. Plasmids containing the cloned 3’ region from each of the six strains 
were sequenced using the dideoxy-sequencing method outlined for the ABI 
PRISM 310 Genetic Analyzer. Standard M13 sequencing primers (M13-Forward 
and M 13-Reverse; Table 1) and two primers internal to the cloned fragment (Hyl- 
M and Hyl-N; Table 1; Fig. 3) were used. The fragments were sequenced in
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both directions. Alignment and homology analysis was performed using the 
Vector NT I Suite (InforMax, MD).
Isolation of chromosomal DNA from S. pyogenes strains containing 
the smaller hyaluronate lyase gene region. Chromosomal DNA was isolated 
from the six strains of S. pyogenes using a previously described protocol (73). 
Briefly, a 50 mL overnight culture of S. pyogenes was diluted 1:1 in pre-warmed 
THB supplemented with 5% horse serum and incubated at 37°C for 1 hour. To 
weaken the cell wall, 1 g sterile glycine was added to the culture and the cultures 
incubated for an additional 1 hour at 37°C. Cells were pelleted by centrifugation 
at 15300 x g for 10 minutes. Pellets were resuspended in 5 mL Lysis buffer 
(10 mM Tris-HCI pH 8,1 mM EDTA pH 8, 50 mg/mL lysozyme, 50 U/mL 
mutanolysin) and incubated at 37°C with shaking. To inactivate nucleases 
200 pg/mL proteinase K and 0.6% sodium dodecyl sulfate (SDS) were added to 
the lysate. Following incubation at 55°C for 1 hour, 25 mL GES (200 mM 
guanidium thiocyanate, 100 mM EDTA pH 8,10% sarkosyl) was added and 
incubated on ice for 10 minutes. Next, 15 mL 7.5 M ammonium acetate and 
25 mL chloroform: isoamyl alcohol (24:1) mix were added. After centrifugation, 
the upper aqueous layer was collected and DNA was precipitated with 0.6 
volume isopropanol at 4°C. Precipitated DNA was pelleted by centrifugation at 
15300 x g, washed with 70% ethanol, and resuspended in TE buffer (10 mM 
Tris-HCI pH 8, 1 mM EDTA pH 8). DNA was further treated one or more times 
with phenol: chloroform extractions, and then concentrated by precipitation by 
adding 0.1 volume 3M sodium acetate pH 5 and 2 volumes 95% ethanol. The
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chromosomal DNA was digested with EcoRI, electrophoresed on a 0.8% TBE 
agarose gel, and transferred by capillary action to a membrane using a standard 
protocol for Southern blotting.
Southern blot hybridization using hylk. Southern blot analysis was 
utilized to confirm the presence of the 3’ region of hylk in the chromosomal DNA 
of strains of S. pyogenes that possess a smaller hylk. Southern blot analysis 
was performed as outlined (6). Following transfer of the DNA to a nylon 
membrane, the DNA was cross-linked to membrane by baking for 30 minutes at 
80°C, followed by ultraviolet-cross-linking. The membrane was pre-hybridized 
with standard hybridization buffer (5X SSC, 0.1% N-lauroylsarcosine, 0.02% 
SDS, 1% Blocking reagent), rotating at 68°C, for at least 2 hours and was 
hybridized overnight, rotating at 68°C, using either a PCR amplified 3’ fragment 
or internal region of hylk labeled with digoxigenin (DIG). Un-hybridized probe 
was removed by subsequent washes. Initially, the blot was washed twice at 
room temperature with a 2X wash solution (2X SSC, 0.1% SDS), followed by two 
washes at 68°C in 0.5X wash solution (0.1X SSC, 0.1% SDS) with constant 
agitation. Following the washes, the membrane was blocked in 1 % blocking 
reagent for 30 minutes and then incubated for 1 hour in 1% blocking reagent 
containing 150 mU/mL anti-DIG-AP. Unbound antibody was removed by 
washing twice in 100 mL washing buffer (0.1 M maleic acid, 0.15 NaCI; adjusted 
to pH 7.5, 0.3% Tween® 20). After washes, the blot was equilibrated in detection 
buffer (0.1 M Tris-HCI, 0.1 M NaCI, 50 mM MgCI2, pH 9.5). The blot was
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developed using the color-substrate solution (detection buffer, NBT/BCIP stock 
solution).
Preparation of the DIG-labeled probe was achieved by heat denaturing 
15 pL purified PCR amplified 3’ or internal regions of hylk for 10 minutes. To the 
denatured DNA, 1X hexanucleotide mix, 1 mM dNTP mix, and 2U Klenow 
fragment of E. coli DNA polymerase I was added. The mix was incubated at 
37°C for at least 1 hour. Following incubation, the reaction was stopped by the 
addition of 0.2 M EDTA, pH 8.0. The labeled DNA was precipitated by 
incubation in 4M lithium chloride (LiCI) and pre-chilled 95% ethanol at -80°C for 
30-60 minutes. Following precipitation, the labeled DNA was pelleted by 
centrifugation at maximum speed for 15 minutes and the pellet washed with cold 
70% ethanol. The DNA was resuspended in 50 pL nuclease-free water and was 
ultimately added to hybridization buffer for blotting. The probe was stored at 
-20°C.
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METHODS FOR INACTIVATION OF hylA STUDIES
Bacterial cultures used in the preparation of a hylA knock-out 
mutant strain 10403:AA»y/A. S. pyogenes ATCC strain 10403 was grown on 
Sheep Blood agar at 37°C, or was inoculated into THB containing 5% horse 
serum grown at 37°C. S. pyogenes strain 10403::pHAS:fry/A (76) was grown on 
THB or THA containing 2.5 pg/mL erythromycin. E. coli strain TOP10F’ 
containing the plasmid pCRNT/T7: hylA (from the culture collection of Dr. W. 
Hynes, Old Dominion University, Norfolk, Virginia) was grown in 2x YT medium 
supplemented with 100 pg/mL ampicillin and grown at 37°C. E. coli strain DB11 
containing plasmid pUC:erm (obtained from the culture collection of Professor 
J.J. Ferretti, University of Oklahoma Health Sciences Center, Oklahoma City, 
Oklahoma) was grown in 2x YT medium supplemented with 250pg/mL 
erythromycin.
Enzymatic digestion of the hyaluronate lyase gene. The plasmid 
containing hylA, pCRNT/T7: hylA, was isolated from E. coli strain TOP10F’ using 
standard protocols (6) and was digested with the restriction enzyme EcoRV. 
EcoRV digests hylA in such a way that a 924 bp internal fragment is removed 
from the gene. The digested plasmid was electrophoresed on a 0.8% TBE 
agarose gel at 150V for 1.5 hours. The 4484 bp fragment was isolated from the 
agarose gel using the QIAEX II Gel Extraction Kit as described. To prevent the 
fragment from re-annealing, the digested fragment was subjected to a calf 
intestine alkaline phosphate (CIAP) treatment. Briefly, CIAP buffer was added to
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the purified fragment to a final volume of 50 pL. CIAP (1U) was added and the 
reaction mixture was incubated at 37°C for 30 -  60 minutes, followed by heat 
inactivation at 85°C for 15 minutes. The ClAP-treated plasmid was stored at 
-20°C.
Isolation of the erythromycin resistance gene from the plasmid 
pUC:erm. To isolate the erythromycin resistance gene (ermR) from the plasmid 
pUC:erm, the plasmid was digested with restriction enzymes, EcoRI and Hind\\\. 
Digestion of the plasmid with these restriction enzymes removes a 1162 bp 
fragment, which encodes ermR. The digest was electrophoresed on a 0.8% 
agarose gel in TAE buffer and the 1162 bp fragment was purified from the gel 
using the QIAEX II Gel Extraction Kit. Following purification, the recessed ends 
of the digested fragment were “filled-in” using standard protocols (6). Briefly, the 
digested fragment was incubated in the presence of the Klenow fragment of E. 
coli DNA polymerase I and all dNTPs. Following the blunt-ending, the ermR was 
ligated with EcoRV-digested pCRNT/T7:/?y/A using standard protocols (6); the 
resulting plasmid was transformed into E. coli strain JM109 and plated on 2x YT 
broth containing 1 mg/mL erythromycin. Selected colonies were screened by 
restriction enzyme digestion. One clone was chosen for further analysis and was 
sequenced using the internal hylk primer Hyl-E (Table 1) to confirm the presence 
of ermR. Sequencing reactions were prepared using the dideoxy-sequencing 
method outlined for the ABI PRISM 310 Genetic Analyzer. Once the presence of 
ermR was confirmed to be contained in the plasmid, primers specific for 
hylk'.ermR region (Hyl-N, Hyl-O; Table 1; Fig. 3) were used for PCR
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amplification. The amplified fragment was purified and was electroporated into 
S. pyogenes strain 10403 (142). Following electroporation and expression in 
THB for 3 hours at 37°C, the culture was plated on THA containing 2.5 jjg/mL 
erythromycin and incubated at 37°C. Colonies were selected for erythromycin 
resistance and were assayed for loss of hyaluronate lyase activity using the BHB 
assay plate (77).
Southern blot analysis for the presence of ermR. Chromosomal DNA 
was isolated (73) from colonies that were erythromycin resistant and HylA', as 
well as from wild-type S. pyogenes strain 10403. The DNA was digested with 
EcoRl and was electrophoresed on a 0.8% agarose gel. The plasmid pUC:erm, 
digested with EcoRl and Hind\\\ (drops out ermR), was also included on the gel. 
The DNA was transferred to a membrane for Southern blot analysis using 
standard protocols (6), and the membrane was hybridized with DIG-labeled 
probes specific for hylk and ermR. The blot was developed using standard 
methods.
Growth curve comparison between wild-type strain 10403 and 
mutant strain 10403A/iy/A. To compare the growth of wild-type S. pyogenes 
strain 10403 and mutant strain 10403A/?y/A, an overnight culture of each was 
diluted into fresh Todd-Hewitt broth (THB) supplemented with 5% horse serum 
and incubated at 37°C. Samples were taken at 60-minute intervals for 
determination of optical density at a wavelength of 600nm.
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Assay for hemolysin activity. To determine hemolysin activity, a single
bacterial colony was stabbed onto Sheep Blood Agar and incubated at 37°C 
overnight. Hemolysin activity was observed as a zone of clearing around the 
point of inoculation.
Assay for protease activity. Cysteine protease activity was determined 
by stabbing a single bacterial colony onto a plate containing Columbia Blood 
Agar and 3% Carnation Skim Milk (81). Cultures were incubated at 37°C 
overnight. Protease activity was indicated by a zone of clearing surrounding the 
point of inoculation.
Preliminary analysis of the role of hyaluronate lyase in streptococcal 
infection. An overnight culture of a single-recombinant mutant strain 
10403::pHAS: hylA (76), which no longer produces hyaluronate lyase, was 
diluted 1:100 into 99 mL pre-warmed THB supplemented with 5% horse serum. 
The culture was grown for 6 hours until cells were in late log phase, pelleted by 
centrifugation at 15300 x g, and washed twice with isotonic saline solution. The 
pellet was resuspended in 1.5 mL of isotonic saline, and a viable count carried 
out (53). One hundred pL of cell suspension was injected subcutaneously into 
each of 5 CD-1 white mice. Mice were observed for formation of lesions or 
abscesses. Once a lesion was observed, the wound was swabbed and plated on 
blood agar plates. Beta hemolytic colonies that grew were analyzed for 
erythromycin resistance, the production of catalase, and for the production of 
hyaluronate lyase. Mice were observed for a period of two weeks. The entire
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procedure was performed on two separate groups of mice. Following 
experimentation, mice were euthanized by subjection to excessive carbon 
dioxide. Prior to experimentation to this animal study, protocols used were 
reviewed and approved by the university’s Institution for Animal Care and Use 
Committee (IACUC) (IACUC Protocol # 00-001).
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RESULTS OF REGULATORY STUDIES 
Hyaluronate lyase activity from strain 10403 during bacterial growth.
Since the time of hyaluronate lyase production by strain 10403 was not known, 
the point at which HylA activity is detected from this strain was determined. HylA 
activity was assessed by applying cell-free culture supernatants obtained over a 
10 hour period, as well as from an 18-hour culture, to a standard hyaluronate 
lyase assay plate (76). Hyaluronate lyase activity was evaluated by observing 
and measuring the diameter of the zone of clearing surrounding the well 
containing the supernatant (Fig. 4). A zone of clearing, indicating hyaluronate 
lyase activity, was first observed at hour two, increased in size until hour 10, and 
remained constant to hour 18.
The time of production for HylA was then correlated with growth. A 
culture of strain 10403 was grown; turbidity was measured at a wavelength of 
600 nm, and assayed for hyaluronate lyase activity each hour for a 10 hour 
period. HylA activity was detected in the early exponential stage of the growth 
cycle. To ascertain the titer of hyaluronate lyase for each time point, the 
supernatant was serially diluted and assayed (Table 2). The titer represents the 
inverse of the greatest dilution of the supernatant to give detectable clearing on a 
hyaluronidase assay plate; this dilution was considered to contain 1 AU. HylA 
titer leveled off at 64 arbitrary units (AU) around hour 7. Culture turbidity and 
specific enzymatic activity (AU/log cfu/mL) were measured and plotted against 
time (Fig. 5).
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Determination of promoter region for hylA from strain 10403. Since 
HylA activity was detected as early as hour 2, it was of interest to establish how 
this gene is regulated. The promoter for hylA is not characterized. Sequence 
analysis of the 3510 bp fragment containing hylA proposed two potential start 
sites, a GTG and an ATG initiation codon. Analysis of the sequence upstream 
revealed a typical ribosome binding site (RBS) 9 bp upstream of the GTG site 
and further upstream were additional regions that resemble potential promoters. 
No RBS or similar promoter region was found appropriately placed upstream of 
the ATG. Since it was only suggestive that promoter activity exists upstream of 
the GTG site or potentially between the two possible start sites, the promoter 
activity of these regions was analyzed by cloning upstream of a promoter-less 
gfp gene. A 128 bp region upstream of the GTG site, a 198 bp region upstream 
of the ATG site (encompassing the GTG site), and a 90 bp region between the 
two sites were PCR amplified. E. coli clones and the plasmids obtained were 
named pSW5-GTG (Fig. 6), pSW5-ATG, and pSWGTG-ATG, for each of the 
respective cloned inserts.
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FIG. 4. Hyaluronate lyase activity of strain 10403 over an 18-hour period 
was determined by the zone of clearing in a plate assay. An increase in the 
zone of activity for hyaluronate lyase was detected up to 10 hours.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
61
Enzymatic activity 
OD600
0 1 2 3 4 5 6 7 8 9  10
Time in hours
FIG. 5. Growth curve and specific enzymatic activity of strain 1Q403 over 
a 10 hour period. Enzymatic activity (representative of hyaluronate lyase 
activity) plotted with growth indicated that HylA activity is produced in early 
exponential phase.
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TABLE 2. Hyaluronate lyase titer of culture supernatants collected over a 10 
hour period
Sample (Timepoint) Titer1 Specific Enzymatic Activity2
0 No activity detected 0
1 No activity detected 0
2 1 AU 0.153
3 2 AU 0.284
4 4 AU 0.532
5 8 AU 1.010
6 16 AU 2.015
7 64 AU 7.947
8 64 AU 7.949
9 64 AU 8.028
10 64 AU 8.443
1- Titer recorded as arbitrary units per mL (AU). The greatest dilution of the 
supernatant to give detectable clearing on hyaluronidase assay plate was 
considered to contain 1 AU.
2- Specific enzymatic activity is the equivalent of titer/(log cfu/mL).
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FIG. 6. Plasmid map of construct pSW5-GTG containing the 128 bp 
fragment of hylA GTG fused to gfp. Plasmid pSW5-GTG was prepared such that 
it contains a hylA promoter-gfp fusion. The primers and their locations for 
sequencing are marked.
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Upon exposure to ultraviolet light, fluorescence was observed, indicating 
promoter activity. However, it was found that some strains of E. coli (DB11) 
were found to fluoresce poorly, whereas other strains (JM109, BHB2600) 
fluoresced quite well. When E. coli strain JM109 was used, two of the three 
regions possessed promoter activity. E. coli containing pSW5-GTG and pSW5- 
ATG glowed fluorescent green when exposed to ultraviolet light, whereas no 
fluorescence was observed from E. coli containing pSWGTG-ATG. Plasmids 
were isolated and sequenced to confirm the presence of the fragments and the 
integrity of the sequence. Sequence analysis confirmed the presence of the 
fragment and that no mutations were introduced by the PCR.
Since pSWGTG-ATG did not show promoter activity and contained a 
90 bp portion of a fragment identical to that of pSW5-ATG, a plasmid having 
promoter activity, it was anticipated that a transcript for the 90 bp fragment would 
be present in strain 10403 as part of hylk transcript. RNA was isolated from 
strain 10403 and analyzed by RT-PCR for the presence of transcript for the three 
regions screened for promoter activity. RT-PCR analysis, using primers Hyl-K 
and Hyl-L (Table 1) showed the presence of a band approximately 90 bp in size; 
however, screening by RT-PCR for transcripts for the region upstream of GTG 
did not result in any amplicons. These results suggest that the promoter region 
was contained in a region upstream of the GTG codon.
Insertion of gfp into S. pyogenes strain 10403. Once the region that 
contained promoter activity in E. coli was determined, the fragment as a gfp 
fusion was excised from the plasmid and inserted into a streptococcal integration
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
vector, p7int (114). By inserting the hylk promoter region-gfp into p7int, it was 
possibfe to integrate the construct (Fig. 7) into the streptococcal chromosome 
without disrupting hylk  and would allow for determination of promoter activity. 
Therefore, both hyaluronate lyase and the hylk promoter-induced GFP would be 
detected. Following electroporation of the new plasmid into S. pyogenes strain 
10403, colonies were screened for erythromycin resistance, hyaluronate lyase 
activity, fluorescence, and (3-hemolysis. Fluorescence was not immediately 
detectable in streptococcal cells. However, using a fluorescent microscope with 
an excitation wavelength of 365 nm and an emission wavelength of 470 nm, 
green fluorescent protein production was observable in some clusters of cells. 
Although green fluorescent protein expression in 10403 was apparent, the 
fluorescing cells were difficult to visualize, as some cells showed a degree of 
autofluorescence (Fig. 8). Autofluorescence was particularly noticeable in 
regions of high cell density.
Since the lack of, or poor, fluorescence in strain 10403 may have been 
due to there being only one copy of gfp in the cells, the same promoter-gfp 
fusion, as inserted into p7int, was inserted into the shuttle vectors pAT28 and 
pAT29 (157), which can replicate in S. pyogenes, thereby resulting in multiple 
copies of gfp in the cells. These plasmid constructs were electroporated into 
strain 10403 and resulting colonies were screened for spectinomycin resistance, 
hyaluronate lyase activity, (3-hemolysis, and fluorescence, Crude cell lysis was 
performed on the resulting clones and the DMA was screened for gfp by PCR. 
PCR resulted in amplification of a single fragment of the approximate size of gfp
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(Fig. 9). Although gfp was inserted into strain 10403, poor fluorescence was still 
observed.
Standard RT-PCR analysis for the detection of hylk transcript in 
strain 10403. Since the gfp reporter assay proved a difficult assay for 
hyaluronate lyase expression in S. pyogenes, an alternative methodology was 
utilized in which RNA transcript levels for hylk were followed. Because HylA was 
detected throughout the growth cycle of strain 10403, hylk expression was 
anticipated to be constitutive. Alternatively, gene expression may have occurred 
early and the protein then being detected throughout growth. To assess the 
presence of hylk transcript, RNA was isolated from strain 10403 every two 
hours, beginning at hour zero, for a period of 10 hours. Reverse transcriptase 
reactions, containing equal concentrations of total RNA, were used to synthesize 
cDNA from any hylk transcript and the resultant cDNA was utilized in PCR for 
amplification of a 90 bp region of the hylk transcript. This region corresponds to 
the 90 bp between the potential start sites, GTG and ATG, which was amplified 
using specific primers (Hyl-K, Hyl-L; Table 1; Fig. 3). Electrophoresis of the 
resultant cDNA indicated the presence of a transcript at all time points, 
suggesting constitutive expression (Fig. 10).
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FIG. 7. Plasmid construct p7int-hylgtg-gfp. This construct was prepared 
for the integration of gfp fused to the hylA promoter into the chromosome of S. 
pyogenes strain 10403.
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FIG. 8. Fluorescence of S. pyogenes strain 10403. Cells containing gfp 
were directly viewed by fluorescent microscopy with an excitation wavelength of 
365 nm and an emission wavelength of 470 nm. Frame A shows cells exhibiting 
GFP, as indicated by the arrow, following electroporation, whereas frame B 
contains wild-type strain 10403 and exhibits only auto-fluorescence.
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FIG. 9. PCR results showing the presence of gfp in S. pyogenes strain 
10403. Primers specific for gfp were used in PCR and amplified a fragment 
approximately 750 bp in size from 4 colonies of S. pyogenes strain 10403 (Lanes 
B-E), which had been electrotransformed with the plasmid pAT28:gfp. Lane A: X- 
sty MW ladder; lane F: pJC2 (contains gfp).
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FIG. 10. Gel showing results of standard RT-PCR indicating the presence 
of hylA transcript throughout the growth of strain 10403. Using primers specific 
for a 90 bp region of the hylA transcript, the desired transcript was detected over 
eighteen hours. The samples are annotated as a RT-PCR sample (+), where 
reverse transcriptase was included in the reaction or a PCR sample (-), where no 
reverse transcriptase was added.
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Real-time quantitative PCR for the quantitation of hylA transcript in 
strain 10403. Because standard RT-PCR does not represent the amount of 
hylk  transcript for each time point, real-time quantitative PCR was utilized.
Equal amounts of total RNA were used in reverse transcription for the synthesis 
of cDNA for hylA and an internal control gyrA, which is constitutively expressed 
in S. pyogenes strain NZ131 (24). Reverse transcription and real-time PCR 
analysis of RNA from strain 10403 confirmed that gyrA expression was also 
constitutive in strain 10403. Prior to real-time analysis, genomic DNA from strain 
10403 was used to generate standard curves for hylA and gyrA, which were 
used for the relative quantification of the cDNA. For real-time PCR analysis, an 
aliquot of cDNA was used in reactions for the amplification of hylA and gyrA 
cDNA. Any DNA contamination that may have been contained in the RNA 
sample following DNase-treatment, as determined by the reverse transcriptase 
negative control, was subtracted from each value. The quantity of cDNA for 
hylA, representative of the amount of hylA transcript, was normalized to that of 
gyrA present in each RNA sample from the various time points. The results for 
strain 10403 revealed an increase in the quantity of hylA transcript during early 
to mid-exponential phase (2-4 hours) of the growth cycle, followed by a decrease 
at hours 6-8. The pattern of expression for hylA in strain 10403 showed a bi- 
modal pattern, in which hour 8 had a very low level of hylA transcript, whereas 
hour 18 had an increase in transcript amounts. Analysis of the hours between 8 
and 18 indicated an increase in hylA transcript at hour 10 that remained steady 
through to hour 16, which was followed by another increase at hour 18 (Fig. 11).
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Comparison of h y lk  transcript levels between different strains of S.
pyogenes. Different strains of S. pyogenes were analyzed for the presence of 
hylk transcript. Transcript levels of strain SF370, an acapsular and non- 
hyaluronate lyase producing strain, and strain 71698, an encapsulated and non- 
hyaluronate lyase producing strain, were investigated and compared to strain 
10403. Cultures of each strain were grown for up to 8 hours with RNA isolated 
every two hours, as well as from an 18-hour culture. Reverse transcriptase 
reactions were carried out for hylA and gyrA cDNA for each sample. The hylk 
raw abundance cDNA values were normalized against the respective gyrA value 
(Appendix III). Neither strain produces active HylA, but both had detectable hylk 
transcript. Analyzing the transcript levels over time for the two strains showed a 
gradual increase over the early to mid-exponential phase (4 hours) of the growth 
cycle, followed by a gradual decrease (Fig. 12). The two non-producing strains 
were found to have a single peak of hylk expression, as compared to the 
bimodal pattern seen in strain 10403. Expression of hylk by strain 71698 was 
greater than that seen in the other two strains, having a peak in transcript level at 
hour 4, followed by a decline. The levels of transcript for strain 71698 were at 
least two times greater than that observed for strain 10403 over the first eight 
hours of growth.
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FIG. 11. Relative quantity of hylA transcript determined over an 18 hour 
growth for strain 10403. The hylA cDNA values were normalized to gyrA cDNA 
values. The results shown are representative of at least two independently 
isolated RNA preparations analyzed in triplicate and represent the mean +/- the 
standard error of the mean for each sample.
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FIG. 12. Comparison of the level of hylk transcript from hyaluronate 
lyase-producing and non-producing strains. Transcript levels for strains 10403 
(acapsular, hyaluronate-lyase producer), SF370 (acapsular, non-hyaluronate- 
lyase producer), and 71698 (encapsulated, non-hyaluronate lyase producer) 
were determined. The cDNA values for hylk were normalized against that of 
gyrA. The experiment was performed using RNA prepared from at least two 
independent RNA isolations for each strain analyzed in triplicate. Each strain 
was independently isolated. The results are representative of the mean relative 
quantity of hylk transcript ± the standard error of the mean.
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Determination of intracellular and extracellular hyaluronate lyase in 
strain 10403. Due to the bi-modal pattern of expression for hylk in strain 10403, 
it was possible a feedback inhibition mechanism may be responsible, such that 
the level of intracellular HylA was inhibiting expression of hylk at hour 8. To 
investigate this possibility, a culture of strain 10403 was grown for 18 hours with 
1 m l aliquots collected at each hour. Culture supernatants and cell lysates were 
assayed for hyaluronate lyase activity. To remove residual extracellular HylA, 
the pellets were washed with isotonic saline prior to lysis by sonication. The 
supernatant samples showed a gradual increase in the diameter of the zone of 
clearing surrounding around the well (Fig. 13). The cell lysate revealed a small 
zone of clearing for all time periods (Fig. 14). To determine that the zone of 
clearing was potentially due to bacteriophage hyaluronidase and not 
representative of intracellular HylA, the isogenic mutant strain 1Q403A/iy/A1 was 
assayed in the same manner. Since expression of hylk in strain 10403A/7y/A1 is 
interrupted and does not produce extracellular hyaluronate lyase, any zone of 
clearing would not be HylA. Assaying revealed the same small zone of clearing 
as seen from strain 10403.
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FIG. 13. Assay of strain 10403 for extracellular hyaluronate lyase activity 
over hours 0-10 and 18. Strain 10403 was grown for 18 hours with aliquots 
collected at each hour. Supernatant was assayed for hyaluronate lyase activity, 
seen as a zone of clearing surrounding the well.
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FIG. 14. Assay of intracellular hyaluronate lyase from strain 10403. 
Following sonication, assaying of cell lysate for HylA shows small zones of 
clearing. Lysates from hours 0-10 and 18 are shown.
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The effect of temperature on hylA expression. The effect of various 
temperatures that may be encountered in vivo during infection on the relative 
amount of hylA transcript over time was examined. Temperatures were chosen 
based on the normal temperatures that may be found on the skin (32°C), 
physiological temperature (37°C), and an elevated temperature representative of 
fever conditions encountered during streptococcal infection (42°C). An overnight 
culture, grown at each of the above temperatures, was inoculated into fresh 
media and incubated for 4 hours (ODeoo= 0.375/ cfu/mL= 3.0 x 107) at the 
specified temperatures. To determine the effect of temperature on hylA 
expression, cDNA was synthesized and quantified by real-time PCR. The raw 
absorbance values for hy/A were normalized against gyrA values to determine 
the relative transcript amount of hylA at the different temperatures. The assay 
was repeated in triplicate from at least two independently prepared RNA isolates 
for each environmental condition. The mean +/- the standard error of the mean 
is reported for each sample. No difference in the level of relative transcript for 
hylA at the different temperatures was seen, with each having approximately 
0.196 RU (Fig. 15). Additionally, no difference was seen in the HylA titer at any 
of the temperatures.
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FIG. 15. The effect of temperature on the level of hylk transcript in strain 
10403. RNA was isolated from cultures grown for 4 hours at temperatures 
(32°C, 37°C, and 42°C). The hylk cDNA values were normalized to gyrk cDNA 
values. The results shown are representative of at least two independently 
isolated RNA preparations for each strain and represent the mean +/- the 
standard error of the mean.
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Effect of pH on hylA expression in strain 10403. The influence of 
different pH levels on hylkexpression by strain 10403 was examined. The 
levels of pH were chosen based on the various pH levels that may be 
encountered during streptococcal infection. An aliquot of overnight culture grown 
at the specified pH was inoculated into fresh media (at the same pH) and 
incubated for 4 hours (OD6oo= 0.375/ cfu/mL= 3.0 x 107). The pH of culture 
supernatant was analyzed and did not show any change in the level of pH 
following growth. Bacterial growth was inhibited at pH 9.0 and therefore, was not 
included in this analysis. Transcript levels for each sample were quantified using 
real-time PCR and the values obtained for hylA were normalized against that of 
gyrA. A comparison of transcript levels between the samples showed little 
difference in the relative amount of hylk transcript between cultures grown at pH 
levels 7.4 and 7.6, 0.216 RU and 0.200 RU respectively; however, at the acidic 
pH (pH 5) a two-fold decrease was seen when compared to values obtained 
from pH 7.4 and 7.6 (Fig. 16). No difference was seen in the HylA titer at the 
different levels of pH.
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FIG. 16. The effect of pH on hylk transcript levels in S. pyogenes strain 
10403. To assess the effect of various pH conditions that may be encountered 
in vivo, RNA was isolated from cultures grown 4 hours under various pH 
conditions (pH 5, 7.4, 7.6) and real-time quantitation was performed. The values 
for hylk cDNA were normalized against cDNA values for the internal control, 
gyrA. The results shown are representative of the mean of at least two 
independent RNA isolations run in triplicate ± the standard error of the mean.
a  pH 5 
■  pH 7.4 
m pH 7.6
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The effect of aeration on hylk  expression. To establish the effect of 
different types of aeration on hylA expression, S. pyogenes strain 10403 was 
grown under aerobic, anaerobic, and increased carbon dioxide conditions. 
Anaerobic conditions were attained by making media anaerobic by incubation in 
an anaerobic jar. Increased carbon dioxide levels were obtained by placement 
of media in a candle jar. An aliquot of 18-hour cultures of S. pyogenes strain 
10403 grown under the various aeration conditions was inoculated into fresh 
media and incubated for 4 hours (OD6oo= 0.375/ cfu/mL= 3.0 x 107) accordingly. 
Cultures grown under anaerobic and increased carbon dioxide conditions had 
approximately the same relative quantity of hylk transcript, 0.349 RU and 0.361 
RU respectively; whereas, cultures grown aerobically had approximately 1,8-fold 
less (Fig. 17). The HylA titer representing active protein was determined to be 
the same for all three aeration conditions, 16-32 AU.
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FIG. 17. The effect of aeration on hylk expression in strain 10403. RNA 
was isolated from S. pyogenes strain 10403 grown under aerobic, anaerobic, 
and increased carbon dioxide conditions. Relative amounts of hylk transcript are
reported, which were obtained by normalizing hylk cDNA values against those of 
gyrA. The experiments were repeated using at least two independent RNA 
isolations; results are representative of the mean of the experiments ± the 
standard error of the mean.
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The effect of gaseous exchange on hylA expression in strain 10403.
To assess the effect of gaseous exchange (shaking) on hylk transcript levels, 
RNA was isolated from cultures grown for 4 hours at 37°C with and without 
shaking. Real-time PCR was utilized to quantify the amount of cDNA in each 
sample and the relative amount of hylk transcript was determined by normalizing 
the cDNA value for hylk against that of gyrA. No difference was seen between 
the two conditions when either relative transcript levels (Fig. 18) or HylA titer, 16- 
32 AU, was determined.
The effect of hyaluronic acid on hylA  expression in S. pyogenes 
strain 10403. The effect of the addition of 600 pg/mL hyaluronic acid on hylk 
expression by strain 10403 was examined. Cultures were inoculated into fresh 
media containing the same components, incubated for a period of 4 hours, and 
RNA isolated at two hour intervals. There was an approximately a 2-fold 
elevation in the amount of hylk transcript amount for cultures grown with the 
addition of 600 pg/mL hyaluronic acid at 2 and 4 hours, 0.304 RU and 0.527 RU, 
when compared to those grown without hyaluronic acid, 0.145 RU and 0.245 RU 
respectively (Fig. 19). No difference was seen in the titer of HylA produced by 
strain 10403 grown with or without hyaluronic acid.
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FIG. 18. The effect of gaseous exchange on hylk transcript levels in S. 
pyogenes strain 10403. The relative amount of hylk transcript was determined 
from RNA isolated from cultures of S. pyogenes strain 10403 grown at 37°C with 
and without exchange of gases (shaking). The values were determined by 
normalizing hylk cDNA values against gyrA values. The experiments were 
performed from at least two independent RNA preparations analyzed in triplicate. 
Results are representative of the mean relative quantity of hylk ± the standard 
error of the mean.
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FIG. 19. The effect of hyaluronic acid on hylA expression in S. pyogenes 
strain 10403. The relative amount of hylA transcript was determined from RNA 
isolated from cultures grown over a period of 4 hours with or without the addition 
of 600 pg/mL hyaluronic acid. Relative quantity of hylA transcript was 
determined by normalizing hylA cDNA values against gyrA values. The 
experiment was performed using RNA prepared from two independent isolations 
and analyzed in triplicate. Results are representative of the mean quantity of 
hylA transcript ± the standard error of the mean.
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A comparison between hylA and hyaluronic acid synthase (hasA) 
expression. Strain 10403 is acapsular and does not have a hasA transcript. 
Because of this, it was necessary to use a strain known to be encapsulated as 
well as having hylA transcript present. Unfortunately, an encapsulated, 
hyaluronate lyase-producing strain was not identified; as a result a strain that 
was a non-producer was utilized. Strain 71698 was used for the comparison of 
hasA and hylA expression. The relative amounts of transcript for hylA and hasA 
were determined by normalizing each cDNA value against that of gyrA. The 
relative amounts of hasA transcript in this strain were much greater than that of 
hylA, making it impossible to compare the pattern of expression for both genes in 
the same graph. The relative quantity of hasA transcript plotted against time is 
shown in Fig. 20 and hylA transcript levels are shown in Fig. 12. In strain 71698, 
hasA expression occurs primarily during the early to mid-exponential phase of 
growth, having the most transcript during hours 2 and 4, and is diminishing at 
later times. Between hours 4 and 6, a 50-fold decrease in the amount of hasA 
transcript is seen. Evaluation of the overall pattern of expression between hasA 
and hylA indicates that they follow the same pattern such that each increase to 
hour four then decrease, suggestive of a normal pattern of distribution. When 
comparing the amount of transcript between the two genes, a minimum of a 25- 
fold difference and maximum of 1800-fold difference between the relative 
amounts of transcript is observed.
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FIG. 20. Relative quantity of hasA transcript from strain 71698 grown 
over 8 hours, as well as from hour 18. Relative quantity of hasA transcript was 
determined by normalizing hasA cDNA values against gyrA values. The 
experiment was performed using RNA prepared from two independent isolations 
and was analyzed in triplicate. Results are representative of the mean relative 
quantity of hasA transcript ± the standard error of the mean.
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RESULTS OF HYALURONATE LYASE GENE SIZE VARIABILITY STUDIES
PCR analysis of S. pyogenes strains for hyaluronate lyase gene.
PCR analysis of the 3’ region of the hyaluronate lyase gene region from 176 
strains of S. pyogenes showed that all strains contained a region with size 
similarity to hylA\ however, 33 strains (20%) gave a smaller amplicon when 
compared to hylA of strain 10403 (Fig. 21). A comparison between hylA from 
strain 10403 and the PCR amplified hyaluronate lyase gene region (3510 bp) 
from these strains, which contain the smaller gene region, indicated a small 
difference in size, confirming the 3’ results (Fig. 22). PCR amplification of the 5’ 
region of the gene and an internal region from the strains resulted in an amplicon 
of the same size, 1.758 kb or 1.356 kb respectively, as that found in S. pyogenes 
strain 10403 (Fig. 23 and Fig. 24). Assaying those strains containing the 
smaller hyaluronate lyase gene for hyaluronate lyase activity revealed that there 
were both hyaluronate lyase-producing and non-producing strains (Fig. 25). A 
list of the 33 strains, which showed a smaller sized hyaluronate lyase gene 
relative to hylA, and their hyaluronate lyase activity, is in Appendix V.
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FIG. 21. PCR amplification of DNA from strains of S. pyogenes showing a 
decrease in the size of the 3’ region of a putative hyaluronate lyase gene relative 
to hylA. Lanes: A, strain 350; B, strain 422; C, strain 872; D, strain 1020; E, 
strain 1055; F, strain 94-146; G, strain 10403.
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FIG. 22. PCR amplification of the entire hyaluronate lyase gene of S. 
pyogenes. Using primers specific for the hyaluronate lyase region, all strains 
amplified a fragment; however, some strains showed a slight decrease in size 
when compared to strain 10403 (Lane I). Lane C is the same size as lane I. 
Lanes: A, X sty MW ladder; B, strain 350; C, strain SF370; D, strain 422; E, 
strain 872; F, strain 1020; G, strain 1055; H, strain 94-146, I, strain 10403.
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FIG. 23. PCR amplification of the 5’ region of the hyaluronate lyase gene. 
Primers specific for the amplification of the 5’ region of the hyaluronate lyase 
gene resulted in an amplicon of 1758 in size. Lanes: A, X sty MW ladder; B, 
strain 350; C, strain SF370; D, strain 422; E, strain 872; F, strain 1020; G, strain 
1055; H, strain 94-146,1, strain 10403. Due to the amount of DNA loaded, lanes 
D and F appear different in size.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
FIG. 24. PCR amplification of the interna! region of the hyaluronate lyase 
gene from S. pyogenes. PCR analysis of 176 strains for the detection of hylA 
using primers specific for the internal region indicated the presence of an 
approximately 1356 bp DNA fragment in each of the strains. The amplified DNA 
did not differ in size from the internal fragment of hylA obtained from 10403. 
Lanes: A, strain 350; B, strain 422; C, strain 872; D, strain 1020; E, strain 1055; 
F, strain 94-146, G, strain 10403.
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FIG 25. Hyaluronate lyase activity of six strains using the brain heart 
infusion-bovine albumin-hyaluronic acid assay plates. Hyaluronate lyase activity 
appears as a zone of clearing and was found in strains 422 (B), 1020 (C), and 
1055 (D). Strains 350 (A), 872 (E) and 94-146 (F) did not produce any obvious 
hyaluronate lyase activity.
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Southern blot analysis. To confirm that the region being amplified was 
the hyaluronate lyase gene region, Southern blot analysis was performed. 
Chromosomal DNA was isolated and digested with EcoRI (Fig. 26). Although it 
is not known where the enzyme EcoRI digests the chromosome of strain 10403, 
there are no sites within the 3.5 kb fragment sequenced. The sequence of strain 
SF370 indicates that following EcoRI digestion the hyaluronate lyase gene would 
be contained in fragments approximately 14.6 kb and 4.7 kb in length, as the 
hylA gene contains a single EcoRI site. However, by comparing the 3510 bp 
hyaluronate lyase gene regions from strains 10403 and SF370, it was found that 
fty/A from SF370 contains an EcoRI site, whereas the region from strain 10403 
does not, suggesting that hylA may be contained in a fragment approximately 
19 kb in length. Sequence analysis (Appendix V) indicated that an EcoRI site 
was contained in the 3’ region of the hyaluronate lyase gene of the strains 
containing the smaller gene. Once transferred to a membrane, the DNA was 
hybridized with either a 1.356 kb internal fragment of hylA or with a 992 bp 3’ 
region of hylA. Following development of the blot, hybridization with the 3’ region 
of hylA was observed (Fig. 27). The strains containing the smaller gene showed 
hybridization to the two fragment lengths predicted, while strain 10403 showed 
one fragment. In all of the samples, an extra band of similarity to the probe, 
approximately 2 kb in size, is evidenced and can be explained as non-specific 
hybridization. Hybridization of the internal probe to a fragment 19 kb in size was 
also observed.
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FIG. 26. EcoRI digested chromosomal DNA from strains containing a 
smaller hyaluronate lyase gene relative to hylA. Lanes: A, X sty MW ladder; B, 
strain 350; C, strain SF370; D, strain 422; E, strain 872; F, strain 1020; G, strain 
1055; H, strain 94-146, I, strain 10403.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
97
FIG. 27. Southern blot analysis showing similarity of the hyaluronate 
lyase gene from strains containing a smaller gene, relative to hyl.A. Although 
bands of hybridization can be seen only in samples C, G, H, and I due to 
photographic insensitivity, bands of the same sizes were present in all samples. 
The anticipated bands are marked with arrows. Lanes: A, X sty MW ladder; B, 
strain 350; C, strain SF370; D, strain 422; E, strain 872; F, strain 1020; G, strain 
1055; H, strain 94-146,1, strain 10403.
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Nucleotide sequence of the 3’ region for S. pyogenes strains 
containing a smaller hyaluronate lyase gene region relative to hylA. Six
strains'having the smaller 3’ region (350, 422, 872, 1020, 1055, and 94146) were 
used for sequence analysis. The six strains included apparently both 
hyaluronate lyase-producing and non-producing strains. The strains were 
isolated from different infections, as well as geographic locations (Appendix V). 
The 3' region of the hyaluronate lyase gene from these strains was cloned, 
sequenced, and compared to the sequence of S. pyogenes strains 10403 (76) 
and SF370 (46). Sequencing of the 3’ region indicated that the fragment was 
809 bp in length for these all strains; this is 183 bp shorter than the 992 bp 
fragment of hylA. Sequences of the 3’ region from these strains can be found in 
Appendix VI.
Alignment of the sequences, with that of hylA, revealed very few 
differences in the nucleotide sequence between the different strains relative to 
hylA, with the exception of a deleted region. Analysis indicated that a deletion of 
183 bp occurred in the same location in all the strains. This was located 
between positions 2273-2455 of hylA from strain 10403 (Fig. 28). Additional 
analysis of the nucleotide sequence indicated that the deletion introduced an 
EcoRI site into this region; hylA from strain 10403 does not contain an EcoRI 
site. Further analysis of the nucleotide sequence in the area of the deletion 
revealed a 9 bp repeated sequence (AAAACAATG) that marks the boundaries of 
the deletion. Only one copy of the repeat is found in those strains that show the 
smaller gene, while two copies of the repeat are found in strain 10403 (Fig. 29).
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FIG. 28. Graphical view of the alignment of the sequences of the 3’ 
region of the hyaluronate lyase gene from six S. pyogenes strains showing a 183 
bp deletion. The deletion spans from position 2273 to 2455 as numbered from 
the first nucleotide in the open reading frame of hylA of strain 10403.
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3 5 0  AAMCAATG--------------------------------- 1 1 --------------------------------------------------------------------- CT
4 2 2  AWSACAATG--------------------------------- / / --------------------------------------------------------------------- CT
872   / / -----------------------------------------------------------------------CT
1 0 2 0   / / -----------------------------------------------------------------------CT
1 0 5 5   / / -----------------------------------------------------------------------CT
9 4 1 4  5 m khC A A TG --------------------------------- / / --------------------------------------------------------------------- CT
104  03  Mft&CA£.TGACAAACTGGCCGCTGT//TTGCTCATCAAGGAATTGCAGCTA&M&CM'I!GCT
FIG. 29. Abridged sequence alignment of the 3’ region of six strains 
showing the deletion relative to hylA. The alignment revealed a 9 bp repeat that 
(highlighted in gray) marks the boundaries of the deletion.
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RESULTS OF INACTIVATION OF hylA STUDIES
Preliminary assessment of the role of hyaluronate lyase in 
streptococcal infections. The role hyaluronate lyase plays in the growth of the 
bacterium or its role in infection is not known. The enzyme’s role in 
streptococcal infection as a virulence factor is merely speculative. To begin to 
understand the role that hyaluronate lyase plays in infection, mice were 
inoculated with the hyaluronate lyase-producing strain 10403 and a single 
recombinant mutant strain 10403::pHAS:/7y/A, which no longer produces 
hyaluronate lyase. Initially, the flanks of five male CD-1 white mice were 
subcutaneously injected with 100 pL (2.0 x 107cfu) of a 6 hour culture of 
10403::pHAS:/iy/A that had been pelleted and washed with isotonic saline. The 
mice were observed for a period of 2 weeks for abscess and/or lesion formation. 
Abscess formation became apparent at about day 4 as a small raised red bump. 
The swelling expanded and lesions became noticeable about a week following 
injection (Fig. 30). Purulent lesions were swabbed, plated on blood agar or 
antibiotic-containing media. Colonies were assayed for hyaluronate-Iyase 
production. Approximately 5.7% of the colonies assayed had reverted from 
hyaluronate lyase non-producing mutants to the wild-type phenotype. The 
colonies that showed reversion were still erythromycin resistant. PCR analysis 
indicated that reversion had occurred, as primers specific for hylA resulted in an 
amplicon approximately 1 kb in size. Had the plasmid still been incorporated in 
the chromosome at the hylA location, no fragment would have amplified using 
the chosen PCR conditions.
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inactivation of hylA. Because the preliminary animal studies showed 
that the single recombinant hyaluronate lyase non-producing mutant strain 
10403::pHAS:/?y/A appeared to revert to its wild-type phenotype, a double 
recombinant mutant was created to “knock-out” hylA expression in strain 10403. 
The sequence of hylA from strain 10403 revealed two internal EcoRV sites that 
would excise a 924 bp fragment from the gene (76). Following removal of the 
924 bp internal fragment of hylA from plasmid pCRNT/T7: hylA, the region was 
replaced by an erythromycin resistance gene, ermR. The presence of ermR in 
hylA was associated with loss of hyaluronate lyase activity, and expression of a 
erythromycin resistance phenotype of the E. coli colonies. Sequencing of a 
plasmid (Fig. 31), using an internal primer, confirmed the presence of ermR in 
hylA. Following PCR amplification, using primers Hyl-0 and Hyl-N (Table 1; Fig. 
3), the hylA.ermR fragment was introduced into S. pyogenes strain 10403 by 
electrotransformation. After electroporation, colonies of strain 10403 were 
obtained that exhibited erythromycin resistance; the loss of hyaluronate lyase 
activity confirmed the interruption of the gene (Fig. 32). Two mutant strains, 
1Q403A/?y/A1 and 10403A/?y/A2, were selected and showed a small amount of 
hyaluronate lyase activity surrounding the inoculum. Since the zone of clearing 
was small, it was most likely due to a bacteriophage associated hyaluronidase 
found in strain 10403.
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FIG. 30. Lesion formation on a CD-1 mouse following subcutaneous 
injection of S. pyogenes mutant strain 10403::pHAS:by/A. Inactivation of hylA 
did not result in a loss of the ability to cause infection as seen by the lesion 
present on the day 12 following subcutaneous injection.
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FIG. 31. Plasmid construct Hyl-ATG-em?. This construct was constructed 
to inactivate hylA. Digesting hyl.A with EcoRV dropped out a 924 bp fragment 
which was replaced with ermR. The hyl-ATG-emi fragment was PCR amplified 
using the primers Hyl-N and Hyl-0 and was inserted into S. pyogenes strain 
10403.
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FIG. 32. BHB assay for the detection of hyaluronate lyase from wild-type 
strain 10403 and mutant strains 10403A/iy/A1 and 10403A/7//A2. Hyaluronate 
lyase activity is evidenced by the zone of clearing surrounding the point of 
inoculation (marked with an arrow). Samples were as follows: A, 10403wt; B, 
10403Afcy/A1; C, 10403A/?y/A2.
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Chromosomal DNA isolated from the mutants, was digested with EcoRI 
(Fig. 33) and analyzed for the presence of ermR and hylA by Southern blotting. 
EcoRI digests the streptococcal chromosome such that hylA is contained in an 
approximately 19 kb fragment (Fig. 27). Since ermR is not digested with EcoRI, 
it too should be contained within such a large-sized fragment. Southern blot 
analysis confirmed the presence of ermR integration into hylA (Fig. 34). Strains 
lacking hyaluronate activity contained an inserted ermR in the size fragment 
predicted. There was no hybridization apparent between ermR and the wild-type 
strain 10403. The 3’ region of hylA hybridized to 10403A/?y/A1 and 
10403A/?y/A2, but not to the plasmid pUC:erm. Hybridization with the 3’ region of 
hylA did result in non-specific binding within the chromosome; the non-specific 
fragments were present in all three streptococcal preparations.
Growth curve comparison between wild-type strain 10403 and 
mutant strain 10403A/J//A. To determine the effect, if any, that hylA 
inactivation has on the growth of strain 10403, a comparison was made between 
the growth of the wild-type strain 10403 and mutant strains 10403Aby/A1 and 
10403Aby/A2. Cultures of wild-type strain 10403 and mutant strains 
10403Aby/A1 and 10403A/?y/A2 were grown and turbidity was measured at a 
wavelength of 600 nm each hour for ten hours and was plotted (Fig. 35). No 
apparent difference in the growth of the strains containing the inactivated hylA 
compared to that of the wild-type 10403 was seen.
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FIG. 33. Chromosomal DNA from wild-type strain 10403 and mutant 
strain 10403Afcy/A digested with EcoRI for Southern blot analysis. EcoR\/Hind\\\ 
digested pUC:erm was included as a positive control for ermR. Lanes: A,
104Q3wt; B, 10403Afty/A1; C, 10403A/?y/A2; D, pUC.erm; E, X sty MW ladder; F, 
10403"*; G, 10403A/7y/A1; H, 10403A/?y/A2; I, pUC:erm. Sizes of the X sty MW 
ladder bands are shown on the left of the figure.
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FIG. 34. Southern blot analysis of wild-type strain 10403 and mutant 
strains 10403A/?y/A1 and 10403A/?y/A2 for the presence of hylA and ermR. 
Lanes A, B, C, and D were hybridized with DIG-labeled pUC:erm. Lanes F, G, 
H, and I were hybridized with DIG-labeled 3’ region of hylA. Lanes: A and F, 
10403**; B, and G, 10403A/?y/A1; C and H, 10403A/?y/A2; D and I, pUC:erm; E, 
X sty MW ladder. Sizes of the X sty MW ladder bands are shown on the left of 
the figure.
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FIG. 35. Growth of wild-type strain 10403 and mutant strains 
10403Ahy/A1 and 10403A/?y/A2. Results are representative of the mean ± 
standard deviation of the mean for turbidity measurements taken at a wavelength 
of 600 nm for each sample.
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Effect of inactivation of hylA on hemolysin and protease activities.
Since the strains containing the inactivated hylA may be used in pathogenesis 
studies designed to establish the role of hyaluronate lyase in streptococcal 
infection, it was necessary to determine the effect, if any, that the inactivation of 
hylA may have on other cellular activities in the cell. For this purpose, strains 
10403A/?y/A1 and 10403A/iy/A2 were assayed for hemolysin and protease 
activities. Following inoculation of strains 10403A/?y/A1 and 10403A/?y/A2, as 
well as wild-type strain 10403 on to blood and milk plates, large zones of clearing 
surrounding the point of inoculation were seen on both assay plates (Fig. 36, Fig. 
37). Due to the obvious hemolytic and protease activities that were observed on 
the assay plates, inactivation of hylA was determined to not have an obvious 
effect on these activities.
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FIG. 36. Effect of inactivation of hylA on hemolysin activity. No obvious 
difference was seen between the hemolysin activity (as indicated by the zone of 
clearing surrounding the colony) of wild-type strain 10403 (A) and mutant strains 
10403Afty/A1 (B) and 10403A/?y/A2 (C). An arrow is pointing to a zone of 
hemolysis.
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FIG. 37. Effect of hylA inactivation on protease activity. Wild-type 10403 
(A) and 10403A/?y/A1 (B) and 10403A/?y/A2 (C) were stabbed onto milk plates to 
assay for protease activity and detected a zone of clearing surrounding the 
colony. An arrow is pointing to a region of protease activity.
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DISCUSSION
Production and expression of hyaluronate lyase in S. pyogenes 
strain 10403. Early studies suggested that hyaluronic acid capsule is produced 
early in the growth of the organism, while hyaluronate lyase is found later in the 
growth cycle (108); however, prior to this study, an in depth molecular analysis 
on the time of production of the hyaluronate lyase from S. pyogenes had not 
been conducted. Hyaluronate lyase activity was detected much earlier than 
previously suggested (108), being present in the early exponential stage of 
growth. One possible explanation for this observation is the lack of hyaluronic 
acid capsule production by strain 10403. This study made an assessment of the 
levels of hyaluronate lyase gene expression during S. pyogenes growth by 
examining both mRNA levels and enzymatic activity.
Sequence analysis from a 3510 bp fragment containing hylk of strain 
10403 indicated three potential translational initiation codons, a GTG at position 
614, an ATG at position 683, or another ATG at position 686 (76). Analysis of 
the sequence upstream of these sites revealed a typical ribosome binding site 
(RBS) 9 bp upstream of the GTG (valine) site; further upstream of the RBS were 
the -10/-35 regions suggestive of a potential promoter region (76). No RBS site 
was found directly upstream of the ATG sites, nor were there -10/-35 regions 
immediately upstream of these sites. Initial analysis, in E. coli, using a gfp 
reporter assay of the regions upstream of the three potential initiation codons 
showed a region capable of functioning as a promoter, which was located 
upstream of the GTG site. This was subsequently confirmed by RT-PCR
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analysis, suggesting that the GTG is the translational initiation codon for HylA. 
Interestingly, another streptococcal virulence factor, the protein involved in 
hyaluronic acid capsule synthesis, HasA, also has a GTG initiation codon (36).
RT-PCR results indicated the presence of the hylA transcript at each time 
point of the eighteen-hour growth, signifying constitutive expression of the gene 
in strain 10403, as well as in strains SF370 and 71698, neither of which produce 
detectable active enzyme. Although there is no detectable hyaluronate lyase 
activity associated with strains SF370 and 71698, these results suggest an 
inactive form of the enzyme may be produced, the enzyme may require some 
post-transcriptional modification, or alternatively there is no translation of mRNA. 
Only approximately 25% of the strains tested with an in vitro assay for 
hyaluronate lyase activity actually produced detectable active enzyme (80). 
Although such in vitro studies suggested only a low percentage of group A 
streptococci produce hyaluronate lyase, antibodies directed to both extracellular 
hyaluronate lyase, as well as bacteriophage hyaluronidases, have been found in 
patients following a streptococcal infection (63, 161,162). The presence of 
these antibodies indicates that hyaluronate lyase is produced in vivo during 
infection. Perhaps those strains not showing active enzyme in vitro may be 
stimulated to produce active enzyme in vivo. Alternatively, these strains may 
produce an inactive protein that still stimulates an antibody response despite the 
lack of enzymatic activity. Such a possibility would still explain the presence of 
the antibodies post-streptococcal infection. Cloning and expression of 
hyaluronate lyase genes from strains that do not appear to produce active HylA,
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followed by western blot analysis, would be one way to assess production of an 
inactive protein.
Growth phase-dependent regulation of virulence factors is a common 
theme in S. pyogenes. In order to assess potential growth phase-dependent 
regulation of hylk expression, hylA transcript was measured using quantitative 
PGR over an 18 hour period. Strains 71698 and SF370 showed a gradual 
increase in relative transcript amounts during the early to mid-exponential phase 
(2-4 hours) of growth which then gradually decreased as growth entered the late 
exponential and stationary phases, suggestive of a single transcriptional peak of 
production with more production during exponential growth. A similar pattern of 
expression has been identified for other group A streptococcal genes, including 
emm, scpA, hasA, and mga, all of which were determined to have maximal gene 
expression during exponential growth (15, 30,111). In contrast, the pattern of 
hylk expression for strain 10403 was the same as that seen with the other two 
strains initially; however, after dropping to almost undetectable amounts of 
transcript at hour 8 (early stationary phase), the relative amount of hylk transcript 
increased as stationary phase progressed. The pattern of distribution for hylk 
transcript was therefore bi-modal, having two peaks of increased transcript 
amounts.
Although a bi-modal pattern of gene expression has not been identified in 
the literature for S. pyogenes genes, other genes that show elevated levels of 
gene expression during stationary phase have been identified and include sagA, 
speA, speB, and speMF (15, 30,111,158). Why there is a difference in the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
pattern of expression between the tested strains is unknown at this time. One 
possibility is that the transcript is synthesized early, gradually degrades or is 
translated to protein and once levels are low, gene expression is stimulated a 
second time. Another possibility may be that the bi-modal expression is a result 
of strain 10403 producing an active enzyme, whereas, strains 71698 and SF370 
do not. During the processing and/or secretion of HylA, there may be some 
unknown factor that results in the inhibition of transcription at that particular 
stage of growth. Alternatively, some factor may inadvertently result in the 
stimulation of transcription and subsequent protein production for strain 10403, 
which may be an explanation for the increased levels of hylk transcript seen in 
strain 10403, while the other two strains have decreased levels. Conversely, 
perhaps the active enzyme is present because of this bi-modal pattern of 
transcript. However, since transcript and HylA are detected early in the growth, 
this possibility seems unlikely. If this bi-modal expression were the reason for 
the active protein, it would be anticipated that active protein would be detected 
later in growth. Preliminary analysis of another S. pyogenes M-type 22 strain, 
622401, which produces active hyaluronate lyase, showed a decrease in hylk 
transcript at hour 8, followed by an increase at hour 18, perhaps suggesting a 
similar bi-modal pattern of expression as that seen in strain 10403. These 
results may give support to a relationship between active protein production and 
gene expression patterns.
Since HylA is a secreted protein, the bi-modal pattern of gene expression 
in strain 10403 may be due to a feedback inhibition mechanism. Perhaps a
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build-up of intracellular HylA over the early stages of growth negatively regulates 
gene expression, thereby resulting in a decline in the relative amount of hylk 
transcript at hour 8. To evaluate this possibility, a comparison was made 
between intracellular and extracellular HylA levels. If feedback inhibition did 
occur, it would be expected that there would be a difference in the titer between 
the two different fractions. Unfortunately, such a relationship could not be 
determined as the intracellular hyaluronate lyase appears to be inactive. Any 
zone of clearing observed was minimal and most likely due to a bacteriophage 
hyaluronidase associated with strain 10403 since the same zone size was found 
with the mutant strain 1Q403A/?y/A1. The finding that intracellular HylA was 
apparently inactive suggests that HylA does not become enzymatically active 
until it is secreted. Other streptococcal products require additional processing 
before becoming active, including SpeB. SpeB is initially produced as a 43 kDa 
protein that is proteolytically processed to its final active 28 kDa protein (64).
The sequence of hylk from strain 10403 indicates the presence of a 
typical type II signal peptide (76), suggesting S. pyogenes utilizes a type II 
secretion pathway for secretion of this protein. The signal peptide ensures that 
the precursor for HylA will be transferred, by way of a signal recognition particle 
pathway or with the assistance of a chaperone protein, from the cytoplasm to the 
cytosolic membrane (159). The positively charged N-terminus makes contact 
with the membrane lipid bilayer, after which SecA, a precursor-stimulated ATP- 
ase, drives the translocation through an aqueous channel or translocase (formed 
by SecY)(159). For translocation to be complete, the signal peptide of the
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precursor protein must be cleaved by a signal peptidase to release the protein 
into the extracellular side of the translocase. Following translocation, the protein 
is processed into its native, potentially active conformation and translocated 
across the cell wall (159). The putative signal peptide cleavage site for HylA is 
located between amino acid positions 32 and 33, which would result in an 
extracellular molecular size of 95.9 kDa (76). Attempts to purify HylA from S. 
pyogenes strain 10403 have resulted in an active protein with a molecular size 
between 55 kDa and 70 kDa (Hynes, personal communication). Clearly, this 
differs from the anticipated molecular size; however, a 90 kDa protein has been 
reported also (76). Further analysis of the amino acid sequence for HylA from 
strain 10403, using a signal peptide predictive program 
(http://genome.cbs.dtu.dk/), indicated another potential cleavage site between 
amino acid positions 625 and 626. Cleavage at this site, as well as the cleaving 
of the signal peptide, would result in a protein of about 67 kDa, a size similar to 
that previously identified. Alternatively, the possibility of another start site for 
HylA exists. If the ATG site, and not the GTG, were the site of initiation, a 
predicted signal peptide cleavage site would be located between amino acid 
positions 601 and 602, which although is far too distant from the ATG site to be 
considered a signal peptide, would yield a protein of 68 kDa. However, the 
possibility of an alternative start site seems unlikely since RT-PCR analysis done 
in this study indicated GTG as the initiation codon. Previous studies reported 
that a hyaluronate lyase from a type 4 strain of S. pyogenes was determined to 
be 50 kDa by SDS-PAGE and 70 kDa by gel filtration (66). Such data suggests
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that proteolytic processing in addition to the cleavage of the signal peptide may 
occur during the production of active HylA. Other hyaluronate lyases have been 
found to exhibit variation in the size of the hyaluronate lyase. The nucleotide 
sequence for the hyaluronate lyase gene from Streptococcus agalactiae (sagHL) 
predicted a protein of 121.2 kDa having a 30-amino acid signal peptide; 
however, SagHL was reported to exist as one of three polypeptides of -118, 
-110, or -9 4  kDa following purification (52). Additionally, an enzymatically active 
89 kDa polypeptide was identified from S. agalactiae. This small product was 
believed to be a degradative product of the native SagHL (52). Also, the 
hyaluronate lyase from Streptococcus pneumoniae (SpnHL) had two identified 
forms, of 89 kDa and 107 kDa (13).
Although processing of hyaluronate lyase has been suggested in other 
strains, the hyaluronate lyase from S. pyogenes requires further investigation.
By PCR amplifying partial regions of hylA, cloning, and assaying for hyaluronate 
lyase activity, it may be possible to gain a better understanding as to what sort of 
proteolytic cleavage may occur for production of the final active protein. Through 
this type of analysis, it may be possible to establish whether the N-terminus is 
cleaved at a site other than that predicted, or if there is an additional site of 
cleavage in the C-terminal region of the precursor peptide. Additionally, through 
the development of anti-hyaluronate lyase antibodies, investigations into the 
relationship between intracellular and extracellular HylA may be conducted to 
obtain an explanation for the production of HylA by strain 10403. By comparing
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the size of intracellular to secreted HylA, it may be possible to ascertain the 
differences in size, as well as, the site of protein cleavage.
The effect of various environmental conditions on hylA expression.
Temperature regulation of virulence factor genes, which are required for 
infection, of bacterial pathogens is a widely distributed mechanism of gene 
control. Temperature regulation of gene expression has been found in Yersinia 
pestis, Shigella, Listeria monocytogenes (88), Borrelia burgdorferi (17, 55), and 
Streptococcus pyogenes (146). Although information regarding the regulation of 
streptococcal iron homeostasis and streptolysin S in response to temperature is 
available (146), no information was available for hylA expression. The effect of 
various physiological conditions on hylk expression was examined. No 
difference was seen in the expression levels of hylk for cultures grown at the 
different temperatures that may be encountered in vivo, sugggesting hylk is not 
regulated by temperature. Similarly, hylk expression at pH 7.4 and pH 7.6 
showed no difference. However, the quantity of hylk transcript from cultures 
grown at pH 5.0 showed a two-fold decrease in transcript compared with cultures 
grown at pH 7.4 and pH 7.6. Hughes et al (74) reported that less than a 2-fold 
change in the levels of gene transcript can be biologically significant. Smoot et 
al (146) used a threshold of 1.5-fold difference as being biologically significant. 
Using these parameters for significance, the two-fold decrease seen in the 
relative amount of hylk transcript from cultures grown at pH 5.0 (relative to pH 
7.4 and pH 7.6) may be biologically significant to the organism during infection. 
Although cultures grown at pH 5.0 had a decrease in the amount of expression,
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no difference between the HylA titer compared to the other pH levels was 
observed. S. pyogenes undergo fermentation, which through the production of 
an acid would decrease the pH level. One possibility may be that at the low pH, 
increased translation to HylA occurs, thereby resulting in a decrease in the 
amount of transcript but no concomitant loss in the amount of protein at the low 
pH.
S. pyogenes is considered an “indifferent anaerobe” due to the use of 
fermentative metabolism regardless of the aeration conditions (119). Analysis of 
the relative amounts of hylk transcript from cultures grown under various 
aeration conditions indicated that S. pyogenes grown under anaerobic and 
increased carbon dioxide conditions had approximately the same quantity of hylk 
transcript, 0.349 RU and 0.361 RU respectively. Cultures grown aerobically had 
approximately a 1.8-fold decrease in relative amount of transcript. Under 
anaerobic conditions, fermentation would result in a decrease in pH. Because of 
this decrease in pH, one would expect that there would be a similarity between 
the amounts of transcript detected under anaerobic and pH 5.0 conditions. 
Conversely, a 3.4-fold increase in the amount of transcript detected in cultures 
grown anaerobically in comparison to transcript amounts at pH 5.0 was 
observed. Since an anaerobic environment would also be acidic, the increase in 
transcript may be due to the effect of an anaerobic environment on other 
streptococcal factors that influence hylk. Under anaerobic conditions, an 
increase in the production of streptococcal proteases may occur, which may 
degrade hyaluronate lyase, necessitating an increase in the amount of
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expression of hylk so that more protein synthesis may occur. Alternatively, 
perhaps more post-translational modification occurs that results in a decreased 
effect on transcript levels. Aeration conditions have been shown to influence 
expression of other streptococcal virulence factors, including mga, emm (M- 
protein), and prtF (fibronectin binding protein). Expression of both mga and 
emm is positively stimulated in the presence of carbon dioxide and shows a 
slight decrease when grown in the presence of oxygen (110,124). Anaerobic 
conditions stimulate the expression of prtF (49). The effect of free exchange of 
gases (shaking vs. stationary) on the relative amount of hylk transcript level 
indicated very little difference, suggesting no effect. Assay of the supernatant of 
cultures grown under the various conditions showed very little difference, if any, 
in the titer of hyaluronate lyase activity.
Early studies showed that when hyaluronic acid was added to the media, 
there was an increase in the production of hyaluronidase as detected by 
enzymatic assay (66). The effect that the addition of hyaluronic acid had on hylk 
expression in strain 10403 over a period of four hours was in agreement with 
these early studies; cultures grown in the presence of hyaluronic acid showed a 
two-fold increase in the relative amount of transcript when compared to those 
grown without the substrate. However, although a two-fold increase in the 
amount of transcript was detected, no difference was found in the titer of 
hyaluronate lyase activity, suggesting that a two-fold change in the amount of 
transcript is not important. However, the appropriate statistical analysis was not
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performed to assess significance due to the weak power of the experimental 
design, which suggested a 99.9% chance of error.
Although this investigation into the effect of changing environments, which 
may be encountered during an infection, on hylA expression revealed some 
changes in the transcript levels, the studies were performed in vitro and cannot 
simulate the extreme response of the host immune system during a 
streptococcal infection. Future studies involving animal models may allow for a 
true assessment of the effect of in vivo conditions on hylA expression. Graham 
et al (58) have recently reported studies in which the level of transcript for genes 
under the control of CovR/CovS was assessed from tissue excised from soft- 
tissue infection. Such studies may promote future possibilities for the study of 
expression levels of different genes in vivo.
The relationship between hyaluronic acid capsule and hyaluronate 
lyase gene expression. Faber and Rosendal (42) reported there were four 
main categories of S. pyogenes: 1) hyaluronate lyase-producing, acapsular; 2) 
non-hyaluronate lyase-producing, acapsular; 3) non-hyaluronate lyase- 
producing, encapsulated; 4) hyaluronate lyase-producing, encapsulated. 
Investigation of 176 strains of S. pyogenes identified the first three of these 
categories; however, our lab has not identified any strain from the fourth 
category, encapsulated hyaluronate lyase-producing strains. One explanation 
for this is that the strains may have lost virulence due to repeated subculturing 
on media, such that they are no longer as virulent as when first clinically isolated, 
In order to do a comparison between hylA and hasA expression, it was
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necessary to use a strain that produced a transcript for both genes. Strain 
10403 does not produce a transcript for hasA\ however, the encapsulated strain 
71698 does produce both transcripts. Comparison of the expression patterns for 
the relative amounts of hylA and hasA indicated a single peak of transcription for 
both genes, showing greatest expression in the early to mid-exponential phases 
of growth. The results obtained for hasA agree with earlier findings from other 
strains, which suggested that hyaluronic acid capsule was produced early in 
growth (30,108). McClean (108) suggested that hyaluronic acid capsule is 
produced early in the growth of the organism, while hyaluronate lyase is found 
later in growth. In contrast, the results obtained from this study indicate that the 
genes for each are expressed simultaneously, perhaps indicating similar 
regulatory mechanisms. Expression of hasA is under the control of the 
CovR/CovS two-component regulatory pathway (97) as well as some form of 
growth phase-dependent regulation (30). Graham et al (58) recently reported 
inactivation of the CovR/CovS system resulted in at least a five-fold increase in 
the amount of hasA, whereas the relative amount of hylA transcript was 
insignificantly changed, suggesting that hylA is not regulated by CovR/CovS. 
However, whether the strain used in their study produced active hyaluronate 
lyase is unknown. Some factor that has not yet been identified may be produced 
during growth that controls the expression of both genes in the strains used in 
this study. The relative amounts of transcript for hasA in strain 71698 were 
much greater than that of hylA, which may explain the predominance of 
hyaluronic acid capsule and lack of detectable hyaluronate lyase in this strain.
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Additionally, the level of hylk transcript from strain 71698 was two times greater 
than that of strain 10403. Since active HylA is not produced in strain 71698, the 
amount of transcript found may be due to the transcript being long-lived, having 
not been processed and degraded. Alternatively, the increase in the amount of 
hylk transcript may be due to the presence of a hyaluronic acid capsule 
possessed by this strain. As shown through studies involving the addition of 
hyaluronic acid to growth conditions, approximately a two-fold increase in the 
amount of hylk transcript was observed. The presence of capsular hyaluronic 
acid seems like a more appropriate reason as strain SF370’s amount of 
transcript is similar to that found in strain 10403 since both strains are acapsular.
Although a comparison was made between hylk and hasA expression in 
strain 71698, whether the same results would be found in a hyaluronate lyase- 
producing strain such as strain 10403 is uncertain. In order to better establish 
the relationship between the two genes, a hyaluronate-lyase producing strain 
that also produces a hasA transcript, or is actually encapsulated, should be 
examined. Furthermore, animal studies may also help to resolve this 
streptococcal paradox. Through such studies, it may be possible to determine 
expression of the necessary genes, and in the process, evaluate any relationship 
between expression between hylk and hasA over the course of streptococcal 
infection.
Size variability of the hyaluronate lyase gene of S. pyogenes. The
sequence for the hyaluronate lyase gene from the ATCC T-type 22 hyaluronate 
lyase-producing strain 10403 (hylk) was previously determined (76). The gene
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is 2607 bp in length, encoding a 99,636 Dalton protein. PCR analysis of the 
hyaluronate lyase gene region from 176 strains of S. pyogenes indicated that all 
strains contained a gene region exhibiting similarity to hylk. PCR amplification of 
the 3’ region of the hyaluronate lyase gene from the 176 strains revealed the 
presence of a deletion within 33 (20%) of the tested strains. No apparent 
association between the size variability and disease, hyaluronate lyase activity, 
or serotype was observed. The 3’ regions of six of these strains were analyzed 
by DNA sequencing. All six strains contained a smaller gene, which had an in­
frame deletion of 183 bp relative to hylk. Alignment of the sequences from the 3’ 
region of the shorter clones, with that of hylk from strain 10403, indicated that 
the deletion occurred in the same location within all the strains and was located 
between positions 2273-2455 of the hylk gene open reading frame. Since 
hyaluronidase activity was detected among some of the strains possessing the 
deletion, it was putatively determined that the deleted fragment has no 
involvement in enzymatic activity; however, this could not be completely 
determined due to the presence of bacteriophage hyaluronidases. By cloning 
and expressing the genes from these strains, any question regarding the 
hyaluronate lyase activity would be answered.
Further evidence that the 3’ region is not involved in hyaluronate lyase 
activity was obtained by comparing expression of the cloned gene from the M1 
strain SF370, a non-hyaluronidase producing strain, to that of expression from 
hylk from strain 10403. The gene from SF370 contains a termination sequence 
at position 2416-2418 of the hylk open reading frame. Termination at this site
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may result in the loss of enzymatic activity seen in this strain. Introduction of a 
premature termination codon into hylk of strain 10403, at the site where 
termination occurs in SF370, did not result in loss of hyaluronate lyase activity 
when cloned into E. coli (Hynes, unpublished data).
A streptococcal bacteriophage hyaluronidase gene, hylP2, also shows a 
deletion when compared to the streptococcal bacteriophage hyaluronidase gene, 
hyIP (80). Alignment studies showed that a collagen-like repeat region of ten 
Gly-X-Y repeats in hyIP was deleted in hylP2. Analysis of the 183 bp region 
deleted from the 3’ region did not show any motifs similar to those found in the 
deleted region in the bacteriophage hyaluronidase gene hylP2. However, a 9 bp 
sequence (AAAACAATG) repeat was found to mark the boundaries of the 
deleted region. Only one copy of the sequence is found in those strains that 
have the smaller gene, while both repeats are found in the larger gene of strain 
10403. Whether this sequence is the site of insertion of a fragment in strain 
10403, or associated with the deletion of the fragment in the other strains is 
unknown. A search of the nucleotide databases did not suggest any association 
of this sequence with an insertion sequence or transposon. A search of the 
streptococcal chromosome from SF370 for the AAAACAATG repeat sequence 
found 57 identical copies of the sequence; however, apart from the repeats 
found within the hyaluronate lyase gene no other repeat pairs were in close 
proximity to one another. Chromosomal sequence analysis of strains 
MGAS8232 (M-type 18) and MGAS315 (M-type 3) showed 59 and 48 identical 
repeats. Additionally, the sequence from S. pyogenes MGAS8232 (145) showed
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that the hylk gene is similar to that of strain 10403, in that it has both copies of 
the repeat sequence. On the other hand, analysis of the sequence from strain 
MGAS315 (10) showed the hylk  gene is shorter relative to strain 10403, and has 
only one copy of the repeat. Additionally, the hylk  from strain MGAS315 had a 
much smaller 3’ region of the gene, suggesting a deletion. A search for similarity 
to the 183 bp fragment missing from the shortened genes indicated no similarity 
other than to that found within the hyaluronate lyase gene, suggesting the 
fragment is not a known insertion sequence.
Although information is available regarding certain aspects of hyaluronate 
lyases, little is known about what part of the protein molecule is needed for 
enzymatic activity. Reports on the active site of hyaluronate lyases from 
Streptococcus agalactiae (SagHL) and Streptococcus pneumoniae (SpnHL) 
suggest that the catalytic region contains conserved histidine, tyrosine, and 
asparagine residues (98, 99). Comparison of the amino acid sequences from 
SagHL and HylA indicates that the asparagine, histidine, and tyrosine residues 
associated with activity are present in HylA, and that the active site region is 
between amino acid residues 257-327, corresponding to nucleotide positions 
769-981 of hylk. This is outside the area associated with the deletion in the 3’ 
region. Whether the same active region of the group A streptococcal 
hyaluronidase gene (hylk) is necessary for hyaluronate lyase activity is not 
known, but it would be likely based on the similarities of the genes.
Although this study has suggested that the deletion may play no role in 
hyaluronate lyase activity, cloning and sequencing entire genes from some of
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these strains having a smaller hylA, assaying for hyaluronate lyase activity, and 
comparing them to strain 10403 may enable a more definitive answer. 
Additionally, by looking at different regions of the hyaluronate lyase gene and at 
how mutations introduced into those regions affect activity, and by cloning and 
expressing recombinant forms of the shorter gene, a better understanding of the 
extracellular hyaluronate lyase of S. pyogenes at the molecular level will be 
gained.
Preliminary assessment of the role of hyaluronate lyase in a 
streptococcal infection. The role of hyaluronate lyase in streptococcal 
infections is unknown. Because of its ability to degrade a major constituent of 
connective tissues (hyaluronic acid) it has been speculated to be a spreading 
factor. The current investigation examined the possible role of hyaluronate lyase 
as a virulence factor. Following subcutaneous injection of a single-recombinant 
mutant strain 10403::pHAS:/7y/A (76) into CD-1 out-bred mice abscess and 
lesion formation were observed. The tissue damage suggests that strains 
lacking an active hyaluronate lyase are able to initiate an infection. Pus taken 
from the lesions and abscesses revealed (3-hemolytic streptococci. Colonies 
were then screened by a hyaluronidase assay (77). Colonies recovered from the 
wound showed two phenotypes, HylA+ and HylA'. Approximately 5.7% of the 
colonies screened showed hyaluronate lyase activity, indicating the potential 
reversion of the mutant to the wild-type form. This occurrence may be indicative 
that hyaluronate lyase is required for S. pyogenes to cause infection as was 
found to be the case for the hyaluronic acid capsule. Following inoculation of a
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mutant strain in which hasA was disrupted by a non-replicative plasmid, only 
revertant encapsulated colonies were recovered (75). The inactivation in strain 
10403::pHAS;/?y/A was by a single recombination event resulting in insertion of 
the entire plasmid into the hylA gene. Reversion to wild-type could be 
accomplished by a reverse recombination event within the cell that results in 
expulsion of the plasmid. Although the colonies screened were both HylA+ and 
HylA', all colonies were still erythromycin resistant and HylA+ colonies amplified 
hylk, suggesting the plasmid still resided within the cell.
Because 10403::pHAS:/?y/A apparently reverted to its wild-type 
phenotype, an accurate assessment of the loss of hyaluronate lyase on infection 
could not be assessed. Because of this, isogenic mutant strains 10403A/?y/A1 
and 10403Ahy/A2 were created by replacing an internal portion of hylk with an 
erythromycin resistance gene (ermR). Reverse recombination similar to what 
appears to have occurred in the single recombinant mutants would result in a 
gene containing a deletion. Inactivation resulted in a loss of hyaluronate lyase 
activity, but did not appear to affect the growth of the organism. Furthermore, 
inactivation did not result in a loss of two other activities important for 
streptococcal virulence, that being the cysteine protease and hemolysin 
activities. Hence, these double recombinant mutant strains should be useful for 
future animal studies to investigate the role of hyaluronate lyase as a virulence 
and/or spreading factor of S. pyogenes.
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CONCLUSIONS
This study has provided an in-depth evaluation into the hyaluronate lyase 
gene of S. pyogenes. Hyaluronate lyase activity was detected in the early 
exponential phase of growth and was detected throughout the growth of strain 
10403. Additionally, it was ascertained that hylk  is expressed not only in 
hyaluronate lyase-producing strains, but also in those that do not produce 
detectable enzymatic activity. Expression of hylk in the enzymatically inactive 
strains, 71698 and SF370, was determined to have a single peak of expression, 
in which the relative levels of transcript were greatest in the early to mid­
exponential with little in the stationary stages of growth. In contrast, strain 10403 
showed a different pattern of expression, having increased relative amounts of 
hylk transcript in the early to mid-exponential growth followed by a decrease at 
hour 8, then another increase in late stationary growth.
The effect of various environmental conditions on hylk expression was 
evaluated by determining the relative amount of hylk transcript present in the 
cell. Temperature had little effect on the relative amount of hylk transcript for 
strain 10403. However, hylk expression was slightly decreased after growth in 
pH 5.0 and was slightly increased under anaerobic and increased carbon dioxide 
conditions. Additionally, the presence of hyaluronic acid in the growth media 
resulted in a two-fold increase in hylk expression. Although a difference was 
seen in the levels of mRNA, no difference was detected in the titer of enzymatic 
activity.
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This study also determined that the time of expression for hylk and hasA 
was the same in strain 71698. The amount of transcript increased until hour 4 
then declined over the rest of growth; however, the relative amount of hasA 
transcript was considerably greater than that of hylk.
All of the streptococcal strains screened had a region with similarity to the 
hyaluronate lyase gene (hylk) of strain 10403 as determined by PCR. However, 
variation in the size of the 3’ region of the hyaluronate lyase region was seen in 
some strains of S. pyogenes. The decreased size results from an in-frame 
deletion of 183 bp compared to hylk, with the boundaries of the deleted region 
being marked by a nine base pair repeat (AAAACAATG).
Finally, a preliminary study into the role of hyaluronate lyase as a putative 
virulence factor during a streptococcal infection was evaluated. Growth in vivo 
resulted in the reversion of a single-recombinant mutant strain from a HylA- 
negative to a HylA-positive phenotype. Also, an isogenic mutant strain 
10403A/?y/A was created by replacing an internal portion of hylk with 
erythromycin resistance gene (ermR). Inactivation of hyaluronate lyase did not 
have any obvious affect on growth, protease, or hemolytic activities.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
133
REFERENCES
1. Alouf, J. E. 1980. Streptococcal toxins (Streptolysin S, Streptolysin S, 
Erythrogenic toxin). Pharmac. Ther. 11:661-717.
2. Andrewes, F. W., and J. Horder. 1906. A study of the streptococci 
pathogenic for man. Lancet 2:708-713; 775-782; 852-855.
3. Anonick, P. K., W. H. Vetter, and S. L. Gonias. 1989. Kinetics of the 
reaction of streptokinase-plasmin complex with purified human and mouse 
alpha 2-macroglobulin. Implications for mechanism. Biochem. J. 264:745- 
752.
4. Anthony, L. C., I. Artsimovitch, V. Svetlov, R. Landick, and R. R. 
Burgess. 2000. Rapid purification of His (6)-tagged Bacillus subtilis core 
RNA polymerase. Protein Expr. Purif. 19:350-354.
5. Ashbaugh, C. D., S. Alberti, and M. R. Wessels. 1998. Molecular 
analysis of the capsule gene region of group A streptococcus: the hasAB 
genes are sufficient for capsule expression. J. Bacteriol. 180:4955-4959.
6. Ausubel, F. A., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. 
A. Smith, and K. Struhl (ed.). 2000. Current Protocols in Molecular 
Biology. John Wiley & Son, Inc., New York.
7. Barnard, W. G., and E. W. Todd. 1940. Lesions in the mouse produced 
by streptolysins O and S. S. J. Pathol. 51:43-47.
8. Beckert, S., B. Kreikemeyer, and A. Podbielkis. 2001. Group A 
streptococcal rofA gene is involved in control of several virulence genes 
and eukaryotic cell attachment and internalization. Infect. Immun. 69:534- 
537.
9. Ben Nasr, A., H. Herwald, U. Sjobring, T. Renne, Muller-Esteri, and L. 
Bjorck. 1997. Absorption of kininogen from human plasma by 
Streptococcus pyogenes is followed by release of bradykinin. J. Biol. 
Chem. 34:25417-25424.
10. Beres, S. B., G. L. Sylva, K. D. Barbian, B. Lei, J. S. Hoff, N. D.
Mammarella, M. Y. Liu, J. C. Smoot, S. F. Porcella, L. D. Parkins, D. S. 
Campbell, T. M. Smith, J. K. McCormick, D. Y. Leung, P. M. Schlievert, 
and J. M. Musser. 2002. Genome sequence of a serotype M3 strain of 
group A Streptococcus: phage-encoded toxins, the high-virulence 
phenotype, and clone emergence. Proc. Natl. Acad. Sci. U. S. A. 
99:10078-10083.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
134
11. Berge, A., and L. Bjorck. 1995. Streptococcal cysteine protease release 
biologically active fragments of streptococcal surface proteins. J. Biol. 
Chem. 270:9862-9867.
12. Bernish, B„, and I. van de Rijn. 1999. Characterization of a two- 
component system in Streptococcus pyogenes which is involved in 
regulation of hyaluronic acid production. J. Biol. Chem. 274:4786-4793.
13. Berry, A. ML, R. A. Lock, S. M. Thomas, D. P. Rajan, D. Hansman, and 
J. C. Paton. 1994. Cloning and nucleotide sequence of the Streptococcus 
pneumoniae hyaluronidase gene and purification of the enzyme from 
recombinant Escherichia coli. Infect. Immun. 62:1101-1108.
14. Berry, A. M., A. D. Ogunniyi, D. C. Miller, and J. C. Paton. 1999. 
Comparative virulence of Streptococcus pneumoniae strains with insertion- 
duplication, point, and deletion mutations in the pneumolysin gene. Infect. 
Immun. 67:981-985.
15. Betschel, S. D., S. M. Borgia, N. Barg, D. Low, and J. C. De Azavedo.
1998. Reduced virulence of group A streptococcal Tn916 mutants that do 
not produce streptolysin S. Infect. Immun. 66:1671-1679.
16. Billroth, T. 1874. Untersuchungen uber die vegetationsformen von 
coccobacteria septica. G. Reimer, Berlin.
17. Bono, J. L., K. Tilly, B. Stevenson, D. Hogan, and P. Rosa. 1998. 
Oligopeptide permease in Borrelia burgdorferi: putative peptide-binding 
components encoded by both chromosomal and plasmid loci. Microbiology 
144 ( Pt 4):1033-1044.
18. Boyle, M., and R. Lottenberg. 1997. Plasminogen activation by invasive 
human pathogens. Thromb. Haemostasis 77:1-10.
19. Burns, E. H., S. Lukomski, J. Rurangirwa, A. Podbielski, and J. M. 
Musser. 1998. Genetic inactivation of the extracellular cysteine protease 
enhances in vitro internalization of group A streptococci by human 
epithelial and endothelial cells. Micro. Path. 24:333-339.
20. Canard, B., T. Gamier, B. Saint-Joanis, and S. T. Cole. 1994. Molecular 
genetic analysis of the nagH gene encoding a hyaluronidase of Clostridium 
perfringens. Mol. Gener. Gen. 243:215-224.
21. Caparon, M. G., R. T. Geist, J. Perez-Casal, and J. R. Scott. 1992. 
Environmental regulation of virulence in group A streptococci: transcription 
of the gene encoding M protein is stimulated by carbon dioxide. J.
Bacteriol. 174:5693-5701.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
135
22. Chaussee, M. S., D. Adjic, and J. J. Ferretti. 1999. The rgg gene of 
Streptococcus pyogenes NZ131 positively influences extracellular SPEB 
production. Infect. Immun. 67:1715-1722.
23. Chaussee, M. S., G. L. Sylva, D. E. Sturdevant, L. M. Smoot, M. R. 
Graham, R. O. Watson, and J. M. Musser. 2002. Rgg influences the 
expression of multiple regulatory loci to coregulate virulence factor 
expression in Streptococcus pyogenes. Infect. Immun. 70:762-770.
24. Chaussee, M. S., R. O. Watson, J. C. Smoot, and J. M. Musser. 2001. 
Identification of Rgg-regulated exoproteins of Streptococcus pyogenes. 
Infect. Immun. 69:822-831.
25. Chen, C., N. Bormann, and P. P. Cleary. 1993. VirR and Mry are
homologous trans-acting regulators of M-protein and C5a peptidase 
expression in group A streptococci. Mol. Gener. Gen. 241:685-693.
26. Cleary, P., D. LaPenta, D. Heath, E. J. Haanes, and C. Chen. 1991. A 
virulence regulon in Streptococcus pyogenes, p. 147-151. In G. Dunny, P. 
Cleary, and L. McKay (ed.), Genetics and molecular biology of 
streptococci, lactococci, and enterococci. Am. Soc. Microbiol., Washington, 
D.C.
27. Cossart, P., M. F. Vicente, F. Baquero, J. C. Perez-Diaz, and P. Berche.
1989. Listeriolysin O is essential for virulence of Listeria monocytogenes: 
direct evidence obtained by gene complementation. Infect. Immun. 
57:3629-3636.
28. Cramer, J. A., L. C. Bailey, C. A. Bailey, and R. T. Miller. 1994. Kinetic 
and mechanistic studies with bovine testicular hyaluronidases. Biochim. 
Biophys. Acta. 1200:315-321.
29. Crater, D. L , B. A. Dougherty, and I. van de Rijn. 1995. Molecular 
characterization of hasC from an operon required for hyaluronic synthesis 
in group A streptococci. J. Biol. Chem. 270:28676-28680.
30. Crater, D. L., and I. van de Rijn. 1995. Hyaluronic acid synthesis operon 
(has) expression in group A streptococci. J. Biol. Chem. 270:18452-18458.
31. Cunningham, M. W. 2000. Pathogenesis of Group A Streptococcal 
Infections. Clin. Microbiol. Rev. 13:470-511.
32. Dale, J. B., and E. C. Chiang. 1995. Intranasal immunization with 
recombinant group A streptococcal M protein fragment fused to the B 
subunit of Escherichia coif labile toxin protects mice against systemic 
challenge infections. J. Infect. Dis. 171:1038-1041.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
136
33. Dale, J. B., M. Simmons, E. C. Chiang, and E, Y. Chiang. 1996. 
Recombinant, octavalent group A streptococcal M protein vaccine. Vaccine 
14:944-948.
34. DeAngelis, P. L., J. Papaconstantinou, and P. H. Weigel. 1993. 
Molecular cloning, identification, and sequence of the hyaluronan synthase 
gene from group A Streptococcus pyogenes. J. Biol. Chem. 268:19181- 
19184.
35. Dougherty, B. A., and I. van de Rijn. 1992. Molecular characterization of 
a locus required for hyaluronic acid capsule production in group A 
streptococci. J. Exp. Med. 175:1291-1299.
36. Dougherty, B. A., and I. van de Rijn. 1994. Molecular characterization of 
hask from an operon required for hyaluronic acid synthesis in group A 
streptococci. J. Biol. Chem. 269:169-175.
37. Dougherty, B. A., and I. van de Rijn. 1992. Molecular characterization of 
hasB from an operon required for hyaluronic acid synthesis in group A 
streptococci. Demonstration of UDP-glucose dehydrogenase activty. J.
Biol. Chem. 268:7118-7124.
38. Dubnau, D. 1993. Bacillus subtilis and other Gram-positive bacteria. Am. 
Soc. Microbiol., Washington, D.C.
39. Duran-Reynals, F. 1942. Tissue permeability and spreading factors in 
infection. Bacteriol. Rev. 6:197-252.
40. Emilsson, V., and C. G. Kurland. 1999. Growth rate dependence of 
global amino acid composition. Biochim. Biophys. Acta. 1050:248-251.
41. Estrada, M. P., L. Hernandez, A. Perez, P. Rodriguez, R. Serrano, R. 
Rubiera, A. Pedraza, G. Padron, W. Antuch, and J. de la Fuente. 1992. 
High level expression of streptokinase in Escherichia coli. Biotechnology 
(NY) 10:1138-1142.
42. Faber, V., and K. Rosendal. 1954. Streptococcal hyaluronidase. II. 
Studies on the production of hyaluronidase and hyaluronic acid by 
representatives of all types of hemolytic streptococci belonging to group A. 
Acta Pathol. Microbiol. Scand. 35:159-164.
43. Farrell, A. ML, D. Taylor, and K. T. Holland. 1995. Cloning, nucleotide 
sequence determination and expression of the Staphylococcus aureus 
hyaluronate lyase gene. FEMS Microbiol. Lett. 130:81-85.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
137
44. Fast, D. J., P. M. Schlievert, and R. D. Nelson. 1989. Toxic shock 
syndrome-associated staphylococcal and streptococcal pyrogenic toxins 
are potent inducers of tumor necrosis factor production. Infect. Immun. 
57:291-294.
45. Federle, M. J., K. Mclver, and J. R. Scott. 1999. A response regulator 
that represses transcription of several virulence operons in the group A 
streptococcus. J. Bacteriol. 181:3649-3657.
46. Ferretti, J. J., W. M. McShan, D. Ajdic, D. J. Savic, G. Savic, K. Lyon,
C. Primeaux, S. Sezate, A. N. Suvorov, S. Kenton, H. S. Lai, S. P. Lin, 
Y. Qian, H. G. Jia, F. Z. Najar, Q. Ren, H. Zhu, L. Song, J. White, X. 
Yuan, S. W. Clifton, B. A. Roe, and R. McLaughlin. 2001. Complete 
genome sequence of an M1 strain of Streptococcus pyogenes. Proc. Natl. 
Acad. Sci. U. S. A. 98:4658-4663.
47. Firshein, W., and W. Braun. 1964. Inhibitors of preferentially stimulated 
deoxyribonucleic acid synthesis in pneumococci. J. Bacteriol. 87:1245- 
1246.
48. Fischetti, V. A. 1991. Streptococcal M protein. Sci. Am. 264:58-65.
49. Fogg, G. C., and M. G. Caparon. 1997. Constitutive expression of 
fibronectin binding in Streptococcus pyogenes as a result of anaerobic 
activation of rofA. J. Bacteriol. 179:6172-6180.
50. Fogg, G. C., C. M. Gibson, and M. G. Caparon. 1994. The identification 
of rofA, a positive regulatory component of prtF expression: use of an y8p- 
based shuttle mutagenesis strategy in Streptococcus pyogenes. Mol. 
Microbiol. 11:671-684.
51. Foley, S. M. J., and W. B. Wood. 1959. Studies of the pathogenicity of 
group A streptococci. II. The antiphagocytic effects of the M protein and 
its capsular gel. J. Exp. Med. 110:617-628.
52. Gase, K., J. Ozegowski, and H. Malke. 1998. The Streptococcus 
agalactiae hylB gene encoding hyaluronate lyase: completion of the 
sequence and expression analysis. Biochim. Biophys. Acta. 1398:86-98.
53. Gerhardt, P., R. G. E. Murray, W. A. Wood, and N. R. Krieg (ed.). 1994. 
Methods for general and molecular bacteriology. Am. Soc. Microbiol., 
Washington, D. C.
54. Giedd, J. f t ,  J. L. Rapoport, M. A. Garvey, S. Perlmutter, and S. E. 
Swedo. 2000. MRI assessment of children with obsessive-compulsive 
disorder or tics associated with streptococcal infection. Am. J. Psychiatry 
157:281-283.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
138
55. Gilmore, R. D., Jr., M. L. Mbow, and B. Stevenson. 2001. Analysis of 
Borrelia burgdorferi gene expression during life cycle phases of the tick 
vector Ixodes scapularis. Microbes Infect. 3:799-808.
56. Ginsburg, 1.1972. Mechanisms of cell and tissue injury induced by group 
A streptococci: relation to poststreptococal sequelae. J. Infect. Dis. 
126:294-340.
57. Ginsburg, 1.1970. Streptolysin S, p. 99-171. In T. C. Montie, S. Kadis, and
S. Ajl (ed.), Microbial toxins, vol. 3. Academic Press, New York.
58. Graham, M. R., L. M. Smoot, C. A. Migliaccio, K. Virtaneva, D. E. 
Sturdevant, S. F. Porcella, M. J. Federle, G. J. Adams, J. R. Scott, and 
J. Musser. 2002. Virulence control in group A streptococcus by a two- 
component gene regulatory system: global expression profiling and in vivo 
infection modeling. Proc. Natl. Acad. Sci. U. S. A. 99:13855-13860.
59. Greiling, H., H. W. Stuhlsatz, T. Eberhard, and A. Eberhard. 1975. 
Studies on the mechanism of hyaluronate lyase action. Conn. Tissue Res. 
3:135-139.
60. Gubba, S., D. E. Low, and J. Musser. 1998. Expression and 
characterization of group A streptococcus extracellular cysteine protease 
recombinant mutant proteins and documentation of seroconversion during 
human invasive disease episodes. Infect. Immun. 66:765-770.
61. Gunther, E., J.-H. Ozegowski, and W. Kohler. 1996. Occurence of 
extracellular hyaluronic acid and hyaluronate lyase in streptococci of 
groups A, B, C, and G. Zentralbl. Bakteriol. 285:64-73.
62. Hackett, S. P., and D. L. Stevens. 1992. Streptococcal toxic shock 
syndrome: synthesis of tumor necrosis factor and interleukin-1 by 
monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J. 
Infect. Dis. 165:879-885.
63. Halperin, S. A., P. Ferrleri, E. D. Gray, E. L. Kaplan, and L. W. 
Wannamaker. 1987. Antibody response to bacteriophage hyaluronidase in 
acute glomerulonephritis after group A streptococcal infection. J. Infect.
Dis. 155:253-261.
64. Hauser, A. R., D. L. Stevens, E. Kaplan, and P. M. Schlievert. 1990. 
Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene 
and toxin relationship to streptococcal proteinase precursor. J. Bacteriol. 
172:4536-4542.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
139
65. Heath, A., V. J. DiRita, N. I .  Barg, and N. C. Engleberg. 1999. A two- 
component regulatory system, CsrR-CsrS, represses expression of three 
Streptococcus pyogenes virulence factors, hyaluronic acid capsule, 
streptolysin S, and pyrogenic exotoxin B. Infect. Immun. 67:5298-5305.
66. Hill, J. 1976. Purification and properties of streptococcal hyaluronate 
lyase. Infect. Immun. 14:726-735.
67. Hirsch, J. G., A. W. Bernherimer, and G. Weissman. 1963. Motion 
picture study of the toxic action of streptolysins on leukocytes. J. Exp. Med. 
118:223-228.
68. Hitchcock, C. H. 1924. Precipitation and complement fixation reactions 
with residue antigens in the non-hemolytic streptococcus group. J. Exper. 
Med. 40:575-581.
69. Hoch, J. A., and T. J. Silhavy (ed.). 1995. Two-Component Signal 
Transduction. Am. Soc. Microbiol., Washington, D.C.
70. Hotez, P., M. Cappelio, J. Hawdon, C. Beckers, and J. Sakanari. 1994. 
Hyaluronidases of the gastrointestinal invasive nematodes Ancylostoma 
caninum and Anisakis simplex: possible functions in the pathogenesis of 
human zoonoses. J. Infect. Dis. 170:918-926.
71. Hotez, P. J., S. Narasimhan, J. Haggerty, L. Milstone, V. Bhopale, G. A. 
Schad, and F. F. Richards. 1992. Hyaluronidase from infective 
Ancylostoma hookworm larvae and its possible function as a virulence in 
tissue invasion and in cutaneous larva migrans. Infect. Immun. 60:1018- 
1023.
72. Howard, J. G., and K. R. Wallace. 1953. The comparative resistance of 
rabbits, guinea pigs and mice to the lethal actions of streptolysin O and 
saponin. Br. J. Exp. Pathol. 34:181-184.
73. Huang, T.-T., H. Malke, and J. J. Ferretti. 1989. Heterogeneity of the 
streptokinase gene in group A streptococci. Infect. Immun. 57:502-506.
74. Hughes, T. R., M. J. Marton, A. Jones, C. J. Roberts, R. Stoughton, C.
D. Armour, H. A. Bennett, E. Coffey, H. Dai, Y. D. He, M. Kidd, A. M. 
King, M. Meyer, D. Slade, P. Y. Lum, S. B. Stepaniants, D. D. 
Shoemaker, D. Gachotte, K. Chakraburtty, J. Simon, M. Bard, and S.
H. Friend. 2000. Functional discovery via a compendium of expression 
profiles. Cell 102:109-126.
75. Husmann, L. K., D.-L. Yung, S. K. Hollingshead, and J. R. Scott. 1997. 
Role of putative virulence factors in Streptococcus pyogenes in mouse 
models of long-term throat colonizaton and pneumonia. Infect. Immun. 
65:1422-1430.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
140
76. Hynes, W. L., A. R. Dixon, S. Walton, and L. J. Aridgides. 2000. The 
extracellular hyaluronidase gene (hylA) of Streptococcus pyogenes. FEMS 
Microbiol. Lett. 184:109-112.
77. Hynes, W. L., and J. J. Ferretti. 1994. Assays for hyaluronidase activity. 
Methods Enzymol. 235:606-616.
78. Hynes, W. L., and J. J. Ferretti. 1989. Sequence analysis and expression 
in Escherichia coli of the hyaluronidase gene of Streptococcus pyogenes 
bacteriophage H4489A. Infect. Immun. 57:533-539.
79. Hynes, W. L., J. J. Ferretti, M. S. Gilmore, and R. A. Segarra. 1992. 
PCR amplification of streptococcal DNA using crude cell lysates. FEMS 
Microbiol. Lett. 94:139-142.
80. Hynes, W. L., L. Hancock, and J. J. Ferretti. 1995. Analysis of a second 
bacteriophage hyaluronidase gene from Streptococcus pyogenes: 
Evidence for a third hyaluronidase involved in extracellular enzymatic 
activity. Infect. Immun. 63:3015-3020.
81. Hynes, W. L., and J. R. Tagg. 1985. A simple plate assay for detection of 
group A streptococcus proteinase. J. Microbiol. Methods 4:25-31.
82. Hynes, W. L., and S. Walton. 2000. Hyaluronidases of gram-positive 
bacteria. FEMS Microbiol. Lett. 183:201-207.
83. Johnson, D. R., D. L. Stevens, and E. Kapian. 1992. Epidemiologic 
analysis of group A streptococcal serotypes associated with severe 
systemic infections, rheumatic fever, or uncomplicated pharyngitis. J.
Infect. Dis. 166:374-382.
84. Jones, D. 1978. Composition and Differentiation of the Genus 
Streptococci, p. 1-49. In F. A. a. Q. Skinner, L. B. (ed.), Streptococci. 
Academic Press, London.
85. Kaplan, E. L. 1991. The resurgence of group A streptococcal infections 
and their sequelae. Eur. J. Microbiol. Infect. Dis. 10:55 - 57.
86. Kapur, V., S. Kanjilal, M. Hamrick, L. L. Li, T. S. Whittam, S. A. Sawyer, 
and J. Musser. 1993. Cleavage of interleukin 1(3 precursor to produce 
active 1L-1 p by a conserved extracellular cysteine protease from 
Streptococcus pyogenes. Proc. Natl. Acad. Sci. U. S. A. 90:7676-7680.
87. Kapur, V., S. Topouzis, W. Majesky, L. L. Li, M. Hamrick, R. J.
Hammill, J. M. Patti, and J. Musser. 1993. A conserved Sitreptococcus 
pyogenes extracellular cysteine protease cleaves human fibronectin and 
degrades vitronectin. Microb. Pathog. 15:327-346.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
141
88. Konkel, M. E., and K. Tilly. 2000. Temperature-regulated expression of 
bacterial virulence genes. Microbes Infect. 2:157-166.
89. Kreikemeyer, B., M. Boyle, B. A. Buttaro, M. Heinemann, and A. 
Podbielkis. 2001. Group A streptococcal growth phase-associated 
virulence factor regulation by a novel operon (Fas) with homologies to two- 
component regulators requires a small RNA molecule. Mol. Microbiol. 
39:392-406.
90. Kubelka, V., F. Altmann, and L  Marz. 1995. The asparagine-linked 
carbohydrate of honeybee venom hyaluronidase. Glycocon. J. 12:77-83.
91. Lancefield, R. C. 1933. A serological differentiation of human and other 
groups of hemolytic streptococci. J. Exp. Med. 57:571-595.
92. Lange, R., C. Wagner, A. de Saizieu, N. Flint, J. Molnos, M. Stieger, P. 
Caspers, M. Kamber, W. Keck, and K. E. Am rein. 1999. Domain 
organization and molecular characterization of 13 two-component systems 
identified by genome sequencing of Streptococcus pneumoniae. Gene 
237:223-234.
93. Lathrop, W. F., E. P. Carmichael, D. G. Myles, and P. Primakoff. 1990. 
cDNA cloning reveals the molecular structure of a sperm surface protein, 
PH-20, involved in sperm-egg adhesion and the wide distribution of its 
gene among mammals. J. Cell Biol. 111:2393-2949.
94. Launay, J. M., and J. Alouf. 1979. Biochemical and ultrastructural study 
of the disruption of blood platelets by streptolysin O. Biochim. Biophys. 
Acta. 556:278-291.
95. Laurent, T. C., and J. R. E. Fraser. 1992. Hyaluronan. FASEB J. 6:2397- 
2404.
96. Lee, M. S., and D. A. Morrison. 1999. Identification of a new regulator in 
Streptococcus pneumoniae linking quorum sensing to competence for 
genetic transformation. J. Bacteriol. 181:5004-5016.
97. Levin, J., and M. R. Wessels. 1998. Identification of csrR/csrS, a genetic 
locus that regulates hyaluronic acid capsule synthesis in group A 
streptococcus. Mol. Microbiol. 30:209-219.
98. Li, S., and M. J. Jedrzejas. 2001. Hyaluronan binding and degradation by 
Streptococcus agalactiae hyaluronate lyase. J Biol Chem 276:41407- 
41416.
99. Li, S., S. J. Kelly, E. Lamani, M. Ferraroni, and M. J. Jedrzejas. 2000. 
Structural basis of hyaluronan degradation by Streptococcus pneumoniae 
hyaluronate lyase. Embo J 19:1228-1240.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
142
100. Li, Z., D. Sledjeski, B. Kreikemeyer, A. Podbielkis, and M. Boyle. 1999. 
Identification of pel, a Streptococcus pyogenes locus that affects both 
surface and secreted proteins. J. Bacteriol. 181:6019-6027.
101. Limbago, B., V. Penumalli, B. Weinrick, and J. R. Scott. 2000. Role of 
streptolysin O in a mouse model of invasive group A streptococcal disease. 
Infect. Immun. 68:6384-6390.
102. Lissemore, J. L., J. T. Jankowski, C. B. Thomas, D. P. Mascotti, and P. 
L. deHaseth. 2000. Green fluorescent protein as a quantitative reporter of 
relative promoter activity in E. coll. BioTechniques 28:82-89.
103. Lottenberg, R.» D. Minning-Wenz, and M. Boyle. 1994. Capturing host 
plasminogen: a common mechanism for invasive pathogens. Trends in 
Microbiol. 2:20-24.
104. Lukomski, S., C. A. Montgomery, J. Rurangirwa, R. S. Geske, J. P. 
Barrish, G. D. Adams, and J. M. Musser. 1999. Extracellular cysteine 
protease produced by Streptococcus pyogenes participates in the 
pathogenesis of invasive skin infection and dissemination in mice. Infect. 
Immun. 67:1779-1788.
105. Lyon, W. R., C. M. Gibson, and M. G. Caparon. 1998. A role for trigger 
factor and an Rgg-like regulator in the transcription, secretion and 
processing of the cysteine proteinase of Streptococcus pyogenes. EMBO 
17:6263-6275.
106. Malke, H., and J. J. Ferretti. 1984. Streptokinase: cloning, expression, 
and excretion by Escherichia coli. Proc.Natl.Acad. Sci. U.S.A. 81:3557- 
3561.
107. Malke, H., U. Mechold, K. Gase, and D. Gerlach. 1994. Inactivation of 
the streptokinase gene prevents Streptococcus equisimilis H46A from 
acquiring cell-associated plasmin activity in the presence of plasminogen. 
FEMS Microbiol. Lett. 116:107-112.
108. McClean, D. 1941. The capsulation of streptococci and its relation to 
diffusion factor (hyaluronidase). J. Pathol. Bacteriol. 53:13-27.
109. Mclver, K. S., A. S. Heath, B. D. Green, and J. R. Scott. 1995. Specific 
binding of the activator Mga to promoter sequences of the emm and scpA 
genes in the group A streptococcus. J. Bacteriol. 177:6619-6624.
110. Mclver, K. S., A. S. Heath, and J. R. Scott. 1995. Regulation of virulence 
by environmental signals in group A streptococci: influence of osmolarity, 
temperature, gas exchange, and iron limitation on emm transcription.
Infect. Immun. 63:4540-4542.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
143
111. Mclver, K. S., and J. R. Scott. 1997. Role of mga in growth phase
regulation of virulence genes of the group A streptococcus. J. Bacteriol. 
179:5178-5187.
112. Mclansborough, L. A., and P. P. Cleary. 1995. Insertional inactivation of 
virR in Streptococcus pyogenes M49 demonstrates that VirR functions as a 
positive regulator of ScpA, FcRA, OF, and M protein. FEMS Microbiol. Lett. 
128:45-52.
113. McLaughlin, R. E., and J. J. Ferretti. 1996. The multiple-sugar 
metabolism (msm) gene cluster of Streptococcus mutans is transcribed as 
a single operon. FEMS Microbiol. Lett. 140:261-264.
114. McShan, W. M., Y. F. Tang, and J. J. Ferretti. 1997. Bacteriophage T12 
of Streptococcus pyogenes integrates into the gene encoding a serine 
tRNA. Mol. Microbiol. 23:719-728.
115. Mechold, U., M. Cashel, K. Steiner, D. Gentry, and H. Malke. 1996. 
Functional analysis of a re!A/spoT gene homolog from Streptococcus 
equisimilis. J. Bacteriol. 178:1401-1411.
116. Mechold, U., and H. Malke. 1997. Characterization of the stringent and 
relaxed responses of Streptococcus equisimilis. J. Bacteriol. 179:2658- 
2667.
117. Moses, A. E., M. R. Wessels, K. Zalcman, S. Albert, S. Natanson- 
Yaron, T. Menes, and E. Hanski. 1997. Relative contribution of hyaluronic 
acid capsule and M protein to virulence in a mucoid strain of the group A 
Streptococcus. Infect. Immun. 65:64-71.
118. Muotiala, A., H. Seppala, P. Huovinen, and J. Vuopio-Varkila. 1997. 
Molecular comparison of group A streptococci of T1M1 serotype from 
invasive and non invasive infections in Finland. J. Infect. Dis. 175:392-399.
119. Neidhardt, F. C., J. L. Ingraham, and M. Schaechter. 1990. Physiology 
of the bacterial cell: a molecular approach. Sinauer Associates, Inc., 
Sunderland.
120. Nizet, V., B. Beall, D. J. Bast, V. Datta, L. Kilburn, D. Low, and J. C. De 
Azavedo. 2000. Genetic locus for streptolysin S production by group A 
Streptococcus. Infect. Immun. 68:4245-4254.
121. Norrby-Teglund, A., D. Newton, M. Kotb, S. E. Holm, and M. Norgren.
1994. Superantigenic properties of the group A streptococcal exotoxin 
SpeF (MF). Infect. Immun. 62:5227-5233.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
144
122. Norrby-Teglund, A., M. Norgren, S. E. Holm, U. Andersson, and J. 
Andersson. 1994. Similar cytokine induction profiles of a novel 
streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect. 
Immun. 62:3731-3738.
123. Ohya, T., and Y. Kaneko. 1970. Novel hyaluronidase from Streptomyces. 
Biochim. Biophys. Acta. 198:607-609.
124. Okada, N., R. T. Geist, and M. G. Caparon. 1993. Positive transcriptional 
control of mry regulates virulence in the group A streptococcus. Mol. 
Microbiol. 7:893-903.
125. Opdyke, J. A., J. R. Scott, and C. P. Moran. 2001. A secondary RNA 
polymerase sigma factor from Streptococcus pyogenes. Mol. Microbiol. 
42:495-502.
126. Parker, M. T. 1978. The pattern of streptococcal disease in man, p. 71-
102. In F. A. Skinner and L. B. Quesnel (ed.), Streptococci. Academic 
Press, London.
127. Perez-Casal, J., M. G. Caparon, and J. R. Scott. 1992. Introduction of the 
emm6 gene into an emm-deleted strain of Streptococcus pyogenes 
restores its ability to resist phagocytosis. Res. Microbiol. 143:549-558.
128. Perez-Casal, J., M. G. Caparon, and J. R. Scott. 1991. Mry, a trans­
acting positive regulator of the M protein gene of Streptococcus pyogenes 
with similarity to the receptor proteins of two-component regulatory 
systems. J. Bacteriol. 173:2617-2624.
129. Perez-Casal, J., N. Okada, M. G. Caparon, and J. R. Scott. 1995. Role 
of the conserved C-repeat region of the M-protein of Streptococcus 
pyogenes. Mol. Microbiol. 15:907-916.
130. Pinkney, M., V. Kapur, and J. E. Smith. 1995. Different forms of 
streptolysin O produced by Streptococcus pyogenes and by Escherichia 
coli expression recombinant toxin: cleavage by streptococcal cysteine 
protease. Infect. Immun. 63:2776-2779.
131. Podbielski, A., A. Flosdorff, and J. Weber-Heynemann. 1995. The 
group A streptococcal virR49 gene controls expression of four structural vir 
regulon genes. Infect. Immun. 63:9-20.
132. Podbielski, A., M. Woischnik, B. A. B. Leonard, and K. Schmidt. 1999. 
Characterization of nra, a global negative regulator gene in group A 
streptococci. Mol. Microbiol. 31:1051-1064.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
145
133. Podbielski, A., I. Zarges, A. Flosdorff, and J. Weber-Heynemann. 1996. 
Molecular characterization of a major serotype M49 group A streptococcal 
DNase gene (sdaD). Infect. Immun. 64:5349-5356.
134. Robbins, J. C., J. G. Spanier, S. J. Jones, W. J. Simpson, and P. P. 
Cleary. 1987. Streptococcus pyogenes type 12 M protein gene regulation 
by upstream sequences. J. Bacteriol. 169:5633-5640.
135. Rosenbach, F. J. 1884. Mikroorganismen bei den wundinfections 
krankheiten des menschen. J. F. Bergman, Weisbaden.
136. Sato, N., M. Shimada, H. Nakajima, H. Oda, and S. Kimura. 1994. 
Cloning and expression in Escherichia coli of the gene encoding the 
Proteus vulgaris chondroitin ABC lyase. App. Microbiol. Biotech. 41:39-46.
137. Schmidt, K. H., E. Gunther, and H. S. Courtney. 1996. Expression of 
both M protein and hyaluronic acid capsule by group A streptococcal 
strains results in a high virulence for chicken embryos. Med. Microbiol. 
Immun. 184:169-173.
138. Schrager, H. M., S. Alberti, C. Cywes, G. J. Dougherty, and ML R. 
Wessels. 1998. Hyaluronic acid capsui modulates M protein-mediated 
adherence and acts as a ligand for attachment of group A streptococcus to 
CD44 on human keratinocytes. J. Clin. Invest. 101:1954-1958.
139. Schrager, H. M., J. G. Rheinwald, and M. R. Wessels. 1996. Hyaluronic 
acid capsule and the role of streptococcal entry into keratinocytes in 
invasive skin infections. J. Clin. Invest. 98:1954-1958.
140. Scott, J. R., W. M. Pulliam, S. K. Hollingshead, and V. A. Fischetti.
1985. Relationship of M protein genes in group A streptococci. Proc. Natl. 
Acad. Sci. U. S. A. 82:1822-1826.
141. Sherman, J. M. 1937. The streptococci. Bacteriol. Rev. 1:3-97.
142. Simon, D., and J. J. Ferretti. 1991. Electrotransformation of 
Streptococcus pyogenes with plasmid and linear DNA. FEMS Microbiol. 
Lett. 82:219-224.
143. Simpson, W. J., D. LaPenta, C. Chen, and P. Cleary. 1990. Coregulation 
of type 12 M protein and streptococcal C5a peptidase genes in group A 
streptococci: evidence for a virulence regulon controlled by the virR locus. 
J. Bacteriol. 172:696-700.
144. Smith, L. D. S. 1979. Virulence factors of Clostridium perfringens.
Rev.Infect. Dis. 1:254-260.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
146
145. Smoot, J. C., K. D. Barbian, J. J. Van Gompel, L. M. Smoot, M. S. 
Chaussee, G. L. Sylva, D. E. Sturelevant, S. M. Ricklefs, S. F. Porcella, 
L. D. Parkins, S. B. Beres, D. S. Campbell, T. M. Smith, Q. Zhang, V. 
Kapur, J. A. Daly, L. G. Veasy, and J, M. Musser. 2002. Genome 
sequence and comparative microarray analysis of serotype M18 group A 
Streptococcus strains associated with acute rheumatic fever outbreaks. 
Proc. Natl. Acad. Sci. U. S. A. 99:4668-4673.
146. Smoot, L  M., J. C. Smoot, M. R. Graham, G. A. Somerville, D. E. 
Sturdevant, C. A. Migliaccio, G. L. Sylva, and J. M. Musser. 2001.
Global differential gene expression in response to growth temperature 
alteration in group A Streptococcus. Proc. Natl. Acad. Sci. U. S. A. 
98:10416-10421.
147. Spanier, J. G., S. J. C. Jones, and P. Cleary. 1984. Small DNA deletions 
creating avirulence in Streptococcus pyogenes. Science 225:935-938.
148. Steiner, B., S. Romero-Steiner, D. Cruce, and R. George. 1997. Cloning 
and sequencing of the hyaluronate lyase gene from Propionibacterium 
acnes. Can. J. Microbiol. 43: 315-321.
149. Steiner, K., and H. Malke. 2000. Life in protein-rich environments: the 
re/A-independent response of Streptococcus pyogenes to amino acid 
starvation. Mol. Microbiol. 38:1004-1016.
150. Steiner, K., and H. Malke. 2001. re/A-independent amino acid starvation 
response network of Streptococcus pyogenes. J. Bacteriol. 183:7354- 
7364.
151. Stevens, D. L. 1996. Invasive group A streptococcal disease. Infect. Agent 
Dis. 5:157-166.
152. Stevens, D. L. 1992. Invasive group A streptococcus infections. Clin.
Infect. Dis. 14:2-13.
153. Stockbauer, K. E., L. Magoun, M. Liu, E. H. Burns, S. Gubba, S.
Renish, X. Pan, S. Bodary, E. Baker, J. Coburn, J. Leong, and J. 
Musser. 1999. A natural variant of the cysteine protease virulence factor of 
group A streptococcus with an arginine-glycine-aspartic acid (RGD) motif 
preferentially binds human integrins avp3 and anbp3. Proc. Natl. Acad. Sci. 
U. S. A. 96:242-247.
154. Stoolmiller, A. C., and A. Dorfman. 1969. The biosynthesis of hyaluronic 
acid by Streptococcus. J. Biol. Chem. 244:236-246.
155. Takao, A. 2003. Cloning and expression of hyaluronate lyase genes from 
Streptococcus intermedius and Streptococcus constellatus subsp. 
constellatus. FEMS Microbiol Lett 219:143-150.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
147
156. Todd, E. W. 1938. The differentiation of two distinct serological varieties of 
streptolysin, streptolysin O and streptolysin S. Scand. J. Pathol. Bacteriol. 
47:423-445.
157. Trieu-Cuot, P., C. Carlier, C. Poyart-Salmeron, and P. Courvalin. 1990. 
A pair of mobilizable shuttle vectors conferring resistance to spectinomycin 
for molecular cloning in Escherichia coli and in gram-positive bacteria. 
Nucleic Acids Res. 18:4296.
158. Unnikrishnan, M., J. Cohen, and S. Sriskandan. 1999. Growth-phase- 
dependent expression of virulence factors in an M1T1 clinical isolate of 
Streptococcus pyogenes. Infect. Immun. 67:5495-5499.
159. van Wely, K. H. ML, J. Swaving, R. FreudI, and A. J. M. Driessen. 2001. 
Translocation of proteins across the cell envelope of Gram positive 
bacteria. FEMS Microbiol. Rev. 25:437-454.
160. Voyich, J. ML, D. E. Sturdevant, K. R. Braughton, S. D. Kobayashi, B. 
Lei, K. Virtaneva, D. W. Dorward, J. Musser, and F. R. DeLeo. 2003. 
Genome-wide protective response used by group A Streptococcus to evad 
destruction by human polymorphonuclear leukocytes. Proc. Natl. Acad.
Sci. U. S. A. 100:1996-2001.
161. Watanabe, N. 1976. Antihyaluronidase levels in children with rheumatic 
fever and other streptococcal infection. Jpn. Heart J. 17:580-591.
162. Watanabe, N. 1978. Significance of measurement of antihyaluronidase 
activity in rheumatic fever. Jpn. Circ. J. 42:30-32.
163. Wessels, M. R., and M. S. Bronze. 1994. Critical role of the group A 
streptococcal capsule in pharyngeal colonization and infection in mice. 
Proc. Natl. Acad. Sci. U. S. A. 91:12238-12242.
164. Wessels, M. R., A. E. Moses, J. B. Goldberg, and T. J. DiCesare. 1991. 
Hyaluronic acid capsule is a virulence factor for mucoid group A 
streptococci. Proc. Natl. Acad. Sci. U.S.A. 88:8317-8321.
165. Whitnack, E., and E. H. Beachey. 1982. Antiopsonic activity of fibrinogen 
bound to M protein on the surface of group A streptococci. Mol. Microbiol. 
69:1042-1045.
166. Whitnack, E., and E. H. Beachey. 1985. Biochemical and biological 
properties of the binding of human fibrinogen to M protein in group A 
streptococci. J. Bacteriol. 164:350-358.
167. Woischnik, M., B. A. Buttaro, and A. Podbielkis. 2000. Inactivation of 
the cysteine protease SpeB affects hyaluronic acid capsule expression in 
group A streptococci. Microb. Pathog. 28:221-226.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
148
APPENDIX I 
MATERIALS AND EQUIPMENT
Materials and equipment used are listed under the respective manufacturers.
1. Fisher Scientific. New Jersey.
i. Yeast Extract
ii. Agarose Low EEO, Electrophoresis Grade
iii. Agar, Granulated Solidifying Agent
iv. Sodium Chloride, Enzyme Grade
v. Tris Crystallized Free Base, Molecular Biology Grade
vi. Sodium Phosphate, Dibasic, Anhydrous, Enzyme Grade
vii. Sodium Phosphate, Monobasic, Anhydrous, Enzyme Grade
viii. Sodium Citrate, Enzyme Grade
ix. Sodium Hydroxide, Molecular Biology Grade
x. Sodium Acetate, Anhydrous, Enzyme Grade
xi. 3-(N-Morpholino) Propane-Sulfonic Acid (MOPS), Enzyme 
Grade
xii. Magnesium Chloride (Hexahydrate), Enzyme Grade
xiii. Maleic Acid, Reagent Grade
xiv. Guanidium Thiocyanate, Molecular Biology Grade
xv. Glycine, Tissue Culture Grade
xvi. EDTA, Disodium Salt, Electrophoresis Grade
xvii. Dextrose, Anhydrous, Molecular Biology Grade
xviii. Boric Acid, Electrophoresis Grade
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xix. Sarkosyl, Molecular Biology Grade
XX. Bovine Serum Albumin (Fract V), Biotechnology Grade
xxi. Saturated Phenol pH 6.6 ± 0.2, Biotechnology Grade
XX! i. Saturated Phenol pH 4.3 ± 0.2, Biotechnology Grade
xxiii. Tween®20, Enzyme Grade
xxiv. Ethidium Bromide, Electrophoresis Grade
XXV. 2-Mercaptoethanol, Electrophoresis Grade
xxvi. 2-Propanol, Certified ACS
xxvii. Chloroform, Molecular Biology Grade
xxviii. Iso-Amyl Alcohol, Biotechnology Research Grade
xxix. Light Mineral Oil (Paraffin Oil, Light)
XXX. Reagent Alcohol, Anhydrous Ethyl Alcohol
xxxi. Potassium Phosphate, Monobasic, Enzyme Grade
xxxii. Potassium Chloride, Enzyme Grade
xxxiii. Ammonium Acetate, Enzyme Grade
xxxiv. Diothiothreitol (DTT), Molecular Biology Grade
Siqma, Missouri
i. Hyaluronic Acid (from Human Umbilical Cord)
ii. Lauryl Sulfate (Sodium Dodecyl Sulfate)
iii. Erythromycin
iv. Igepal CA-630
V. Ampicillin (D (84)-a-Aminobenzylpenicillin)
vi. Fusidic Acid
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vii. Rifampin (3-[4-Methylpiperazinyl-iminomethyl]rifamycin SV)
viii. Mutanolysin (from Streptomyces globisporus ATCC 21553)
ix. Nylon Membrane, BioBond
3. Ambion, Texas
i. The RNA Storage Solution
ii. RNAseZap
4. Promeqa, Wisconsin
i. Taq DNA Polymerase in Storage Buffer B
ii. PCR Markers
iii. Improm-ll Reverse Transcription System
iv. RQI DNase
V. Wizard Plus SV Miniprep Plasmid Purification Kit
vi. pGEM-Teasy Vector System
vii. Klenow Fragment of E. coli DNA Polymerase I
5. Becton-Dickinson, Maryland
i. Bacto™ Tryptone, Pancreatic Digest of Casein
ii. Bacto™ Todd Hewitt
iii. BBL GasPak Plus Anaerobic System Envelopes with Palladium 
Catalyst
iv. BBL Dry Anaerobic Indicator Strips
v. TSA containing 5% Sheep’s Blood
6. Amresco. Ohio
i. Agarose SFR, Biotechnology Grade
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ii. Diethylpyrocarbonate (DEPC), High Purity Grade
iii. Dimethyl Sulfoxide (DMSO), ACS Grade
7. United States Biological. Massachusetts
i. Lysozyme, Chicken Egg White Muramidase, Molecular Biology 
Grade
8. MBI Fermentas. New York
i. Restriction Enzymes
ii. DNA Ligase
9. Bioline USA. Incorporated. New Jersey
i. Bioline Half-Dye™ Buffer
10. Invitroqen. California
i. pCR 2.1 Vector System
11. Roche. Germany
i. DIG DNA Labeling and Detection Kit
12. Applied Biosvstems. California
i. ABl PRISM Template Suppression Reagent
ii. Big Dye™ Terminator v3.0 Cycle Sequencing Ready Reaction
iii. ABl PRISM 310 Genetic Analyzer
13. Cepheid, California
i. Smart Cycler™ System
14. The Virtis Company. New York
i. Virsonic Cell Disrupter
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15. Sequoia-Turner Corporation. California
i. Model 690 Spectrophotometer
16. Eppendorf, Germany
i. Eppendorf Biophotometer
17. BTX. California
i. BTX Transporator™ Plus
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APPENDIX II 
S. PYOGENES STRAINS USED IN THIS STUDY
Strain M(T)-type Disease Hyaluronate lyase
_______________________________________________________________activity
7 T-11 Negative
39 PT2841 Positive
51 22 Scarlet Fever Positive
58 T8/25 Scarlet Fever Negative
61 4 Scarlet Fever Positive
73 T4/49 Scarlet Fever Positive
99 T2/28 Negative
114 3 Positive
125 78 Negative
163 Positive
170 Negative
175 Negative
199 3 Scarlet Fever Positive
203 T8/25 Scarlet Fever Negative
208 T2 Scarlet Fever Negative
209 6 Scarlet Fever Negative
210 T3/13 Scarlet Fever Positive
218 1 Scarlet Fever Negative
220 T12/B3264 Scarlet Fever Positive
227 1 Negative
250 T3 Carrier Positive
258 8 Nasopharyngitis Negative
260 60 Nephritis Positive
264 49 Acute Glomerulonephritis Negative
275 1 Scarlet Fever Negative
287 1 Tonsilitis Negative
300 T4/28 Acute Glomerulonephritis Positive
302 ulcerative Negative
307 abscess Positive
315 p. anricular abscess Negative
322 Empyema Positive
329 Impetigo Positive
335 Acute Glomerulonephritis Negative
350 Scarlet Fever Negative
364 5 Cellulitis Positive
SF370 1 Wound Infection Negative
380 3 Scarlet Fever Positive
389 Scarlet Fever Positive
402 18 Acute Rheumatic Fever Negative
410 T4/28 Scarlet Fever Positive
422 T3/B3264 Scarlet Fever Positive
430 T4/28 Positive
440 T9 Negative
448 T22 Positive
451 1 Acute Rheumatic Fever Negative
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APPENDIX II. CONTINUED.
Strain M(T)-type Disease Hyaluronate lyase
 ___________ •___________     activity
462 30 Scarlet Fever/Acute Rheumatic Fever Negative
470 Acute Rheumatic Fever Negative
478 Acute Rheumatic Fever Negative
486 Acute Rheumatic Fever Positive
499 Negative
505 Rheumatoid Infection Negative
519 T11/12 Negative
530 T11/12 Negative
537 Negative
545 T1 Negative
552 Negative
561 Positive
573 31 Septicemia Positive
576 12 Septicemia/tonsilitis Negative
581 T12 Septicemia Negative
585 4 Bacteremia Positive
593 Negative
600 T22 Negative
606 Negative
625 12 Negative
629 Positive
638 1 Negative
650 T4 Positive
670 T3/13/B Negative
675 Negative
695 Col type I Necrotizing fasciitis Negative
696 Col type II Necrotizing fasciitis Negative
703 Rheumatic Fever Positive
704 1 Rheumatic Fever Positive
709 Rheumatic Fever Positive
714 1 Severe Invasive Negative
722 1 Severe Invasive Negative
740 1 Negative
745 Negative
749 1 Pharyngits Negative
759 12 Acute Post-streptococcal Glomerulonephritis Negative
760 56 Acute Glomerulonephritis Positive
772 9 Negative
775 14 Negative
777 17 Negative
785 28 Negative
788 32 Negative
793 36 Positive
795 39 Negative
801 49 Positive
805 53 Negative
808 55 Negative
811 57 Positive
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APPENDIX II. CONTINUED.
Strain M(T)-type Disease Hyaluronate lyase 
activity
817 60 Positive
821 66 Positive
825 47 Negative
835 49 Skin Infection Positive
845 1 Toxic Shock-like Syndrome Negative
850 1 Toxic Shock-like Syndrome Negative
862 1 Blood Negative
863 1 Necrotizing fasciitis Negative
864 T28 Blood Negative
869 Negative
871 Blood Positive
872 Wound Negative
875 Toxic Shock-like Syndrome Negative
879 Toxic Shock-like Syndrome Negative
880 Toxic Shock-like Syndrome Negative
909 Negative
922 Negative
944 Positive
950 Positive
960 Positive
972 Positive
979 Positive
1007 Negative
1013 Foot Negative
1020 Throat Positive
1025 Lung Negative
1030 Blood Negative
1045 Blood Positive
1055 Blood Positive
1059 Hand Negative
1074 Throat Positive
1080 Positive
1084 Positive
10403 22 Throat Positive
13218 Negative
74-755 49 Negative
77-588 49 Negative
80-003 49 Negative
81-071 49 Negative
81-081 49 Negative
81-185 49 Positive
84-404 49 Positive
85-069 49 Negative
86-715 49 Negative
869A Negative
869B Negative
87-263 49 Negative
87-300 49 Positive
90-025 49 Negative
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APPENDIX II. CONTINUED.
Strain M(T)-type Disease Hyaluronate lyase
 __________________________________________________________ activity
90-131 49 Negat ve
90-195 49 Negat ve
90-214 49 Negat ve
90-223 49 Negat ve
90-225 49 Negat ve
92-362- Negat ve
0637
93-B15539 Negative
94-146 Negative
94-163- Positive
1367
94-175- Positive
1578
94-321- Negative
1885
95-10369 Positive
95-10497 Negative
95-12682 Negative
95-12725 Negative
95-17664 Positive
95-279- Negative
3671
95-30375 Positive
95-4383 Positive
96-05396 Negative
96-012- Negative
3884
96-070- Negative
0918
96-096- Negative
2862
96-241- Negative
3401-2
97-087- Negative
1138
BL-46- Negative
02469
CGH-97-1 Pos tive
GT6266 49 Pos tive
GT6267 49 Pos tive
GT6479 49 Pos tive
GT8760 49 Pos tive
GT9538 49 Pos tive
71698 28 Negative
FF22 52 Negative
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APPENDIX III
COMPARISON BETWEEN STRAINS: MEAN RAW ABUNDANCE VALUES
Strain Time Extraction Mean hylA 
abundance value*
Mean gyrA 
abundance value*
10403 0 1 0.243 1.34
10403 0 2 0.067 0.452
10403 2 1 . 0.027 0.36
10403 2 2 0.0355 0.325
10403 4 1 1.78 3.879
10403 4 2 0.019 0.459
10403 4 3 0.043 0.238
10403 6 1 0.209 10.473
10403 6 2 0.011 0.873
10403 8 1 0.003 1.627
10403 8 2 0.006 1.04
10403 10 1 0.045 0.18
10403 10 2 0.02 0.141
10403 12 1 0.645 2.546
10403 12 2 0.293 1.03
10403 14 1 0.156 0.79
10403 14 2 0.394 1.125
10403 14 3 0.029 0.089
10403 16 1 0.065 0.022
10403 16 2 0.0085 0.021
10403 18 1 0.389 0.694
10403 18 2 0.44 1.79
SF370 0 1 0.056 0.6
SF370 0 2 0.05 0.578
SF370 2 1 5.51 43
SF370 2 2 0.063 0.278
SF370 2 3 0.055 0.206
SF370 4 1 0.673 15.13
SF370 4 2 0.026 0.5
SF370 4 3 0.144 0.81
SF370 6 1 6.48 9.13
SF370 6 2 0.096 0.829
SF370 6 3 0.08 0.232
SF370 8 1 0.013 0.144
SF370 8 2 0.011 0.321
SF370 8 3 0.017 0.123
SF370 18 1 0.017 0.2
SF370 18 2 0.008 0.029
SF370 18 3 0.0035 0.047
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APPENDIX III. CONTINUED.
Strain Time Extraction Mean hylA 
abundance value*
Mean gyrA 
abundance value*
71698 0 1 0.215 0.449
71698 0 2 0.525 0.509
71698 2 1 0.643 1.034
71698 2 2 0.024 0.056
71698 4 1 0.341 0.452
71698 4 2 0.033 0.044
71698 6 1 0.023 0.025
71698 6 2 0.012 0.034
71698 8 1 0.025 0.085
71698 8 2 0.009 0.041
71698 18 1 0.084 0.221
71698 18 2 0.086 0.278
^Represents the mean raw abundance value from triplicate real-time 
analyses.
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APPENDIX IV 
EFFECT OF ENVIRONMENTAL CONDITIONS ON 
MEAN RAW ABUNDANCE VALUES
Treatment Extraction Mean hylk 
abundance value*
Mean gyrA 
abundance value*
32C 1 0.498 3.452
32C 2 0.189 2.216
32C 3 0.17 0.68
37C 1 0.25 0.656
37C 2 0.202 1.24
37C 3 0.187 0.486
42C 1 1.1175 10.93
42C 2 0.139 0.695
42C 3 0.193 0.828
Aerobic 1 0.25 0.656
Aerobic 2 0.202 1.24
Aerobic 3 0.187 0.486
Increased C02 1 0.147 0.411
Increased C02 2 0.791 1.938
Anaerobic 1 0.316 0.911
Anaerobic 2 0.043 0.124
With Gaseous 1 0.016 0.145
Exchange
With Gaseous 2 0.277 1.13
Exchange
pH5.0 1 0.09 0.6
pH5.0 2 0.009 0.106
pHS.O 3 0.007 0.054
pH7.4 1 0.661 2.667
pH7.4 2 0.412 2.243
pH7.6 1 0.232 0.877
pH7.6 2 0.25 0.656
pH7.6 3 0.187 0.486
With Hyaluronic Acid 0 1 0.002 0.0425
With Hyaluronic Acid 0 2 0.62 0.407
With Hyaluronic Acid 2 1 0.022 0.0533
With Hyaluronic Acid 2 2 0.055 0.3
With Hyaluronic Acid 4 1 0.155 0.441
With Hyaluronic Acid 4 2 0.185 0.28
‘ Represents the mean raw abundance value from triplicate real-time 
analyses.
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APPENDIX V
S. PYOGENES STRAINS HAVING SIZE VARIABILITY IN THE 3’ REGION OF 
THE HYALURONATE LYASE GENE REGION AS 
COMPARED TO STRAIN 10403
Strain M(T)-type Disease Hyaluronate lyase 
activity
7 T-11 Negative
58 T8/25 Scarlet Fever Negative
114 3 Positive
250 T3 Carrier Positive
350* Scarlet Fever Negative
364 5 Cellulitis Positive
380 3 Scarlet Fever Positive
389 Scarlet Fever Positive
422* T3/B3264 Scarlet Fever Positive
440 T9 Negative
462 30 Scarlet Fever/Acute 
Rheumatic Fever
Negative
561 Positive
600 T22 Negative
703 Rheumatic Fever Positive
777 17 Negative
788 32 Negative
795 39 Negative
871 Blood Positive
872* Wound Negative
880 Toxic Shock-like 
Syndrome
Negative
944 Positive
1013 Foot Negative
1020* Throat Positive
1045 Blood Positive
1055* Blood Positive
1074 Throat Positive
869A Negative
869B Negative
19617 Tissue Positive
92-362-0637 Negative
94-146* Negative
95-4383 Positive
CGH-97-1 Positive
indicates strains in which the 3’ region of the hylA gene 
was sequenced (Appendix VI)
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APPENDIX VI
SEQUENCES FOR THE 3’ REGION OF THE HYALURONATE LYASE GENE 
REGION FROM STRAINS USED IN SPECIFIC AIM 2
Strain 350 3’ region of hyaluronate lyase
1 CAAAAGTACCCTTACT GTT CTTAT GTTAACAATCAACCCGTT G ACTT GAA 
51 T AAT C AG CT AGTT G ATTTT ACAAACACTAA AAGT ATTTT CCTT G AAAGT G 
101 AT GAT CCCGCT C AAAATATT G GTTACTACTT CTT C AAG CCAAC AAC ACTT 
151 AGCAT AAGTAAGGCACTT CAAACAGGGAAAT GGCAAAACATAAAAGCT G A 
201 T G ACAAAT CACCAG AAGCCAT CAAAGAAGTTT CAAAT ACCTTT AT CACT A 
251 T CAT GCAAAACCATACT CAAGATGGCGATCGTTAT GCCT ATAT G ATGCTT 
301 CCAAATAT G ACT CGT CAAGAATTT G AAACCT ATATTAGCAAGCTT GATAT 
351 C G ACTT GTTAG AAAAC AAT G CT CTTAACTCT CATAAAATT CCC C AG AAAA 
401 G ACAACG ACG CTTACCG CATACTGGGTAT CAGT CCT CCT CTTT AG AATT C 
451 TT AGGT GG AGCTTTAGTTGCTT CTTTTAACCATAT CACAAAACCCTTTCG 
501 TAAG AAAG ACTTAAG G ATTT AG CTGTTATT G G AAAGT AAGGGTTAACAAT 
551 GAAACGTTATT AAAGACAAAAAACT GGAAACTGCACT GAGCCCCAAAAGT 
601 TG G CTACT CTATTT G AAGTAAAG G ATTTAGTTCTGTATT GTAG AGG ACT A 
651 AGTCCTTTTCGTTTTATTTTGATACGGTTATTGGTGCAATAATCGATGAT 
701 AAT AGT AGGT AG AACG AGT C ACTTT AGCCGT CCTT AAAAG AAAAT CT AAT 
751 CAG ACT CGT CTTT GT CC ATT CTTTAT AAT G GTTTTTT GT CTT CTT CTTTT 
801 CAGAGATGC
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APPENDIX VI. CONTINUED.
Strain 422 3’region of the hyaluronate lyase gene region
1 CAAAAGTACCCTTACT GTT CTTAT GTT AACAAT CAACCCGTT G ACTT GAA 
51 TAAT CAGCTAGTT GATTTTACAAACACT AAAAGT ATTTT CCTTG AAAGT G 
101 AT GATCGCGCT CAAAATATTGGTTACT ACTT CTT CAAGCCAACAACACTT 
151 AGCATAAGTAAGGCACTTCAAACAGGGAAATGGCAAAACATAAAAGCTGA 
201 TGACAMT CACCAG AAGCCAT CAAAGAAGTTT CAAATACCTTT ATC ACTA 
251 T CAT GCAAAACCAT AGT CAAGATGGCG ATCGTTATGCCTAT AT GATGCTT 
301 CCAAAT AT G ACT CGT CAAGAATTT GAAACCT AT ATT AGCAAGCTT GAT AT 
351 CGACTT GTTAG AAAACAATGCT CTTAACT CT CAT AAAATT CCCCACAAAA 
401 G ACAACG ACG CTTACCG C ATACTG GGTAT G AGT CCTCCT CTTTAG AATT C 
451 TT AGGT GG AGCTTT AGTTGCTTCTTTT AACCATAT CACAAAACCCTTT CG 
501 T AAGAAAG ACTT AAGGATTTAGCT GTTATTGGAAAGTAAGGGTTAACAAT 
551 GAAACGTTATTAAAGACAAAAAACTGGGAACTGCACTGAGCCCCAAAAGT 
601 TG GCTACT CT ATTT G AAGTAAAGG ATTTAGTT CT GTATT GT AG AGG ACTA 
651 AGT CCTTTT CGTTTT ATTTT GAT ACGGTT ATT GGTGCAAT AAT CG AT GAT 
701 AATAGT AGGTAGAACGAGT CACTTT AGCCGT CCTT AAAAG AAAAT CT AAT
801 CAGAGATGC
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APPENDIX VI. CONTINUED.
Strain 872 3’region of the hyaluronate lyase gene region
1 CAAAAGTACCCTTACT GTT CTT AT GTT AACAAT CAACCCGTT G ACTT GAA 
51 TAAT CAG CTAGTT G ATTTT AC AAACACTAAAAGT ATTTTCCTT G AAAGT G 
101 AT GAT CCCGCT CAAAATATTGGTT ACTACTT CTT CAAGCCAACAACACTT 
151 AG CATAAGTAAGG CACTT CAAACAG GG AAATGGC AAAAC ATAAAAG CT G A 
201 T G ACAAAT CACC AG AAG CCAT CAAAG AAGTTT CAAATACCTTT AT CACT A 
251 T CAT GC AAAACCAT ACT CAAG AT GGCG AT CGTT ATG CCT AT AT GAT GCTT 
301 CCAAATATGACTCGTCAAGAATTTGAAACCTATATTAGCAAGCTTGATAT 
351 CGACTTGTT AGAAAACAAT GCTCTTAACT CTCATAAAATT CCCCACAAAA 
401 G ACAACGACGCTT ACCGCATACT GGGTAT CAGTCCTCCT CTTT AG AATT C 
451 TTAGGT G G AG CTTTAGTT G CTT CTTTT AACCATAT C AC AAAACCCTTTCG 
501 T AAGAAAGACTTAAGGATTTAGCT GTT ATT GG AAAGT AAGGGTTAACAAT 
551 GAAACGTTATTAAAGACAAAAAACTGGAAACTGCACTGAGCCCCAAAAGT 
601 TG G CTACT CT ATTT G AAGTAAAG G ATTTAGTTCTGTATT GTAGAGGACTA 
651 AGT CCTTTT CGTTTT ATTTT GAT ACGGTTATTGGTGCAAT AAT CG AT GAT 
701 AATAGTAGGTAG AACG AGT CACTTTAG CC GT CCTT AAAAG AAAAT CT AAT 
751 CAG ACT CGT CTTT GT CCATT CTTTAT AAT GGTTTTTT GT CTT CTT CTTTT 
801 CAGAGATGC
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APPENDIX VI. CONTINUED.
Strain 1020 3’region of the hyaluronate lyase gene region
1 CAAAAGTACCCTT ACT GTT CTTAT GTTAACAAT CAACCCGTT GACTT GAA 
51 TAAT CAG CTAGTT G ATTTTACAAACACTAAAAGTATTTT CCTT G AAAGT G 
101 AT GAT CCCGCT CAAAAT ATTGGTT ACT ACTT CTT CAAGCCAACAACACTT 
151 AGCATAAGTAAGGCACTT CAAACAG G G AAAT G GC AAAAC ATAAAAG CTG A 
201 TGACAAAT CACC AG AAGCCAT CAAAGAAGTTT CAAAT ACCTTT AT CACT A 
251 T CAT GCAAAACCATACT CAAGATGGCGAT CGTTAT GCCT AT AT G ATGCTT 
301 CCAAATAT G ACT CGT CAAGAATTT GAAACCTATATTAGCAAGCTT GAT AT 
351 CG ACTT GTTAG AAAACAAT G CT CTTAACT CT CATAAAATT CCCCAC AAAA 
401 GACAACG ACGCTTACCGCATACTGGGTAT CAGT CCT CCT CTTTAG AATT C 
451 TT AGGT GGAGCTTT AGTT GCTTCTTTT AACCAT AT CACAAAACCCTTT CG 
501 TAAGAAAG ACTT AAGG ATTT AGCT GTT ATT GGAAAGT AAGGGTT AACAAT 
551 GAAACGTTATTAAAGACAAAAAACTGGAAACTGCACTGAGCCCCAAAAGT 
601 TG G CTACT CTATTT G AAGTAAAG G ATTT AGTT CTGT ATT GT AG AG G ACTA 
651 AGTCCTTTTCGTTTTATTTTGATACGGTTATTGGTGCAATAATCGATGAT 
701 AATAGTAGGTAGAACGAGT CACTTTAGCCGT CCTT AAAAG AAAAT CT AAT 
751 CAG ACT CGT CTTT GT CCATT CTTTATAATGGTTTTTT GT CTT CTT CTTTT 
801 CAGAGATGC
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APPENDIX VI. CONTINUED.
Strain 1055 3’region of the hyaluronate lyase gene region
1 CAAAAGTACCCTTACT GTT CTT AT GTT AACAAT CAACCCGTT GACTT GAA 
51 TAAT CAG CTAGTT G ATTTTAC AAAC ACTAAAAGTATTTT CCTT G AAAGT G 
101 AT GAT CCCGCT CAAAAT ATTGGTTACTACTT CTT CAAGCCAACAAGACTT 
151 AGCATAAGTAAGGCACTTCAAACAGGGAAATGGCAAAACATAAAAGCTGA 
201 T G ACAAAT CACCAGAAGCCATCAAAGAAGTTT CAAAT ACCTTTAT CACT A 
251 T CATGCAAAACCATACT CAAG AT GGCGAT CGTTATGCCT ATAT GAT ACTT 
301 CCAAATAT GACT CGT CAAG AATTTG AAACCTATATT AGCAAGCTT G ATAT 
351 CG ACTT GTTAG AAAACAAT G CT CTTAACT CT CAT AAAATT CCCC AGAAAA 
401 GACAACG ACGCTT ACCGCAT ACT GGGT AT CAGTCCT CCT CTTT AGAATT C 
451 TT AG GTGG AG CTTT AGTT GCTT CTTTT AACC AT AT CACAAAACCCTTT CG 
501 TAAG AAAG ACTT AAG G ATTT AG CT GTTATT GG AAAGT AAG G GTTAACAAT 
551 GAAACGCTATT AAAGACAAAAAACTGG AAACT GCACT GAGCCCCAAAAGT 
601 TGG CTACT CTATTT G AAGTAAAG G ATTT AGTT CT GT ATT GTAGAGG ACTA 
651 AGT CCTTTT CGTTTTATTTT GAT ACGGTT ATT GGTGCAATAAT CG AT GAT 
701 AAT AGT AGGT AGAACG AGT CACTTT AGCCGT CCTT AAAAG AAAAT CT AAT 
751 CAG ACT CGT CTTT GT CCATT CTTTAT AAT G GTTTTTT GT CTT CTT CTTTT 
801 CAGAGATGC
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APPENDIX VI. CONTINUED.
Strain 94146 3’region of the hyaluronate lyase gene region
1 CAAAAGTACCCTT ACT GTT CTTAT GTT AACAAT CAACCCGTT G ACTT G AA 
51 TAAT CAG CTAGTT G ATTTT ACAAAC ACTAAAAGT ATTTT CCTT G AAAGT G 
101 AT GAT CCCGCT CAAAATATTGGTTACTACTT CTT CAAGCCAACAACACTT 
151 AG CATAAGTAAGGCACTT CAAACAG G G AAAT G G C AAAAC ATAAAAG CTG A 
201 T GACAAAT CACCAGAAGCCAT CAAAGAAGTTT CAAAT ACCTTT AT CACT A 
251 T CAT GCAAAACCATACT CAAG ATGGCG AT CGTTATGCCT AT AT GAT GCTT 
301 CC AAATAT G ACT CGT CAAG AATTT G AAACCT ATATT AG CAAG CTT GATAT 
351 CG ACTT GTT AGAAAACAAT GCT CTTAACT CT CATAAAATT CCCCACAAAA 
401 GACAACGACGCTT ACCGCAT ACT GGGTAT CAGT CCT CCT CTTTAG AATT C 
451 TTAGGTGGAGCTTTAGTTGCTT CTTTT AACCAT AT CACAAAACCCTTT CG 
501 T AAG AAAG ACTT AAG G ATTTAG GTGTT ATT G G AAAGT AAG G GTTAACAAT 
551 G AAACGTTATT AAAGACAAAAAACTGG AAACT GCACT GAGCCCCAAAAGT 
601 TGGCTACTCT ATTT G AAGT AAAG G ATTT AGTTCTGT ATT GTAGAGGACTA 
651 AGT CCTTTT CGTTTTATTTT GATACGGTT ATT GGTGCAATAAT CGAT GAT 
701 AAT AGTAGGT AG AACGAGT CACTTT AGCCGT CCTT AAAAG AAAAT CT AAT 
751 CAGACT CGT CTTT GT CCATT CTTTATAATGGTTTTTT GTCTT CTT CTTTT 
801 CAGAGATGC
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APPENDIX VI. CONTINUED.
Strain 10403 3’region of the hyaluronate lyase gene region
1 CAAAAGTACCCTTACT GTT CTTAT GTTAACAAT CAACCCGTT GACTT GAA 
51 TAAT CAG CT AGTT G ATTTTACAAAC ACT AAAAGTATTTT CCTT G AAAGT G 
101 AT GAT CCCGCT CAAAAT ATTGGTTACTACTT CTT CAAGCCAACAACACTT 
151 AGCATAAGTAAGGCGCTTCAAACAGGGAAATGGCAAAACATAAAAGCTGA 
201 T G ACAAAT CACC AG AAG CCAT CAAAG AAGTTT CAG AT ACCTTT AT CACTA 
251 T CATGCAAAACCAT ACT CAAGATGGCG AT CGTTATGCCT AT AT GAT GCTT 
301 CCAAATAT G ACT CGT CAG G AATTT G AAACCTATATT AGC AAG CTT GATAT 
351 CGACTT GTTAGAAAACAAT G ACAAACTGGCCGCT GT CTACGAT CAT GAT A 
401 GT CAAC AG AT G CACGT C ATT CACT AT G AAAAAAAAG C AACG ACGTTTT CA 
451 AAT CATAAT CTTT CT CAT CAAGG CTTTTATAGTTTT CCT C ATCCT GT CAA 
501 GCAAAAT CAGCAACAAAAGTTTGCT CAT CAAGGAATTGCAGCT AAAAACA 
551 ATGCT CTT AACT CT CAT AAAATT CCCCACAAAAG ACAACG ACGCTT ACCG 
601 CGTACTG GGTATCAGTCCTCCT C ATT AG AGTT CTTAG GT GG AG CTTTAGT 
651 TG CTT CTTTT AACC ATAT C ACAAAACCCT CTCGT AAG AAAG ACTT AAGG A 
701 TTTAG CTGTT ATT G G AAAGT AGGG GTTAACAAT G AAACGTTATTAAAG AC 
751 AAAAAAG ACT G G AAACT G CACT G AGCCCCAAAAGTTGG CT ACT CTATTT G 
801 AAGT AAAGGATTT AGTT CT GTATT GT AG AGGACT AAGT CCTTTT CGTTTT 
851 ATTTT GATACGTTTATT GTTG CAAT AAT CG AT GATAAT AGTAG GT AG AAC 
901 G AGT CAAT AT AG CCGTCCTT AAAAG AAAAT CT AAT CAG AACT CGT CTTT G
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
168
CURRICULUM VITA
Sheryl Lynne Walton
314 Reflections Drive, Apt. #201 • Virginia Beach, Virginia 23452 
•sherylw@exis.net
EDUCATION________ ____________________________________________
OLD DOMINION UNIVERSITY
Department of Biological Sciences, Norfolk, Virginia 23529 
Doctor of Philosophy, May 2003 
Pure and Applied Biomedical Science
VIRGINIA WESLEYAN COLLEGE
Department of Biology, 1584 Wesleyan Drive, Norfolk, Virginia 23502 
Bachelor of Arts Degree, Biology Major, 1997
EXPERIENCE_____________ ___ _____________________ ____ _________
Old Dominion University 
Graduate Research Assistant
- Spring 2001 to present
- Develop and utilize molecular assays for the detection of Pfiesteria sp. and 
other harmful dinoflagellates in water samples
Tidewater Community College- Norfolk Campus 
Adjunct Faculty General Biology and Microbiology
- August 2000 to present
Old Dominion University 
Doctoral Teaching Assistant
- Anatomy and Physiology (Fall 1998, Spring & Summer 1999, Fall 2000)
- Molecular and Immunological Techniques (Fall 1999, Spring 2000)
- General Microbiology (Summer 2000 and 2001)
PUBLICATIONS ________ ___ ____________________ ____ _________
Hynes, Wayne L. & S. Walton. 2000. Hyaluronidases of Gram positive bacteria. 
FEMS Microbiol. Lett. 183:201-207.
Hynes, W.L, A.R. Dixon, S. Walton, and L.J. Aridgides. 2000. The extracellular 
hyaluronidase gene (hylA) of Streptococcus pyogenes. FEMS Microbiol. Lett.. 
184:109-112.
Walton, S., W. Hynes, & H. M. Marshall. 2002. The use of real-time molecular 
diagnostics for the rapid detection of the dinoflagellates Pfiesteria piscicida and 
P. shumwayae. VAJS. 53: 80.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
